Cover Page
Cover Page - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Feb. 03, 2023 | Jul. 01, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Transition Report | false | ||
Entity File Number | 001-32891 | ||
Entity Registrant Name | Hanesbrands Inc. | ||
Entity Incorporation, State or Country Code | MD | ||
Entity Tax Identification Number | 20-3552316 | ||
Entity Address, Address Line One | 1000 East Hanes Mill Road | ||
Entity Address, City or Town | Winston-Salem, | ||
Entity Address, State or Province | NC | ||
Entity Address, Postal Zip Code | 27105 | ||
City Area Code | 336 | ||
Local Phone Number | 519-8080 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Title of 12(b) Security | Common Stock, Par Value $0.01 | ||
Trading Symbol | HBI | ||
Security Exchange Name | NYSE | ||
Entity Public Float | $ 3,566,558,174 | ||
Entity Common Stock, Shares Outstanding | 349,361,517 | ||
Documents Incorporated by Reference | Part III of this Form 10-K incorporates by reference to portions of the registrant’s proxy statement for its 2023 annual meeting of stockholders. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001359841 | ||
Current Fiscal Year End Date | --12-31 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Audit Information [Abstract] | |
Auditor Name | PricewaterhouseCoopers LLP |
Auditor Firm ID | 238 |
Auditor Location | Greensboro, North Carolina |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Income Statement [Abstract] | |||||
Net sales | $ 1,473,286 | $ 1,752,349 | $ 6,233,650 | $ 6,801,240 | $ 6,127,161 |
Cost of sales | 971,309 | 1,084,621 | 4,012,542 | 4,149,541 | 4,524,461 |
Gross profit | 501,977 | 667,728 | 2,221,108 | 2,651,699 | 1,602,700 |
Selling, general and administrative expenses | 441,642 | 512,162 | 1,701,563 | 1,853,971 | 1,560,034 |
Operating profit | 60,335 | 155,566 | 519,545 | 797,728 | 42,666 |
Other expenses | 3,646 | 47,359 | 9,734 | 53,586 | 20,655 |
Interest expense, net | 49,665 | 35,307 | 157,073 | 163,067 | 164,238 |
Income (loss) from continuing operations before income tax expense | 7,024 | 72,900 | 352,738 | 581,075 | (142,227) |
Income tax expense (benefit) | 425,132 | 4,946 | 483,907 | 60,107 | (109,940) |
Income (loss) from continuing operations | (418,108) | 67,954 | (131,169) | 520,968 | (32,287) |
Income (loss) from discontinued operations, net of tax | 0 | (7,921) | 3,965 | (443,744) | (43,292) |
Net income (loss) | $ (418,108) | $ 60,033 | $ (127,204) | $ 77,224 | $ (75,579) |
Earnings (loss) per share - basic: | |||||
Continuing operations | $ (1.19) | $ 0.19 | $ (0.37) | $ 1.48 | $ (0.09) |
Discontinued operations | 0 | (0.02) | 0.01 | (1.26) | (0.12) |
Net income (loss) | (1.19) | 0.17 | (0.36) | 0.22 | (0.21) |
Earnings (loss) per share - diluted: | |||||
Continuing operations | (1.19) | 0.19 | (0.37) | 1.48 | (0.09) |
Discontinued operations | 0 | (0.02) | 0.01 | (1.26) | (0.12) |
Net income (loss) | $ (1.19) | $ 0.17 | $ (0.36) | $ 0.22 | $ (0.21) |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Consolidated Statements of Comprehensive Income [Abstract] | |||
Net income (loss) | $ (127,204) | $ 77,224 | $ (75,579) |
Other comprehensive income (loss): | |||
Translation adjustments | (94,802) | (81,181) | 104,318 |
Unrealized gain (loss) on qualifying cash flow hedges, net of tax of $(226), $(9,170), and $6,870, respectively | 3,239 | 22,612 | (24,454) |
Unrecognized income (loss) from pension and postretirement plans, net of tax of $(650), $(25,644), and $10,195, respectively | 131,158 | 73,925 | (29,175) |
Total other comprehensive income (loss) | 39,595 | 15,356 | 50,689 |
Comprehensive income (loss) | $ (87,609) | $ 92,580 | $ (24,890) |
Consolidated Statements of Co_2
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Consolidated Statements of Comprehensive Income [Abstract] | |||
Tax portion of unrealized gain (loss) on qualifying cash flow hedges | $ (226) | $ (9,170) | $ 6,870 |
Tax portion of unrecognized income (loss) from pension and postretirement plans | $ (650) | $ (25,644) | $ 10,195 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Assets | ||
Cash and cash equivalents | $ 238,413 | $ 536,277 |
Trade accounts receivable, net | 721,396 | 894,151 |
Inventories | 1,979,672 | 1,584,015 |
Other current assets | 178,946 | 186,503 |
Current assets of discontinued operations | 13,327 | 327,157 |
Total current assets | 3,131,754 | 3,528,103 |
Property, net | 442,404 | 441,401 |
Right-of-use assets | 414,894 | 363,854 |
Trademarks and other identifiable intangibles, net | 1,255,693 | 1,220,170 |
Goodwill | 1,108,907 | 1,133,095 |
Deferred tax assets | 20,162 | 327,804 |
Other noncurrent assets | 130,062 | 57,009 |
Total assets | 6,503,876 | 7,071,436 |
Liabilities and Stockholders’ Equity | ||
Accounts payable | 917,481 | 1,214,847 |
Accrued liabilities and other: | ||
Payroll and employee benefits | 85,392 | 155,859 |
Advertising and promotion | 168,717 | 241,555 |
Other | 243,919 | 263,364 |
Lease liabilities | 114,794 | 109,526 |
Accounts Receivable Securitization Facility | 209,500 | 0 |
Current portion of long-term debt | 37,500 | 25,000 |
Current liabilities of discontinued operations | 13,327 | 316,902 |
Total current liabilities | 1,790,630 | 2,327,053 |
Long-term debt | 3,612,077 | 3,326,091 |
Lease liabilities - noncurrent | 326,644 | 281,852 |
Pension and postretirement benefits | 116,167 | 248,518 |
Other noncurrent liabilities | 260,094 | 185,429 |
Total liabilities | 6,105,612 | 6,368,943 |
Stockholders’ equity: | ||
Preferred stock (50,000,000 authorized shares; $.01 par value) Issued and outstanding — None | 0 | 0 |
Common stock (2,000,000,000 authorized shares; $.01 par value) Issued and outstanding —349,009,147 and 349,903,253, respectively | 3,490 | 3,499 |
Additional paid-in capital | 334,676 | 315,337 |
Retained earnings | 572,106 | 935,260 |
Accumulated other comprehensive loss | (512,008) | (551,603) |
Total stockholders’ equity | 398,264 | 702,493 |
Total liabilities and stockholders’ equity | $ 6,503,876 | $ 7,071,436 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2022 | Jan. 01, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, shares authorized | 2,000,000,000 | 2,000,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares issued | 349,009,147 | 349,903,253 |
Common stock, shares outstanding | 349,009,147 | 349,903,253 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss |
Beginning Balance at Dec. 28, 2019 | $ 1,236,595 | $ 3,624 | $ 304,395 | $ 1,546,224 | $ (617,648) |
Beginning Balance, Shares at Dec. 28, 2019 | 362,449,000 | ||||
Net income (loss) | (75,579) | (75,579) | |||
Dividends ($0.60 per common share) | $ (213,230) | (213,230) | |||
Dividends, per common share | $ 0.60 | ||||
Other comprehensive income (loss) | $ 50,689 | 50,689 | |||
Stock-based compensation | 18,664 | 18,664 | |||
Net exercise of stock options, vesting of restricted stock units and other, shares | 817,000 | ||||
Net exercise of stock options, vesting of restricted stock units and other | (2,912) | $ 9 | (2,921) | ||
Share repurchases, shares | (14,464,000) | ||||
Share repurchases | (200,269) | $ (145) | (12,255) | (187,869) | |
Ending Balance at Jan. 02, 2021 | 813,958 | $ 3,488 | 307,883 | 1,069,546 | (566,959) |
Ending Balance, Shares at Jan. 02, 2021 | 348,802,000 | ||||
Net income (loss) | 77,224 | 77,224 | |||
Dividends ($0.60 per common share) | $ (211,510) | (211,510) | |||
Dividends, per common share | $ 0.60 | ||||
Other comprehensive income (loss) | $ 15,356 | 15,356 | |||
Stock-based compensation | 16,290 | 16,290 | |||
Net exercise of stock options, vesting of restricted stock units and other, shares | 1,101,000 | ||||
Net exercise of stock options, vesting of restricted stock units and other | (8,825) | $ 11 | (8,836) | ||
Ending Balance at Jan. 01, 2022 | $ 702,493 | $ 3,499 | 315,337 | 935,260 | (551,603) |
Ending Balance, Shares at Jan. 01, 2022 | 349,903,253 | 349,903,000 | |||
Net income (loss) | $ (127,204) | (127,204) | |||
Dividends ($0.60 per common share) | $ (212,375) | (212,375) | |||
Dividends, per common share | $ 0.60 | ||||
Other comprehensive income (loss) | $ 39,595 | 39,595 | |||
Stock-based compensation | 23,157 | 23,157 | |||
Net exercise of stock options, vesting of restricted stock units and other, shares | 683,000 | ||||
Net exercise of stock options, vesting of restricted stock units and other | (2,384) | $ 7 | (2,391) | ||
Share repurchases, shares | (1,577,000) | ||||
Share repurchases | (25,018) | $ (16) | (1,427) | (23,575) | |
Ending Balance at Dec. 31, 2022 | $ 398,264 | $ 3,490 | $ 334,676 | $ 572,106 | $ (512,008) |
Ending Balance, Shares at Dec. 31, 2022 | 349,009,147 | 349,009,000 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Jan. 02, 2021 USD ($) | |
Operating activities: | |||
Net income (loss) | $ (127,204) | $ 77,224 | $ (75,579) |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Depreciation | 76,294 | 81,669 | 95,759 |
Amortization of acquisition intangibles | 18,204 | 20,390 | 24,718 |
Other amortization | 11,769 | 12,139 | 11,969 |
Inventory write-down charges | 0 | 0 | 584,671 |
Impairment of intangible assets and goodwill | 0 | 163,047 | 45,492 |
(Gain) loss on sale of business and classification of assets held for sale | (3,162) | 312,359 | 0 |
Loss on extinguishment of debt | 0 | 43,739 | 0 |
Amortization of debt issuance costs | 7,300 | 12,305 | 11,565 |
Stock compensation expense | 23,457 | 16,630 | 18,969 |
Deferred taxes | 388,607 | 3,934 | (161,215) |
Other | 7,511 | (2,084) | 8,501 |
Changes in assets and liabilities: | |||
Accounts receivable | 154,145 | (181,173) | (6,945) |
Inventories | (437,641) | (293,455) | (136,057) |
Other assets | (107,742) | (40,636) | (1,144) |
Accounts payable | (241,557) | 368,753 | (32,641) |
Accrued pension and postretirement benefits | (2,023) | (40,768) | (18,832) |
Accrued liabilities and other | (126,760) | 69,336 | 79,238 |
Net cash from operating activities | (358,802) | 623,409 | 448,469 |
Investing activities: | |||
Capital expenditures | (112,122) | (69,272) | (53,735) |
Purchase of trademarks | 103,000 | 0 | 0 |
Proceeds from sales of assets | 157 | 2,809 | 671 |
Other | (1,463) | 14,008 | 11,982 |
Net cash from investing activities | (216,428) | (52,455) | (41,082) |
Financing activities: | |||
Borrowings on Term Loan Facilities | 0 | 1,000,000 | 0 |
Repayments on Term Loan Facilities | (25,000) | (925,000) | 0 |
Borrowings on Accounts Receivable Securitization Facility | 1,840,389 | 0 | 227,061 |
Repayments on Accounts Receivable Securitization Facility | (1,630,889) | 0 | (227,061) |
Borrowings on Revolving Loan Facilities | 1,792,000 | 0 | 1,638,000 |
Repayments on Revolving Loan Facilities | (1,439,500) | 0 | (1,756,189) |
Borrowings on Senior Notes | 0 | 0 | 700,000 |
Repayments on Senior Notes | 0 | (700,000) | 0 |
Borrowings on International Debt | 0 | 0 | 31,222 |
Repayments on International Debt | 0 | 0 | (36,383) |
Borrowings on notes payable | 21,454 | 149,287 | 234,682 |
Repayments on notes payable | (21,713) | (149,739) | (239,008) |
Share repurchases | (25,018) | 0 | (200,269) |
Cash dividends paid | (209,312) | (209,484) | (210,385) |
Payments to amend and refinance credit facilities | (3,159) | (43,186) | (15,018) |
Other | (3,423) | (9,898) | (4,483) |
Net cash from financing activities | 295,829 | (888,020) | 142,169 |
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | (42,815) | (32,908) | 31,124 |
Change in cash, cash equivalents and restricted cash | (322,216) | (349,974) | 580,680 |
Cash, cash equivalents and restricted cash at beginning of year | 560,629 | 910,603 | 329,923 |
Cash, cash equivalents and restricted cash at end of year | 238,413 | 560,629 | 910,603 |
Less restricted cash at end of year | 0 | 0 | 1,166 |
Cash and cash equivalents at end of year | 238,413 | 560,629 | 909,437 |
Balances included in the Consolidated Balance Sheets: | |||
Cash and cash equivalents | 238,413 | 536,277 | 900,615 |
Cash and cash equivalents at end of year | 238,413 | 560,629 | 909,437 |
Discontinued Operations, Held-for-sale | European Innerwear | |||
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
(Gain) loss on sale of business and classification of assets held for sale | 373 | 273,995 | 0 |
Cash and cash equivalents included in current assets held for sale | $ 0 | $ 24,352 | $ 8,822 |
Basis of Presentation
Basis of Presentation | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Basis of Presentation | Basis of Presentation Hanesbrands Inc., a Maryland corporation (the “Company”), is a consumer goods company with a portfolio of leading apparel brands, including Hanes, Champion, Bonds , Maidenform, Bali, Playtex, Bras N Things , JMS/Just My Size, Gear for Sports, Wonderbra, Berlei, Comfortwash, and Alternative. The Company designs, manufactures, sources and sells a broad range of basic apparel such as T-shirts, bras, panties, shapewear, underwear, socks and activewear. The Company’s fiscal year ends on the Saturday closest to December 31. All references to “2022”, “2021” and “2020” relate to the 52-week fiscal year ended on December 31, 2022 and January 1, 2022, and the 53-week fiscal year ended on January 2, 2021, respectively. Two subsidiaries of the Company close one day after the Company’s consolidated year end. The difference in reporting of financial information for these subsidiaries did not have a material impact on the Company’s financial condition, results of operations or cash flows. Business Strategy In late 2020, the Company undertook a comprehensive global business review focused on building consumer-centric growth. The review resulted in the Company’s Full Potential plan, which is its multi-year growth strategy that focuses on four pillars to drive growth and enhance long-term profitability and identifies the initiatives to unlock growth. The Company’s four pillars of growth are to grow the Champion brand globally, drive growth in Innerwear with brands and products that appeal to younger consumers, drive consumer-centricity by delivering innovative products and improving awareness through investments in brand marketing and digital capabilities, and streamline its global portfolio. In the fourth quarter of 2020, the Company began the implementation of its Full Potential plan and as part of its strategy to streamline its portfolio, the Company determined that its personal protective equipment (“PPE”) business was no longer a growth opportunity and recorded a charge of $362,913 to write down its entire PPE inventory balance to its estimated net realizable value and a charge of $26,400 to accrue for vendor commitments for PPE materials that were paid in 2021. Additionally, the Company commenced an initiative to reduce 20% of its SKUs in inventory in order to streamline product offerings while also implementing a formal lifecycle management process. As a result, the Company recorded a charge of $192,704 to write down inventory to its estimated net realizable value taking into account these initiatives. These initiatives will position the Company for long-term growth by driving higher margin sales, lowering costs and improving service to customers. In the first quarter of 2021, the Company announced that it reached the decision to exit its European Innerwear business as part of its strategy to streamline its portfolio under its Full Potential plan and determined that this business met held-for-sale and discontinued operations accounting criteria. Accordingly, the Company began to separately report the results of its European Innerwear business as discontinued operations in its Consolidated Statements of Income, and to present the related assets and liabilities as held for sale in the Consolidated Balance Sheets. On November 4, 2021, the Company announced that it reached an agreement to sell its European Innerwear business to an affiliate of Regent, L.P. and completed the sale on March 5, 2022. Unless otherwise noted, discussion within these notes to the consolidated financial statements relates to continuing operations. See Note “Assets and Liabilities Held for Sale” for additional information. In addition, in the fourth quarter of 2021, the Company reached the decision to divest its U.S. Sheer Hosiery business, including the L’eggs brand, as part of its strategy to streamline its portfolio under its Full Potential plan and determined that this business met held-for-sale accounting criteria, The related assets and liabilities are presented as held for sale in the Consolidated Balance Sheets at December 31, 2022 and January 1, 2022. The operations of the U.S. Sheer Hosiery business are reported in “Other” for all periods presented in Note “Business Segment Information”. The Company is currently exploring potential purchasers for this business and expects to complete the sale within the next 12 months. See Note “Assets and Liabilities Held for Sale” for additional information. Ransomware Attack As previously disclosed, on May 24, 2022, the Company identified that it had become subject to a ransomware attack and activated its incident response and business continuity plans designed to contain the incident. As part of the Company’s forensic investigation and assessment of the impact, the Company determined that certain of its information technology systems were affected by the ransomware attack. Upon discovering the incident, the Company took a series of measures to further safeguard the integrity of its information technology systems, including working with cybersecurity experts to contain the incident and implementing business continuity plans to restore and support continued operations. These measures also included resecuring data, remediation of the malware across infected machines, rebuilding critical systems, global password reset and enhanced security monitoring. The Company notified appropriate law enforcement authorities as well as certain data protection regulators, and in addition to the Company’s public announcements of the incident, the Company provided breach notifications and regulatory filings as required by applicable law starting in August 2022. At this time, the Company believes the incident has been contained, the Company has restored its critical information technology systems, and manufacturing, retail and other internal operations continue. There is no ongoing operational impact on the Company’s ability to provide its products and services. The Company maintains insurance, including coverage for cyber-attacks, subject to certain deductibles and policy limitations, in an amount that the Company believes appropriate. The Company is named in two pending lawsuits in connection with its previously disclosed ransomware incident. On October 7, 2022, a putative class action was filed against “Hanes Brands [sic], Inc.” alleging, among other things, negligence, negligence per se, breach of implied contract, unjust enrichment, breach of implied covenant of good faith and fair dealing, unfair business practices under the California Business and Professions Code, and violations of the California Confidentiality of Medical Information Act in connection with the ransomware incident. The litigation is entitled, Roman v. Hanes Brands [sic], Inc., and is pending in the United States District Court for the Central District of California. Plaintiff Roman also subsequently filed a second putative class action with regard to the ransomware incident in the United States District Court for the Middle District of North Carolina on January 16, 2023, entitled Roman v. Hanesbrands,[sic] Inc., which was voluntarily dismissed without prejudice on January 20, 2023. On October 13, 2022, another putative class action was filed against HanesBrands Inc. alleging, among other things, negligence, negligence per se, breach of implied contract, invasion of privacy, and unjust enrichment in connection with the ransomware incident. The litigation is entitled, Toussaint v. HanesBrands,[sic] Inc. and is pending in the United States District Court for the Middle District of North Carolina. The pending lawsuits seek, among other things, monetary and injunctive relief. The Company is vigorously defending these matters and believes the cases are without merit. The Company does not expect any of these claims, individually or in the aggregate, to have a material adverse effect on its consolidated financial position or results of operations. However, at this early stage in the proceedings, the Company is not able to determine the probability of the outcome of these matters or a range of reasonably expected losses, if any. The Company maintains insurance, including coverage for cyber-attacks, subject to certain deductibles and policy limitations, in an amount that the Company believes appropriate. During the year ended December 31, 2022, the Company incurred costs of $15,427, net of expected insurance recoveries, related to the ransomware attack. The costs for the year ended December 31, 2022 included $14,168 related primarily to supply chain disruptions, which are reflected in the “Cost of sales” line of the Consolidated Statements of Income and $1,259, net of expected insurance recoveries, related primarily to legal, information technology and consulting fees, which are reflected in the “Selling, general and administrative expenses” line of the Consolidated Statements of Income. The Company continues to assess the security event and cannot determine, at this time, the full extent of the impact from such event on its business, results of operations or financial condition or whether such impact will ultimately have a material adverse effect. Financing Arrangements |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies (a) Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation, except for certain intercompany sales and related profit and receivables from the Company’s supply chain to the European Innerwear business, which is classified as discontinued operations in the consolidated financial statements and was sold on March 5, 2022. See Note “Assets and Liabilities Held for Sale” for additional information. (b) Use of Estimates The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make use of estimates and assumptions that affect the reported amount of assets and liabilities, certain financial statement disclosures at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results may vary from these estimates. (c) Foreign Currency Translation Foreign currency-denominated assets and liabilities are translated into U.S. dollars at exchange rates existing at the respective balance sheet dates. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of accumulated other comprehensive loss (“AOCI”) within stockholders’ equity. The Company translates the results of operations of its foreign operations at the average exchange rates during the respective periods. Gains and losses resulting from foreign currency transactions are included in both the “Cost of sales” and “Selling, general and administrative expenses” lines in the Consolidated Statements of Income. (d) Sales Recognition and Incentives The Company recognizes revenue when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. The Company records a sales reduction for returns and allowances based upon historical return experience. The Company earns royalty revenues through license agreements with manufacturers of other consumer products that incorporate certain of the Company’s brands. The Company accrues revenue earned under these contracts based upon reported sales from the licensee. The Company offers a variety of sales incentives to resellers and consumers of its products, and the policies regarding the recognition and display of these incentives within the Consolidated Statements of Income are as follows: Discounts, Coupons, and Rebates The Company provides customers with discounts and rebates that are explicitly stated in the Company’s contracts and are recorded as a reduction of revenue in the period the product revenue is recognized. The cost of these incentives is estimated using a number of factors, including historical utilization and redemption rates. The Company includes incentives offered in the form of free products in the determination of cost of sales. For all variable consideration, where appropriate, the Company estimates the amount using the expected value, which takes into consideration historical experience, current contractual requirements, specific known market events and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates of the amount of consideration to which the customer is entitled based on the terms of the contracts. Volume-Based Incentives Volume-based incentives involve rebates or refunds of cash that are redeemable only if the customer completes a specified number of sales transactions. Under these incentive programs, the Company estimates the anticipated rebate to be paid and allocates a portion of the estimated cost of the rebate to each underlying sales transaction with the customer. The Company records volume-based incentives as a reduction of revenue. Cooperative Advertising Under cooperative advertising arrangements, the Company agrees to reimburse the retailer for a portion of the costs incurred by the retailer to advertise and promote certain of the Company’s products. The Company recognizes the cost of cooperative advertising programs in the period in which the advertising and promotional activity takes place as a reduction of revenue. Fixtures and Racks Store fixtures and racks are periodically used by resellers to display Company products. The Company expenses the cost of these fixtures and racks in the period in which they are delivered to the resellers. The Company includes the costs of fixtures and racks incurred by resellers and charged back to the Company in the determination of net sales. Fixtures and racks purchased by the Company and provided to resellers are included in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. Product Returns The Company generally offers customers a limited right of return for a purchased product. The Company estimates the amount of its product sales that may be returned by its customers and records this as a reduction of revenue in the period the related product revenue is recognized. (e) Advertising Expense Advertising represents one of several brand building methods used by the Company. Advertising costs, which include the development and production of advertising materials and the communication of these materials through various forms of media, are expensed in the period the advertising first takes place. The Company recognized advertising expense in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income of $208,881, $208,998 and $113,586 in 2022, 2021 and 2020, respectively. (f) Shipping and Handling Costs Revenue received for shipping and handling costs is included in net sales and was $13,578, $19,461 and $18,943 in 2022, 2021 and 2020, respectively. Shipping costs, which comprise payments to third-party shippers, and handling costs, which consist of warehousing costs in the Company’s various distribution facilities, were $415,989, $447,131 and $389,252 in 2022, 2021 and 2020, respectively. The Company recognizes shipping, handling and distribution costs in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. (g) Research and Development Research and development costs are expensed as incurred and are included in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. Research and development includes expenditures for new product, technological improvements for existing products and process innovation, which primarily consist of salaries, consulting and supplies attributable to time spent on research and development activities. Additional costs include depreciation and maintenance for research and development equipment and facilities. Research and development expense was $38,911, $39,320 and $37,367 in 2022, 2021 and 2020, respectively. (h) Defined Contribution Benefit Plans The Company sponsors 401(k) plans as well as other defined contribution benefit plans. Expense for these plans was $26,296, $37,979 and $34,720 in 2022, 2021 and 2020, respectively. (i) Cash and Cash Equivalents All highly liquid investments with an original maturity of three months or less at the time of purchase are considered to be cash equivalents. Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included within “Other current assets” in the Consolidated Balance Sheets. As of January 2, 2021, an indemnification escrow balance of A$1,517 (U.S. $1,166) related to the Company’s 2018 acquisition of BNT Holdco Pty Limited was held in one of the Company’s bank accounts and classified as restricted cash in the “Other current assets” line in the Consolidated Balance Sheets. This balance was paid to the sellers in the second quarter of 2021. The Company had no restricted cash as of December 31, 2022 and January 1, 2022. (j) Accounts Receivable Valuation Accounts receivable are stated at their net realizable value. The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the accounts receivable portfolio. Trade receivables are evaluated on a collection (pool) basis and aggregated on the basis of similar risk characteristics which are determined on the basis of historical losses, the aging of trade receivables, industry trends, and its customers’ financial strength, credit standing and payment and default history. (k) Inventory Valuation Inventories are stated at the estimated lower of cost or net realizable value. Cost is determined by the first-in, first-out, or “FIFO”, method for inventories. Obsolete, damaged, and excess inventory is carried at the net realizable value, which is determined by assessing historical recovery rates, current market conditions and future marketing and sales plans. Rebates, discounts and other cash consideration received from a vendor related to inventory purchases are reflected as reductions in the cost of the related inventory item and are therefore reflected in cost of sales when the related inventory item is sold. (l) Property Property is stated at historical cost and depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. Machinery and equipment is depreciated over periods ranging from one Property is tested for recoverability whenever events or changes in circumstances indicate that its carrying value may not be recoverable. Such events include significant adverse changes in the business climate, several periods of operating or cash flow losses, forecasted continuing losses or a current expectation that an asset or an asset group will be disposed of before the end of its useful life. Recoverability of property is evaluated by a comparison of the carrying amount of an asset or asset group to future net undiscounted cash flows expected to be generated by the asset or asset group. If these comparisons indicate that an asset is not recoverable, the impairment loss recognized is the amount by which the carrying amount of the asset exceeds the estimated fair value. When an impairment loss is recognized for assets to be held and used, the adjusted carrying amount of those assets is depreciated over its remaining useful life. Restoration of a previously recognized impairment loss is not permitted under GAAP. (m) Leases The Company accounts for leases under the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)”. The Company determines whether an arrangement is a lease at inception. At inception, a right of use asset and lease liability is recorded. The Company has operating leases for real estate (primarily retail stores and operating facilities) and certain equipment. The Company’s finance leases are not material. Leases with a term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The exercise of lease renewal options is at the Company’s sole discretion. In general, for leased retail real estate, the Company will not include renewal options in the underlying lease term. However, if a situation arises where the lessor has control over the option periods, then the Company will include these periods within the lease term. The depreciable life of assets and leasehold improvements are limited by the expected lease term. Certain of the Company’s lease agreements include rental payments based on a percentage of retail sales over contractual levels and others include rental payments adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. In light of temporary store closures related to the COVID-19 pandemic, the Company took actions in 2020, 2021 and 2022 with respect to certain of its existing leases, including withholding rent payments and engaging with landlords to obtain rent deferrals and other rent concessions. Consistent with updated guidance from the FASB in April 2020, the Company elected to treat agreed-upon payment deferrals that resulted in the total payments required by the modified contract being substantially the same as total payments required by the contract as if there were no modifications to the lease contract. The Company elected to treat other agreed-upon rent concessions, which resulted in reduced minimum lease payments, as variable lease payments. For any agreed-upon rent concessions, which change the payment terms from minimum rental amounts to amounts based on a percentage of sales volume, the Company elected to treat such changes as lease modifications under the current lease guidance. (n) Trademarks and Other Identifiable Intangible Assets The primary identifiable intangible assets of the Company are trademarks, licensing agreements, customer and distributor relationships and computer software. Identifiable intangible assets with finite lives are amortized and those with indefinite lives are not amortized. The estimated useful life of a finite-lived intangible asset is based upon a number of factors, including the effects of demand, competition, expected changes in distribution channels and the level of maintenance expenditures required to obtain future cash flows. Trademarks determined to have finite lives are generally amortized over periods ranging from 10 to 20 years, license agreements are generally amortized over periods ranging from three one Identifiable intangible assets that are subject to amortization are evaluated for impairment using a process similar to that used in evaluating elements of property. Identifiable intangible assets not subject to amortization are assessed for impairment at least annually, as of the first day of the third fiscal quarter, and as triggering events occur. The impairment test for identifiable intangible assets not subject to amortization consists of comparing the fair value of the intangible asset, which is determined using the income approach, to its carrying value. If the carrying value exceeds the fair value of the asset, an impairment loss is recognized in an amount equal to such excess. Fair values of intangible assets are primarily based on future cash flows projected to be generated from that asset. In performing the discounted cash flow analysis, management makes various judgments, estimates and assumptions, the most significant of which are the assumptions related to revenue growth rates, operating profit margin rates, terminal growth rates, and discount rates. Rates used to discount cash flows are dependent upon interest rates and the cost of capital at a point in time. There are inherent uncertainties related to these factors and management’s judgment in applying them to the analysis of intangible asset impairment. The Company capitalizes internal software development costs incurred during the application development stage, which include the actual costs to purchase software from vendors and generally include personnel and related costs for employees who were directly associated with the enhancement and implementation of purchased computer software. Additions to computer software are included in the “Capital expenditures” line in the Consolidated Statements of Cash Flows. (o) Goodwill Goodwill is the amount by which the purchase price exceeds the fair value of the assets acquired and liabilities assumed in a business combination. When a business combination is completed, the assets acquired and liabilities assumed are assigned to the reporting unit or units of the Company given responsibility for managing, controlling and generating returns on these assets and liabilities. In many instances, all of the acquired assets and assumed liabilities are assigned to a single reporting unit and in these cases, all of the goodwill is assigned to the same reporting unit. In those situations in which the acquired assets and liabilities are allocated to more than one reporting unit, the goodwill to be assigned to each reporting unit is determined in a manner similar to how the amount of goodwill recognized in a business combination is determined. Goodwill is not amortized; however, it is assessed for impairment at least annually, as of the first day of the third quarter, and as triggering events occur. In evaluating the recoverability of goodwill, the Company estimates the fair value of its reporting units, which is determined using the income approach, and compares it to the carrying value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to such excess. Fair values of reporting units are primarily based on future cash flows projected to be generated from that business. In performing the discounted cash flow analysis, management makes various judgments, estimates and assumptions, the most significant of which are the assumptions related to revenue growth rates, operating profit margin rates, terminal growth rates, and discount rates. Rates used to discount cash flows are dependent upon interest rates and the cost of capital at a point in time. There are inherent uncertainties related to these factors and management’s judgment in applying them to the analysis of goodwill impairment. (p) Cloud Computing Arrangements The Company’s cloud computing arrangements (“CCA”) include software licenses purchased from external vendors. Software license costs, implementation costs incurred during the application development stage and other costs meeting certain criteria are capitalized while all other costs are expensed as incurred. These assets are included in computer software in the “Trademarks and other identifiable intangibles, net” line in the Consolidated Balance Sheets and amortize on a straight-line basis over their assessed useful lives. See Note “Intangible Assets and Goodwill” for additional information. If a CCA does not include the purchase of a software license, the arrangement is accounted for as a service contract and the fees associated with the hosting service are expensed as incurred. These costs are included in prepaid assets in the “Other current assets” line in the Consolidated Balance Sheets. Implementation costs incurred during the application development stage as well as costs meeting certain criteria are capitalized and expensed on a straight-line basis over the term of the hosting contract. These assets are included in the “Other noncurrent assets” line in the Consolidated Balance Sheets. As of December 31, 2022, net capitalized CCA assets were $53,637. Changes in these assets are included in the “Other assets” line within operating activities in the Consolidated Statements of Cash Flows. (q) Insurance Reserves The Company is self-insured for property, workers’ compensation, medical and other casualty programs up to certain stop-loss limits. Undiscounted liabilities for self-insured exposures are accrued at the present value of the expected aggregate losses below those limits and are based on a number of assumptions, including historical trends, actuarial assumptions and economic conditions. (r) Stock-Based Compensation The Company established the Hanesbrands Inc. Omnibus Incentive Plan (As Amended and Restated), (the “Omnibus Incentive Plan”) to award stock options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, performance shares and cash to its employees, non-employee directors and employees of its subsidiaries to promote the interests of the Company, incent performance and retain employees. Stock-based compensation is estimated at the grant date based on the award’s fair value and is recognized as expense over the requisite service period. The Company estimates forfeitures for stock-based awards granted that are not expected to vest. (s) Income Taxes Deferred taxes are recognized for the future tax effects of temporary differences between financial and income tax reporting using tax rates in effect for the years in which the differences are expected to reverse. Given continuing losses in certain jurisdictions in which the Company operates on a separate return basis, a valuation allowance has been established for the deferred tax assets in these specific locations. The Company periodically estimates the probable tax obligations using historical experience in tax jurisdictions and informed judgment. There are inherent uncertainties related to the interpretation of tax regulations in the jurisdictions in which the Company transacts business. The judgments and estimates made at a point in time may change based on the outcome of tax audits, as well as changes to, or further interpretations of, regulations. Income tax expense is adjusted in the period in which these events occur, and these adjustments are included in the Company’s Consolidated Statements of Income. If such changes take place, there is a risk that the Company’s effective tax rate may increase or decrease in any period. A company must recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company continues to use a portfolio approach to release the income tax effects in accumulated other comprehensive loss related to pension and postretirement benefits. Under this approach, the income tax effects are released from accumulated other comprehensive loss based on the pre-tax adjustments to pension liabilities or assets recognized within other comprehensive income. Any tax effects remaining in accumulated other comprehensive loss are released only when the entire portfolio of the pension and postretirement benefits is liquidated, sold or extinguished. (t) Financial Instruments The Company uses forward foreign exchange contracts and cross-currency swap contracts to manage its exposures to movements in foreign exchange rates. The Company also uses a combination of cross-currency swap contracts and long-term debt to manage its exposure to foreign currency risk associated with the Company’s net investment in certain European subsidiaries. The use of these derivative and nonderivative financial instruments modifies the Company’s exposure to these risks with the goal of reducing the risk or cost to the Company. The Company does not use derivatives for trading purposes and is not a party to leveraged derivative contracts. Depending on the nature of the underlying risk being hedged, these derivative and nonderivative financial instruments are accounted for either as cash flow, net investment or mark to market hedges against changes in the value of the hedged item. Derivatives are recorded in the Consolidated Balance Sheets at fair value. The fair value is based upon either market quotes for actively traded instruments or independent bids for nonexchange traded instruments. The accounting for changes in fair value of a derivative instrument depends on whether the instrument has been designated and qualifies as part of a hedging relationship. The Company determines whether a derivative instrument meets the criteria for cash flow or net investment hedge accounting treatment on the date the derivative is executed. Derivatives accounted for as mark to market hedges are not designated as hedges for accounting purposes. The Company formally documents its hedge relationships, including identifying the hedging instruments and the hedged items, as well as its risk management objectives and strategies for undertaking the hedge transaction. This process includes linking financial instruments to the hedged assets, liabilities, firm commitments, forecasted transactions or net investments. The Company may be exposed to credit losses in the event of nonperformance by individual counterparties or the entire group of counterparties to the Company’s derivative contracts. Risk of nonperformance by counterparties is mitigated by dealing with highly rated counterparties and by diversifying across counterparties. Cash Flow Hedges For a cash flow hedge, the Company formally assesses, both at inception and on at least a quarterly basis thereafter, whether the designated derivative instrument is highly effective in offsetting changes in cash flows of the hedged item. The change in the fair value of a derivative instrument that is designated and highly effective as a cash flow hedge is recorded as a deferred gain or loss in the “Accumulated other comprehensive loss” line in the Consolidated Balance Sheets. When the hedged item affects the income statement, the deferred gain or loss on the derivative instrument is reclassified from AOCI and recorded on the same line in the Consolidated Statements of Income as the hedged item. The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. If it is determined that a designated derivative instrument ceases to be a highly effective cash flow hedge, or if the anticipated transaction is no longer likely to occur, the Company discontinues hedge accounting, and any deferred gain or loss is reclassified from AOCI and recorded on the same line in the Consolidated Statements of Income as the hedged item. Cash flows from derivatives designated as cash flow hedges are classified in the same category as the item being hedged in the Consolidated Statements of Cash Flows. Net Investment Hedges For a net investment hedge, the Company formally assesses, both at inception and on a quarterly basis thereafter, whether the designated financial instrument is highly effective as an economic hedge of foreign exchange risk associated with the hedged net investment. The change in the fair value of a derivative instrument or the change in the carrying value of a nonderivative financial instrument that is designated and highly effective as a net investment hedge is recorded as a deferred gain or loss in the cumulative translation adjustment component of AOCI, offsetting the translation gain or loss for the net investment being hedged. The Company assesses net investment hedge effectiveness and measures net investment hedge results for both derivative and nonderivative hedging instruments on an after-tax basis. The interest component of a cross-currency swap derivative contract designated in a highly effective net investment hedge is excluded from the assessment of hedge effectiveness and is initially recorded in the cumulative translation adjustment component of AOCI. This excluded component is amortized in earnings using a systematic and rational method over the term of the cross-currency swap derivative contract and recorded in the “Interest expense, net” line in the Consolidated Statements of Income. If a net investment hedging relationship ceases to be highly effective, the Company discontinues hedge accounting, and any future change in the fair value of the derivative hedging instrument or future change in the carrying value of the nonderivative hedging instrument is recorded in the “Other expenses” line in the Consolidated Statements of Income, which is where the gain or loss on the sale or substantial liquidation of the underlying net investment would be recorded. However, any deferred gain or loss previously recorded in the cumulative translation adjustment component of AOCI will remain in AOCI until the hedged net investment is sold or substantially liquidated, at which time the cumulative deferred gain or loss is reclassified from AOCI and recorded in the “Other expenses” line in the Consolidated Statements of Income. Cash flows from the periodic and final settlements of the cross-currency swap contracts are reported as cash flows from investing activities in the Consolidated Statements of Cash Flows because the hedged item is a net investment in foreign subsidiaries, and the cash paid or received from acquiring or selling the subsidiaries would typically be classified as investing. Mark to Market Hedges A derivative instrument whose change in fair value is used to hedge against changes in the value of a hedged item, but which is not designated as a hedge under the accounting standards, is accounted for as a mark to market hedge. These derivatives are recorded at fair value in the Consolidated Balance Sheets when the hedged item is recorded as an asset or liability and then are revalued each accounting period. Changes in the fair value of derivatives accounted for as mark to market hedges are reported in the “Cost of sales” and “Selling, general and administrative expenses” lines in the Consolidated Statements of Income. Cash flows from derivatives not designated as hedges are classified as cash flows from operating activities in the Consolidated Statements of Cash Flows. (u) Assets and Liabilities Acquired in Business Combinations Business combinations are accounted for using the purchase method, which requires the Company to allocate the cost of an acquired business to the acquired assets and assumed liabilities based on their estimated fair values at the acquisition date. The Company recognizes the excess of an acquired business’ cost over the fair value of acquired assets and assumed liabilities as goodwill. Fair values are determined using the income approach based on market participant assumptions focusing on future cash flow projections and accepted industry standards. (v) Recently Issued Accounting Pronouncements Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01, “Reference Rate Reform: Scope.” The new accounting rules provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. In December 2022, the FASB deferred the expiration date of Topic 848 with the issuance of ASU 2022-06, “Reference Rate Reform: Deferral of the Sunset Date of Topic 848.” The new accounting rules extend the relief in Topic 848 beyond the cessation date of USD LIBOR. The new accounting rules must be adopted by the fourth quarter of 2024. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows and disclosures. Business Combinations In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.” The new accounting rules require entities to apply “Revenue from Contracts with Customers (Topic 606)” to recognize and measure contract assets and contract liabilities in a business combination. The new accounting rules will be effective for the Company in the first quarter of 2023, including interim periods. The adoption impact of the new accounting rules will depend on the magnitude of future acquisitions. Derivatives and Hedging In March 2022, the FASB issued ASU 2022-01, “Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method.” The new accounting rules allow entities to expand the use of the portfolio layer method to all financial assets and designate multiple hedged layers within a single closed portfolio. The new accounting rules also clarify guidance related to hedge basis adjustments and the related disclosures for these adjustments. The new accounting rules will be effective for the Company in the first quarter of 2023, including interim periods. The Company does not currently have any fair value hedging programs that leverage the portfolio layer method, therefore, the Company does not |
Assets and Liabilities Held for
Assets and Liabilities Held for Sale | 12 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets and Liabilities Held for Sale, Disclosure | Assets and Liabilities Held for Sale Assets and liabilities classified as held for sale in the Consolidated Balance Sheets as of December 31, 2022 and January 1, 2022 consist of the following: December 31, January 1, U.S. Sheer Hosiery business - continuing operations $ 13,327 $ 5,426 European Innerwear business - discontinued operations — 321,731 Total current assets held for sale $ 13,327 $ 327,157 U.S. Sheer Hosiery business - continuing operations $ 13,327 $ 5,426 European Innerwear business - discontinued operations — 311,476 Total current liabilities held for sale $ 13,327 $ 316,902 U.S. Sheer Hosiery Business - Continuing Operations In 2020, the Company determined that there was a triggering event associated with its U.S. Sheer Hosiery reporting unit due to a significant decline in performance below management’s expectations and loss of a future wholesale sheer hosiery program. As a result, the Company recorded impairment charges for the full amount of goodwill related to the U.S. Sheer Hosiery reporting unit of $25,173, which are reflected in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income in 2020. In the fourth quarter of 2021, the Company reached the decision to divest its U.S. Sheer Hosiery business, including the L’eggs brand, as part of its strategy to streamline its portfolio under its Full Potential plan and determined that this business met held-for-sale accounting criteria. The related assets and liabilities are presented as held for sale in the Consolidated Balance Sheets at December 31, 2022 and January 1, 2022. The Company recorded a non-cash charge of $38,364 in the fourth quarter of 2021 to record a valuation allowance against the net assets held for sale to write down the carrying value of the disposal group to the estimated fair value less costs of disposal. In 2022, the Company recognized a non-cash gain of $3,535 to adjust the valuation allowance resulting from a decrease in carrying value due to changes in working capital. These valuation allowance adjustments are reflected in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. The operations of the U.S. Sheer Hosiery business are reported in “Other” for all periods presented in Note “Business Segment Information”. The Company is currently exploring potential purchasers for this business and expects to complete the sale within the next 12 months. European Innerwear Business - Discontinued Operations In the first quarter of 2021, the Company announced that it reached the decision to exit its European Innerwear business as part of its strategy to streamline its portfolio under its Full Potential plan and determined that this business met held-for-sale and discontinued operations accounting criteria. Accordingly, the Company began to separately report the results of its European Innerwear business as discontinued operations in its Consolidated Statements of Income, and to present the related assets and liabilities as held for sale in the Consolidated Balance Sheets. On November 4, 2021, the Company announced that it had reached an agreement to sell its European Innerwear business to an affiliate of Regent, L.P. and completed the sale on March 5, 2022. Under the agreement, the purchaser received all the assets and operating liabilities of the European Innerwear business. The operations of the European Innerwear business were previously reported primarily in the International segment. Upon meeting the criteria for held-for-sale classification in the first quarter of 2021, which qualified as a triggering event, the Company performed a full impairment analysis of the disposal group's indefinite-lived intangible assets and goodwill. As a result of the strategic decision to exit the European Innerwear business, forecasts were revised to include updated market conditions and the removal of strategic operating decisions that would no longer occur under the Company's ownership. The revised forecasts indicated impairment of certain indefinite-lived trademarks and license agreements as well as the full goodwill balance attributable to the European Innerwear business. As a result of this impairment analysis, a non-cash charge of $155,745 was recorded as "Impairment of intangible assets and goodwill" in the summarized discontinued operations financial information in 2021. In addition, the Company recorded a valuation allowance against the net assets held for sale to write down the carrying value of the disposal group to the estimated fair value less costs of disposal, resulting in non-cash charges of $7,253 and $273,995 for the quarter and year ended January 1, 2022, respectively, as "Loss on sale of business and classification of assets held for sale" in the summarized discontinued operations financial information. The non-cash charge recorded in the quarter ended January 1, 2022 primarily resulted from changes in working capital balances and foreign exchange rates. In the year ended December 31, 2022, the Company recorded the final loss on the sale of the European Innerwear business of $373 primarily resulting from changes in working capital balances and foreign exchange rates. Additionally, the Company recorded an impairment charge of $7,302 in continuing operations on an indefinite-lived trademark in 2021 which is reflected in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. This charge relates to the full impairment of an indefinite-lived trademark related to a specific brand within the European Innerwear business that was excluded from the disposal group as it was not marketed for sale. During the second quarter of 2020, the Company completed a quantitative impairment analysis for certain indefinite-lived intangible assets as a result of the significant impact of the COVID-19 pandemic on their performance. Based on this analysis, the Company recorded impairment charges of $20,319 on certain indefinite-lived trademarks and other intangible assets within the European Innerwear business which are reflected in the “Impairment of intangible assets and goodwill” line in the summarized discontinued operations financial information in 2020. The Company has continued certain sales from its supply chain to the European Innerwear business on a transitional basis after the sale of the business. Under the terms of the Manufacturing and Supply Agreement that was signed as part of closing the transaction, the Company will provide these services for periods up to 34 months from the closing date of the transaction. Additionally, the Company entered into a Transitional Services Agreement pursuant to which the Company will provide transitional services including information technology, human resources, facilities management, and limited finance and accounting services for periods up to 12 months from the closing date of the transaction. The sales and the related profit are included in continuing operations in the Consolidated Statements of Income and in “Other” in Note “Business Segment Information” in all periods presented and have not been eliminated as intercompany transactions in consolidation for the period when the European Innerwear business was owned by the Company. The related receivables from the European Innerwear business are included in “Trade accounts receivable, net” in the Consolidated Balance Sheets for all periods presented. The operating results of the discontinued operations only reflect revenues and expenses that are directly attributable to the European Innerwear business. Discontinued operations does not include any allocation of corporate overhead expense or interest expense. The key components from discontinued operations related to the European Innerwear business are as follows: Years Ended December 31, January 1, January 2, Net sales $ 101,314 $ 546,558 $ 598,322 Cost of sales 60,415 294,383 352,758 Gross profit 40,899 252,175 245,564 Selling, general and administrative expenses 54,689 274,408 261,410 Impairment of intangible assets and goodwill — 155,745 20,319 Loss on sale of business and classification of assets held for sale 373 273,995 — Operating loss (14,163) (451,973) (36,165) Other expenses 283 2,178 2,477 Interest expense, net 10 613 2,253 Loss from discontinued operations before income tax expense (benefit) (14,456) (454,764) (40,895) Income tax expense (benefit) (18,421) (11,020) 2,397 Net income (loss) from discontinued operations, net of tax $ 3,965 $ (443,744) $ (43,292) Assets and liabilities of discontinued operations classified as held for sale in the Consolidated Balance Sheets as of December 31, 2022 and January 1, 2022 consist of the following: December 31, January 1, Cash and cash equivalents $ — $ 24,352 Trade accounts receivable, net — 87,353 Inventories — 141,653 Other current assets — 21,926 Property, net — 62,659 Right-of-use assets — 32,603 Trademarks and other identifiable intangibles, net (1) — 205,204 Deferred tax assets — 4,174 Other noncurrent assets — 4,127 Allowance to adjust assets to estimated fair value, less costs of disposal — (262,320) Total assets of discontinued operations $ — $ 321,731 Accounts payable $ — $ 84,327 Accrued liabilities — 122,620 Lease liabilities — 6,562 Notes payable — 329 Lease liabilities - noncurrent — 27,426 Pension and postretirement benefits — 38,325 Other noncurrent liabilities — 31,887 Total liabilities of discontinued operations $ — $ 311,476 (1) The “Trademarks and other identifiable intangibles, net” line in the table above includes $161,693 of indefinite-lived trademarks as of January 1, 2022. The cash flows related to discontinued operations have not been segregated and are included in the Consolidated Statements of Cash Flows. The following table presents cash flow and non-cash information related to discontinued operations: Years Ended December 31, January 1, January 2, Depreciation $ — $ 2,608 $ 11,650 Amortization $ — $ 1,460 $ 5,829 Capital expenditures $ 715 $ 8,462 $ 4,160 Impairment of intangible assets and goodwill $ — $ 155,745 $ 20,319 Loss on sale of business and classification of assets held for sale $ 373 $ 273,995 $ — Capital expenditures included in accounts payable at end of period $ — $ 1,079 $ 3,767 Right-of-use assets obtained in exchange for lease obligations $ — $ 8,672 $ 3,738 |
Revenue Recognition
Revenue Recognition | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition Revenue is recognized when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. Variable consideration includes trade discounts, rebates, volume-based incentives, cooperative advertising and product returns, which are offered within contracts between the Company and its customers, employing the practical expedient for contract costs. Incidental items that are immaterial to the context of the contract are recognized as expense at the transaction date. The following table presents the Company’s revenues disaggregated by the customer’s method of purchase: Years Ended December 31, January 1, January 2, Third-party brick-and-mortar wholesale $ 4,348,424 $ 4,777,623 $ 4,334,088 Consumer-directed 1,885,226 2,023,617 1,793,073 Total net sales $ 6,233,650 $ 6,801,240 $ 6,127,161 Revenue Sources Third-Party Brick-and-Mortar Wholesale Revenue Third-party brick-and-mortar wholesale revenue is primarily generated by sales of the Company’s products to retailers to support their brick-and-mortar operations. Also included within third-party brick-and-mortar wholesale revenue is royalty revenue from licensing agreements. The Company earns royalties through license agreements with manufacturers of other consumer products that incorporate certain of the Company’s brands. The Company accrues revenue earned under these contracts based upon reported sales from the licensees. Additionally, third-party brick-and-mortar wholesale revenue for the year ended January 2, 2021 includes $518,309 of revenue from contracts with governments generated from the sale of both cloth face coverings and gowns for use to help mitigate the spread of the virus during the COVID-19 pandemic. Consumer-Directed Revenue |
Earnings Per Share
Earnings Per Share | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Earnings Per Share | Earnings Per ShareBasic earnings per share (“EPS”) was computed by dividing net income (loss) by the number of weighted average shares of common stock outstanding during the period. Diluted EPS was calculated to give effect to all potentially issuable dilutive shares of common stock using the treasury stock method. The reconciliation of basic to diluted weighted average shares outstanding is as follows: Years Ended December 31, January 1, January 2, Basic weighted average shares outstanding 349,970 351,028 352,766 Effect of potentially dilutive securities: Stock options — 16 — Restricted stock units — 1,031 — Employee stock purchase plan and other — 3 — Diluted weighted average shares outstanding 349,970 352,078 352,766 The following securities were excluded from the diluted earnings per share calculation because their effect would be anti-dilutive: Years Ended December 31, January 1, January 2, Stock options 252 167 219 Restricted stock units 1,907 32 621 Employee stock purchase plan and other 8 — 5 In 2022 and 2020, all potentially dilutive securities were excluded from the diluted earnings per share calculation because the Company incurred a net loss for these years and their inclusion would be anti-dilutive. |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation The Company established the Omnibus Incentive Plan to award stock options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, performance shares and cash to its employees, non-employee directors and employees of its subsidiaries to promote the interests of the Company, incent performance and retain employees. In April 2020, the stockholders of the Company approved the Hanesbrands Inc. 2020 Omnibus Incentive Plan (the “2020 Omnibus Plan”). The Company satisfies the requirement for common shares for share-based payments to employees pursuant to the 2020 Omnibus Plan by issuing newly authorized shares. The 2020 Omnibus Plan authorized a total of 11,000 shares of common stock of the Company for awards granted under the 2020 Omnibus Plan, plus the number of shares of common stock of the Company available for grant under the predecessor Hanesbrands Inc. Omnibus Incentive Plan (the “Prior Plan”) that had not yet been made subject to awards under the Prior Plan as of the effective date of the 2020 Omnibus Plan. The 2020 Omnibus Plan authorized 74,220 shares for awards of stock options and restricted stock units, of which 14,033 shares were available for future grants as of December 31, 2022. In addition, during 2020, the Company granted stock awards to two newly hired executive officers outside of the 2020 Omnibus Plan in reliance on the employment inducement exemption under the New York Stock Exchange’s Listed Company Manual Rule 303A.08. Stock Options Under the Omnibus Incentive Plan, the exercise price of each stock option equals the closing market price of the Company’s stock on the date of grant. Options granted vest ratably over three During 2020, the Company granted 250 stock options to a newly hired executive officer outside of the 2020 Omnibus Plan in reliance on the employment inducement exemption under the New York Stock Exchange’s Listed Company Manual Rule 303A.08. The exercise price of each stock option equals either the closing market price of the Company’s stock on the date of grant or the closing market price of the Company’s stock on the date of grant multiplied by a specified exercise premium factor applicable to each option. Options granted vest ratably over three following table includes the assumptions for the Black-Scholes option-pricing model used in determining the fair value of these options granted during 2020. Year Ended January 2, Dividend yield 5.00 % Risk-free interest rate 0.31 % Volatility 39.97 % Expected term (years) 6 The dividend yield assumption is based on the Company’s historical dividend payments. The risk-free rate of interest is based on the yield of a zero-coupon U.S. Treasury bond on the date the award is granted having a maturity approximately equal to the expected term of the award. The expected volatility, expected term and forfeitures are estimated based on the historical experience of the Company’s stock price, exercise experience and employee turnover data, respectively. A summary of the changes in stock options outstanding to the Company’s employees is presented below: Shares Weighted- Aggregate Weighted- Options outstanding at December 28, 2019 471 $ 6.79 $ 3,786 0.94 Granted 250 17.18 Exercised (471) 6.79 Options outstanding at January 2, 2021 250 $ 17.18 $ 22 9.59 Granted — — Exercised — — Options outstanding at January 1, 2022 250 $ 17.18 $ 200 8.59 Granted — — Exercised — — Options outstanding at December 31, 2022 250 $ 17.18 $ — 7.59 Options exercisable at December 31, 2022 167 $ 15.75 $ — 7.59 There were no stock option exercises during 2022 or 2021. The total intrinsic value of options that were exercised during 2020 was $3,299. Stock Unit Awards Under the Omnibus Incentive Plan, restricted stock units (“RSUs”) of the Company’s stock are granted to certain Company non-employee directors and employees to incent performance and retention over periods of one three During 2020, the Company granted 225 RSUs to two newly hired executive officers outside of the 2020 Omnibus Plan in reliance on the employment inducement exemption under the New York Stock Exchange’s Listed Company Manual Rule 303A.08. These grants included 119 non-performanced based awards which vest upon continued future service to the Company and 106 performanced-based awards which have a performanced-based vesting feature. These RSUs are granted to induce employment and incent performance and retention over periods of two to three years. Upon vesting, the RSUs are converted into shares of the Company’s common stock on a one-for-one basis and issued to the grantees. The cost of these awards is determined using the fair value of the shares on the date of grant, and compensation expense is recognized over the period during which the grantees provide the requisite service to the Company. A summary of the changes in the restricted stock unit awards outstanding is presented below: Shares Weighted- Aggregate Weighted- Nonvested share units outstanding at December 28, 2019 1,867 $ 16.93 $ 27,692 1.50 Granted — non-performanced based 1,006 14.26 Granted — performanced based 1,124 14.40 Vested (803) 19.08 Forfeited (83) 15.53 Nonvested share units outstanding at January 2, 2021 3,111 $ 14.64 $ 45,361 1.32 Granted — non-performanced based 970 16.11 Granted — performanced based (149) 16.22 Vested (1,694) 14.87 Forfeited (117) 15.36 Nonvested share units outstanding at January 1, 2022 2,121 $ 16.53 $ 35,455 1.18 Granted — non-performanced based 1,178 15.39 Granted — performanced based 1,624 16.98 Vested (829) 15.92 Forfeited (435) 16.84 Nonvested share units outstanding at December 31, 2022 3,659 $ 16.46 $ 23,268 1.24 The total fair value of shares vested during 2022, 2021 and 2020 was $13,199, $25,201 and $15,325, respectively. Certain participants elected to defer receipt of shares earned upon vesting. In addition to granting RSUs that vest solely upon continued future service to the Company, the Company also grants performanced-based RSUs where the number of shares of the Company’s common stock that will be received upon vesting range from 0% to 200% of the number of units granted based on the Company’s achievement of certain performance metrics. These performanced-based stock awards, which are included in the table above, represent awards that are earned based on future performance and service. As reported in the above table, the number of performanced-based RSUs granted each year represents the initial units granted on the date of grant plus or minus any adjustment for units that were earned based on the final achievement of the respective performance thresholds. For all share-based payments under the Omnibus Incentive Plan and outside the Omnibus Incentive Plan in 2020, the Company recognized compensation expense and deferred tax benefits as follows: Years Ended December 31, January 1, January 2, Compensation expense included in continuing operations $ 23,357 $ 16,065 $ 18,202 Compensation expense included in discontinued operations (200) 225 462 Total compensation expense $ 23,157 $ 16,290 $ 18,664 Deferred tax benefit recognized in continuing operations $ — $ 2,499 $ 1,808 |
Trade Accounts Receivable
Trade Accounts Receivable | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Trade Accounts Receivable | Trade Accounts Receivable Allowances for Trade Accounts Receivable The changes in the Company’s allowance for doubtful accounts and allowance for chargebacks and other deductions are as follows: Allowance Allowance Total Balance at December 28, 2019 $ 16,277 $ 10,213 $ 26,490 Charged to expenses 31,661 14,631 46,292 Deductions, write-offs and adjustments (14,986) (9,864) (24,850) Currency translation 651 162 813 Balance at January 2, 2021 $ 33,603 $ 15,142 $ 48,745 Charged to expenses 2,279 24,501 26,780 Deductions, write-offs and adjustments 2,663 (15,245) (12,582) Currency translation (707) (288) (995) Balance at January 1, 2022 $ 37,838 $ 24,110 $ 61,948 Charged to expenses 6,721 20,432 27,153 Deductions, write-offs and adjustments (19,753) (16,180) (35,933) Currency translation (658) (487) (1,145) Balance at December 31, 2022 $ 24,148 $ 27,875 $ 52,023 Charges to the allowance for doubtful accounts are reflected in the “Selling, general and administrative expenses” line and charges to the allowance for customer chargebacks and other customer deductions are primarily reflected as a reduction in the “Net sales” line in the Consolidated Statements of Income. Deductions and write-offs, which do not increase or decrease income, represent write-offs of previously reserved accounts receivable and allowed customer chargebacks and deductions against gross accounts receivable. Sales of Accounts Receivable The Company has entered into agreements to sell selected trade accounts receivable to financial institutions based on programs offered by certain of the Company’s largest customers as well as programs sponsored by the Company. As a result of the strong credit worthiness of these customers, the discount taken on most of these programs is less than the marginal borrowing rate on the Company’s variable rate credit facilities. In all agreements, after the sale, the Company does not retain any beneficial interests in the receivables. The applicable financial institution services and collects the accounts receivable directly from the customer for programs offered by the Company’s customers. For programs sponsored by the Company, the Company maintains continued involvement as the servicer to collect the accounts receivable from the customer and remit payment to the financial institution. Net proceeds of these accounts receivable sale programs are recognized in the Consolidated Statements of Cash Flows as part of operating cash flows. The Company recognized total funding fees of $8,823, $3,312 and $4,932 in 2022, 2021 and 2020, respectively, for sales of accounts receivable to financial institutions in the “Other expenses” line in the Consolidated Statements of Income. |
Inventories
Inventories | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Inventories | Inventories Inventories consisted of the following: December 31, January 1, Raw materials $ 69,279 $ 68,683 Work in process 107,904 110,246 Finished goods 1,802,489 1,405,086 $ 1,979,672 $ 1,584,015 |
Property, Net
Property, Net | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Property, Net | Property, Net Property is summarized as follows: December 31, January 1, Land $ 26,209 $ 26,368 Buildings and improvements 430,043 430,235 Machinery and equipment 994,829 998,891 Construction in progress 50,895 42,375 1,501,976 1,497,869 Less accumulated depreciation 1,059,572 1,056,468 Property, net $ 442,404 $ 441,401 |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases Disclosure | Leases The Company has operating leases for real estate (primarily retail stores and operating facilities) and certain equipment. The Company does not have any finance leases. The Company’s leases have remaining lease terms of one Total operating lease costs, which includes short-term leases and variable cost, were $239,854, $236,139 and $218,506 for 2022, 2021 and 2020, respectively. For 2022, 2021 and 2020, variable costs of $82,165, $77,496 and $69,210, respectively, were included in total operating lease costs. Short-term lease costs were immaterial for 2022, 2021 and 2020. The following table presents supplemental cash flow and non-cash information related to leases: Years Ended December 31, January 1, January 2, Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from leases $ 146,439 $ 157,138 $ 179,591 Right-of-use assets obtained in exchange for lease obligations - non-cash activity $ 81,571 $ 59,864 $ 47,349 The following table presents supplemental information related to lease terms and discount rates: Years Ended December 31, January 1, January 2, Weighted average remaining lease term 5.0 years 4.7 years 5.0 years Weighted average discount rate 4.77 % 4.55 % 4.65 % The following table presents maturities of operating lease liabilities as of December 31, 2022: 2023 $ 127,996 2024 108,165 2025 75,007 2026 71,011 2027 48,370 Thereafter 69,034 Total lease payments 499,583 Less interest 58,145 $ 441,438 As of December 31, 2022, the Company’s operating lease liabilities exclude $55,240 of additional operating lease commitments that have not yet commenced. These operating lease liabilities will be paid over a period of 10 years. |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Intangible Assets and Goodwill | Intangible Assets and Goodwill (a) Intangible Assets The primary components of the Company’s intangible assets and the related accumulated amortization are as follows: Gross Accumulated Net Book Year ended December 31, 2022: Intangible assets subject to amortization: Trademarks and brand names $ 40,128 $ 28,633 $ 11,495 Licensing agreements 89,523 68,205 21,318 Customer and distributor relationships 122,283 81,099 41,184 Computer software 109,209 72,626 36,583 Other intangibles 5,160 5,043 117 $ 366,303 $ 255,606 110,697 Intangible assets not subject to amortization: Trademarks 1,142,746 Perpetual licensing agreements and other 2,250 Net book value of intangible assets $ 1,255,693 Gross Accumulated Net Book Year ended January 1, 2022: Intangible assets subject to amortization: Trademarks and brand names $ 43,187 $ 29,678 $ 13,509 Licensing agreements 92,370 65,828 26,542 Customer and distributor relationships 132,971 78,647 54,324 Computer software 97,464 62,064 35,400 Other intangibles 3,984 3,720 264 $ 369,976 $ 239,937 130,039 Intangible assets not subject to amortization: Trademarks 1,087,881 Perpetual licensing agreements and other 2,250 Net book value of intangible assets $ 1,220,170 In June of 2022, the Company purchased the Champion trademark for footwear in the United States, Puerto Rico and Canada from Keds, LLC (“KEDS”) for $102,500. The trademark was recorded in “Trademarks and other identifiable intangibles, net” line in the Consolidated Balance Sheets and has an indefinite life. The Company previously licensed the Champion trademark for footwear in these locations. The purchase of the trademark was part of an agreement with KEDS settling litigation between the two parties and is another step forward in the Company’s Full Potential plan of growing the global Champion brand. In connection with the annual impairment testing performed in the third quarter of 2022, the Company performed a quantitative assessment, utilizing an income approach to estimate the fair value of each indefinite-lived intangible asset. The most significant assumptions include the weighted average cost of capital, revenue growth rate, terminal growth rate and operating profit margin, all of which are used to estimate the fair value of the indefinite-lived intangible assets. The tests indicated the indefinite-lived intangible assets had fair values that exceeded their carrying values, and no impairment of trademarks or other identifiable intangible assets was identified as a result of the annual testing conducted in 2022. In the first quarter of 2021, the Company recorded an impairment charge of $7,302 to fully impair an indefinite-lived trademark related to a specific brand within the European Innerwear business that was excluded from the disposal group as it was not marketed for sale. This impairment charge is reflected in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income for the year ended January 1, 2022. The amortization expense in continuing operations for intangible assets subject to amortization was $29,973, $31,069 and $30,858 for 2022, 2021 and 2020, respectively. The estimated amortization expense for the next five years, assuming no change in the estimated useful lives of identifiable intangible assets or changes in foreign exchange rates is as follows: $29,728 in 2023, $25,338 in 2024, $21,602 in 2025, $12,234 in 2026 and $5,261 in 2027. (b) Goodwill Goodwill and the changes in those amounts during the period are as follows: Innerwear Activewear International Other Total Net book value at January 2, 2021 $ 406,853 $ 316,384 $ 433,201 $ 2,500 $ 1,158,938 Currency translation — — (25,843) — (25,843) Net book value at January 1, 2022 $ 406,853 $ 316,384 $ 407,358 $ 2,500 $ 1,133,095 Currency translation — — (24,188) — (24,188) Net book value at December 31, 2022 $ 406,853 $ 316,384 $ 383,170 $ 2,500 $ 1,108,907 In connection with the annual goodwill impairment testing performed during the third quarter of 2022, the Company performed a quantitative assessment utilizing an income approach to estimate the fair value of each reporting unit. The most significant assumptions include the weighted average cost of capital, revenue growth rate, terminal growth rate and operating profit margin, all of which are used to estimate the fair value of the reporting units. The tests indicated the reporting units had fair values that exceeded their carrying values, and no impairment of goodwill was identified as a result of the annual testing conducted in 2022. In 2020, the Company determined that there was a triggering event associated with its U.S. Sheer Hosiery reporting unit due to a significant decline in performance below management’s expectations and loss of a future wholesale sheer hosiery program. As a result, the Company recorded impairment charges for the full amount of goodwill related to the U.S. Sheer Hosiery reporting unit of $25,173, which are reflected in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income in 2020. In the fourth quarter of 2021, the Company reached the decision to divest its U.S. Sheer Hosiery business, including the L’eggs brand, as part of its strategy to streamline its portfolio under its Full Potential plan. See Note “Assets and Liabilities Held for Sale” for additional information. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | Debt A summary of the Company’s debt is presented below: Interest Rate as of December 31, Principal Amount December 31, January 1, Maturity Date Senior Secured Credit Facility: Revolving Loan Facility 5.83% $ 352,500 $ — November 2026 Term Loan A 5.92% 975,000 1,000,000 November 2026 4.875% Senior Notes 4.88% 900,000 900,000 May 2026 4.625% Senior Notes 4.63% 900,000 900,000 May 2024 3.5% Senior Notes 3.50% 535,275 568,634 June 2024 Accounts Receivable Securitization Facility 5.09% 209,500 — June 2023 3,872,275 3,368,634 Less long-term debt issuance costs 13,198 17,543 Less current maturities 247,000 25,000 $ 3,612,077 $ 3,326,091 As of December 31, 2022 the Company’s primary financing arrangements were the senior secured credit facility (the “Senior Secured Credit Facility”), 4.875% senior notes (the “4.875% Senior Notes”), 4.625% senior notes (the “4.625% Senior Notes”), 3.5% senior notes (the “3.5% Senior Notes”) and the accounts receivable securitization facility (the “ARS Facility”). The outstanding balances at December 31, 2022 and January 1, 2022 are reported in the “Accounts Receivable Securitization Facility”, “Current portion of long-term debt” and “Long-term debt” lines in the Consolidated Balance Sheets. The Company intends to refinance certain of its indebtedness with upcoming maturities, including an aggregate of approximately $1,435,275 of its 4.625% Senior Notes due in May 2024 and its 3.5% Senior Notes due in June 2024 in the first quarter of 2023. Any such refinancings will depend on market conditions and other relevant factors and there can be no assurance such refinancings will be pursued or completed. Senior Secured Credit Facility In March 2021, the Company repaid the outstanding balance of the Term Loan B which consisted of a required excess cash flow prepayment of $238,936 and a voluntary prepayment of $61,064. In November 2021, the Company amended and restated its Senior Secured Credit Facility to provide for potential committed aggregate borrowings of up to $2,000,000, consisting of a $1,000,000 Revolving Loan Facility and a $1,000,000 Term Loan Facility, to extend the maturity date of the Senior Secured Credit Facility from December 2022 to November 2026 and to refinance the Australian Revolving Loan Facility that was originally entered into in July 2016 under the Company’s Syndicated Facility as a joinder to the Senior Secured Credit Facility. The Australian Revolving Loan Facility, which was previously amended in July 2021 to extend the maturity date to July 2022, was incorporated into the $1,000,000 Revolving Loan Facility on the date the amendment to the Senior Secured Credit Facility became effective. The $1,000,000 Revolving Loan Facility, a portion of which is available to be borrowed in Euros or Australian dollars, is used for general corporate purposes and working capital needs. All borrowings under the Revolving Loan Facility may be repaid and reborrowed from time to time without penalty but must be repaid in full upon maturity. The proceeds of the $1,000,000 Term Loan Facility were used to refinance the Term Loan A, which resulted in an increase in term loan borrowings of $390,625 in November 2021 when the amendment became effective, and to redeem, together with cash on hand, the 5.375% Senior Notes. Outstanding borrowings under the Term Loan A are repayable in equal quarterly installments of the following amounts per annum, calculated as a percentage of the original principal amount: 2.5% in years one and two, 5.0% in years three and four and 7.5% in year five, with the remainder to be repaid at maturity. The Company is required to prepay any outstanding amounts in connection with (i) the incurrence of certain indebtedness and (ii) non-ordinary course asset sales or other dispositions (including as a result of casualty or condemnation) that exceed certain thresholds in any period of twelve-consecutive months, with customary reinvestment provisions. In 2021, redemption of the 5.375% Senior Notes required payment of a make-whole premium of $34,840 and the redemption of the 5.375% Senior Notes and the refinancing of the Senior Secured Credit Facility resulted in a non-cash charge of $8,899 for the write-off of unamortized debt issuance costs. Additionally, in 2021, the Company incurred fees of $9,729 related to the refinancing, of which $1,960 was charged to expense and $7,769 was capitalized as debt issuance costs that are being amortized to interest expense over the remaining term of the Senior Secured Credit Facility. The make-whole premium payment, debt issuance costs write-off and fees charged to expense resulted in a one-time charge of $45,699, which is reported in the “Other expenses” line in the Consolidated Statements of Income in 2021. The cash payments for the make-whole premium and fees capitalized as debt issuance costs are reported in “Net cash from financing activities” in the Consolidated Statements of Cash Flows in 2021. Prior to the amendments of the Senior Secured Credit Facility in November 2022 and in February 2023 described below, borrowings under the Senior Secured Credit Facility bear interest at a variable rate based on, at the Company’s option, either LIBOR or an alternative base rate (both as defined in the Senior Secured Credit Facility), or the appropriate LIBOR benchmark for non-U.S. dollar borrowings, plus, in each case, an applicable margin. The applicable margin is based on the Company’s leverage ratio (as defined in the Senior Secured Credit Facility), ranging from a maximum of 1.75% in the case of LIBOR-based loans and 0.75% in the case of base rate loans if the Company’s leverage ratio is greater than or equal to 4.50 to 1.00, and steps down in varying increments to a minimum of 1.00% in the case of LIBOR-based loans and 0.00% in the case of base rate loans if the Company’s leverage ratio is less than 2.25 to 1.00. The Senior Secured Credit Facility provides a mechanism for determining an alternative rate of interest in the event that the LIBOR or LIBOR benchmark rates cease to be provided or are no longer representative of the underlying market and economic reality they are intended to measure and, in conjunction with the November 2022 amendment described below, the Company transitioned the Senior Secured Credit Facility from the London Interbank Offered Rate (“LIBOR”) to the Secured Overnight Financing Rate (“SOFR”). The applicable margin for SOFR-based loans are the same as LIBOR-based loans prior to the amendment of the Senior Secured Credit Facility in November 2022. The amendments of the Senior Secured Credit Facility in November 2022 and in February 2023 added two new tiers to the top of the pricing grid for the leverage ratio which resulted in an increase in the maximum applicable margin to 2.25% in the case of SOFR-based loans and 1.25% in the case of base rate loans if the Company’s leverage ratio is greater than or equal to 5.50 to 1.00 during the covenant relief period and will revert back to the original ranges subsequent to the covenant relief period. The applicable margin was 1.50% plus a 10 basis points credit spread adjustment for SOFR-based loans and 0.50% for base rate loans as of December 31, 2022. Interest is payable quarterly for base rate loans, but the Company has the option to pay interest on a more frequent, or less frequent, basis for LIBOR-based loans. T he commitment fee for the unused portion of the Revolving Loan Facility is based on the Company’s leverage ratio, prior to the amendments of the Senior Secured Credit Facility in November 2022 and in February 2023 described below, (as defined in the Senior Secured Credit Facility), ranging from a maximum of 0.25% when the leverage ratio is greater than or equal to 4.50 to 1.00, and will step down in varying increments to a minimum of 0.15% when the leverage ratio is less than 2.25 to 1.00. The amendments of the Senior Secured Credit Facility in November 2022 and in February 2023 as described below added two new tiers to the top of the pricing grid for the leverage ratio which resulted in an increase in the maximum commitment fee to 0.35% if the Company’s leverage ratio is greater than or equal to 5.50 to 1.00 during the covenant relief period and will revert back to the original ranges subsequent to the covenant relief period. The commitment fee was 0.25% as of December 31, 2022. A portion of the Revolving Loan Facility is available for the issuances of letters of credit and the making of swingline loans, and any such issuance of letters of credit or making of a swingline loan will reduce the amount available under the Revolving Loan Facility. As of December 31, 2022, the Company had $642,546 of borrowing availability under the Revolving Loan Facility after taking into account $352,500 of USD revolver loans and $4,954 of standby and trade letters of credit issued and outstanding under this facility. At the Company’s option, it may add one or more tranches of term loans or increase the commitments under the Revolving Loan Facility so long as certain conditions are satisfied, including, among others, that no default or event of default is in existence, the Company is in pro forma compliance with the financial covenants set forth in the Senior Secured Credit Facility and the Company’s senior secured leverage ratio is not greater than 3.50 to 1.00 on a pro forma basis after giving effect to the incurrence of such indebtedness. The Senior Secured Credit Facility is guaranteed by substantially all of the Company’s existing and future direct and indirect U.S. subsidiaries and certain foreign subsidiaries, with certain customary or agreed-upon exceptions for certain subsidiaries. The Senior Secured Credit Facility is secured by the equity interests of substantially all of the Company’s direct and indirect U.S. subsidiaries and 65% of the voting securities of certain first tier foreign subsidiaries and substantially all present and future property and assets of the Company and each guarantor, except for certain enumerated interests. The Senior Secured Credit Facility requires the Company to comply with customary affirmative, negative and financial covenants. The financial covenants include a minimum interest coverage ratio and a maximum total debt to EBITDA (earnings before interest, income taxes, depreciation expense and amortization, as computed pursuant to the Senior Secured Credit Facility), or leverage ratio, each of which is defined in the Senior Secured Credit Facility. The method of calculating all of the components used in the covenants, is included in the Senior Secured Credit Facility. In November 2022 and in February 2023, given the economic conditions and the associated impact on earnings, the Company amended the credit agreement governing its Senior Secured Credit Facility to modify the financial covenants in order to avoid a potential covenant violation and to provide operating flexibility. The amendments effect changes to certain provisions and covenants under the Senior Secured Credit Facility during the period beginning with the fiscal quarter ended December 31, 2022 and continuing through the fiscal quarter ending March 30, 2024 or such earlier date as we may elect (such period of time, the “Covenant Relief Period”), including: (a) an increase in the maximum consolidated net total leverage ratio to 5.25 to 1.00 for the quarter ended December 31, 2022, 6.75 to 1.00 for the quarter ending April 1, 2023, 7.25 to 1.00 for the quarter ending July 1, 2023, 6.75 to 1.00 for the quarter ending September 30, 2023, 5.25 to 1.00 for the quarter ending December 30, 2023, and 5.00 to 1.00 for the quarter ending March 30, 2024, and reverting back to 4.50 to 1.00 for each quarter after the Covenant Relief Period has ended; (b) a reduction of the minimum interest coverage ratio from 3.00 to 1.00 to 2.60 to 1.00 for the quarter ended December 31, 2022 and the quarter ending April 1, 2023, 2.00 to 1.00 for the quarters ending July 1, 2023, September 30, 2023 and December 30, 2023, and 2.50 to 1.00 for the quarter ending March 30, 2024, with an increase to 2.75 to 1.00 for each quarter after the Covenant Relief Period has ended; (c) suspension of restricted payments in connection with share repurchases; (d) suspension of restricted payments pursuant to the Company's leverage ratio-based and "Available Amount" restricted payments baskets, (e) a cap on annual dividend payments of $75,000, which will revert back to the greater of (x) $350,000 and (y) 8.0% of Total Tangible Assets after the Covenant Relief Period has ended; (f) suspension of the Company’s “Available Amount” basket for investments in foreign subsidiaries and other investments; (g) suspension of the 0.50 to 1.00 increase in the maximum permitted consolidated net total leverage ratio resulting from a material permitted acquisition; and (h) the addition of two new tiers to the top of the pricing grid if the maximum consolidated net total leverage ratio exceeds 5.00 to 1.00 and 5.50 to 1.00. In conjunction with the Second Amendment, we transitioned the Senior Secured Credit Facility from the London Interbank Offered Rate to the Secured Overnight Financing Rate with a 10 basis points credit spread adjustment already included in the Senior Secured Credit Facility. In addition, the Third Amendment limits the Company's ability to incur incremental secured indebtedness during the Covenant Relief Period to $1,750,000, subject to compliance with the financial covenants. The Senior Secured Credit Facility contains customary events of default, including nonpayment of principal when due; nonpayment of interest, fees or other amounts after stated grace period; material inaccuracy of representations and warranties; violations of covenants; certain bankruptcies and liquidations; any cross-default to material indebtedness; certain material judgments; certain events related to the ERISA, actual or asserted invalidity of any guarantee, security document or subordination provision or non-perfection of security interest, and a change in control (as defined in the Senior Secured Credit Facility). As of December 31, 2022, the Company was in compliance with all financial covenants related to the Senior Secured Credit Facility. The Company expects to maintain compliance with its financial covenants, as amended in February 2023, for at least one year from the issuance of these financial statements based on its current expectations and forecasts. If economic conditions worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders. 5.375% Senior Notes In May 2020, the Company issued $700,000 aggregate principal amount of 5.375% Senior Notes, with interest payable on May 15 and November 15 of each year. The 5.375% Senior Notes, which were scheduled to mature in May 2025, were redeemed in full in November 2021 in connection with the refinancing of the Senior Secured Credit Facility. 4.875% Senior Notes and 4.625% Senior Notes In May 2016, the Company issued $900,000 aggregate principal amount of 4.875% Senior Notes and $900,000 aggregate principal amount of 4.625% Senior Notes (collectively, the “USD Senior Notes”), with interest payable on May 15 and November 15 of each year. The 4.875% Senior Notes will mature in May 2026 and the 4.625% Senior Notes will mature in May 2024. The issuance of the USD Senior Notes resulted in net proceeds of approximately $1,773,000, which were used to redeem in full the Company’s 6.375% Senior Notes and reduce the outstanding borrowings under the Revolving Loan Facility. On or after February 15, 2026, in the case of the 4.875% Senior Notes, and February 15, 2024, in the case of the 4.625% Senior Notes, the Company may redeem all or a portion of such notes at a price equal to 100% of the principal amount, plus any accrued and unpaid interest. The USD Senior Notes are senior unsecured obligations of the Company and are fully and unconditionally guaranteed, subject to certain exceptions, by substantially all of the Company’s current domestic subsidiaries. The indenture governing the USD Senior Notes limits the ability of the Company and its subsidiaries to incur liens, enter into certain sale and leaseback transactions and consolidate, merge or sell all or substantially all of their assets. The indenture also contains customary events of default which include (subject in certain cases to customary grace and cure periods), among others, nonpayment of principal or interest; breach of other agreements in such indenture; failure to pay certain other indebtedness; failure to pay certain final judgments; failure of certain guarantees to be enforceable; and certain events of bankruptcy or insolvency. The USD Senior Notes were issued in a transaction exempt from registration under the Securities Act and do not require disclosure of separate financial information for the guarantor subsidiaries. 3.5% Senior Notes In June 2016, the Company issued €500,000 aggregate principal amount of 3.5% Senior Notes, with interest payable on June 15 and December 15 of each year. The 3.5% Senior Notes will mature in June 2024. The issuance of the 3.5% Senior Notes resulted in net proceeds of approximately €492,500, which were used to fund a portion of the acquisition of Champion Europe and Hanes Australasia. On or after March 15, 2024, the Company may redeem all or a portion of the 3.5% Senior Notes at a price equal to 100% of the principal amount, plus any accrued and unpaid interest. The Company may also redeem all, but not less than all, of the 3.5% Senior Notes upon the occurrence of certain changes in applicable tax law. The 3.5% Senior Notes are senior unsecured obligations of the Company and are fully and unconditionally guaranteed, subject to certain exceptions, by the Company and certain of its subsidiaries under the Company’s Senior Secured Credit Facility. The indenture governing the 3.5% Senior Notes limits the ability of the Company and other guarantors to incur certain liens, enter into certain sale and leaseback transactions and consolidate, merge or sell all or substantially all of their assets. The indenture also contains customary events of default which include (subject in certain cases to customary grace and cure periods), among others, nonpayment of principal or interest; breach of other agreements in the indenture; failure to pay certain other indebtedness; certain events of bankruptcy, insolvency or reorganization; failure to pay certain final judgments; and failure of certain guarantees to be enforceable. The 3.5% Senior Notes were issued in a transaction exempt from registration under the Securities Act and do not require disclosure of separate financial information for the guarantor subsidiaries. ARS Facility Borrowings under the ARS Facility, which was entered into in November 2007, are permitted only to the extent that the face value of the receivables in the collateral pool, net of applicable concentrations, reserves and other deductions, exceeds the outstanding loans and are also subject to a quarterly fluctuating facility limit, which is not to exceed $225,000 (previously $175,000) resulting from the Company’s amendment of the facility in June 2022, which also extended the maturity date to June 2023. Additionally, the amendment changed the Company’s interest rate option as defined in the ARS Facility from the rate announced from time to time by PNC Bank, N.A. as its prime rate or the LIBOR to the rate announced from time to time by PNC Bank, N.A. as its prime rate or the SOFR and increased certain receivables to the pledged collateral pool for the facility. The Company’s maximum borrowing capacity under the ARS Facility was $222,693 as of December 31, 2022. The Company had $13,193 of borrowing availability under the ARS Facility at December 31, 2022. Under the terms of the ARS Facility, the Company and certain of its subsidiaries sell or otherwise assign, on an ongoing basis, certain domestic trade receivables to HBI Receivables LLC (“Receivables LLC”), a wholly owned bankruptcy-remote subsidiary that in turn pledges the trade receivables to secure the borrowings, which are funded through conduits and financial institutions that are not affiliated with the Company. Funding under the ARS Facility is received either from conduits party to the ARS Facility through the issuance of commercial paper in the short-term market or through committed bank purchasers. The assets and liabilities of Receivables LLC are fully reflected on the Consolidated Balance Sheets, and the securitization is treated as a secured borrowing by Receivables LLC from the third-party conduits and financial institutions party thereto for accounting purposes, but the assets of Receivables LLC will be used solely to satisfy the creditors of Receivables LLC, not the Company’s other creditors. The borrowings under the ARS Facility remain outstanding throughout the term of the agreement subject to Receivables LLC maintaining sufficient eligible receivables, by continuing to acquire trade receivables from the Company and certain of its subsidiaries, unless an event of default occurs. Availability of funding under the ARS Facility depends primarily upon the eligible outstanding receivables balance. The outstanding balance under the ARS Facility is reported on the Consolidated Balance Sheets in the line “Accounts Receivable Securitization Facility.” In the case of any creditors party to the ARS Facility that are conduits, the yield on the commercial paper, which is the conduits’ cost to issue the commercial paper plus certain dealer fees, is considered a financing cost and is included in the “Interest expense, net” line in the Consolidated Statements of Income. In the case of any creditors party to the ARS Facility that are committed bank purchasers, the interest rate would be payable at the Company’s option at the rate announced from time to time by PNC Bank, N.A. as its prime rate or at the SOFR (as defined in the ARS Facility) plus the applicable margin in effect from time to time. If the SOFR (as defined in the ARS Facility) is unavailable or otherwise does not accurately reflect the costs to these creditors related to the borrowings, the interest rate would generally default to the prime rate. These amounts are also considered financing costs and are included in the “Interest expense, net” line in the Consolidated Statements of Income. In addition, Receivables LLC is required to make certain indemnity and other payments to a conduit purchaser, a committed purchaser, or certain entities that provide funding to or are affiliated with them, including in the event that assets and liabilities of a conduit purchaser subject to the ARS Facility are consolidated for financial and/or regulatory accounting purposes with certain other entities. The ARS Facility contains customary events of default and requires the Company to maintain the same interest coverage ratio and leverage ratio contained from time to time in the Senior Secured Credit Facility, provided that any changes to such covenants will only be applicable for purposes of the ARS Facility if approved by the managing agents or their affiliates. As of December 31, 2022, the Company was in compliance with all financial covenants. Other The Company had $32,266 of borrowing availability under other international credit facilities after taking into account outstanding borrowings and letters of credit outstanding under the applicable facilities at December 31, 2022. Future Principal Payments Future principal payments for all of the facilities described above are as follows: $247,000 due in 2023, $1,485,275 due in 2024, $62,500 due in 2025, and $2,077,500 due in 2026. Cash Paid for Interest Total cash paid for interest related to debt in 2022, 2021 and 2020 was $150,452, $161,202 and $157,094, respectively. Debt Issuance Costs During 2022, 2021 and 2020, the Company paid $3,159, $8,346 and $15,010, respectively, in capitalized debt issuance costs related to the Company’s financing arrangements within continuing operations. Debt issuance costs are amortized to interest expense over the respective lives of the debt instruments, which range from one |
Defined Benefit Pension Plans
Defined Benefit Pension Plans | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Defined Benefit Pension Plans | Defined Benefit Pension Plans At December 31, 2022, the Company’s pension plans consisted of the U.S. pension plans, which includes the Hanesbrands Inc. Legacy Pension Plan and the Hanesbrands Inc. Pension Plan (together, the “U.S. Pension Plans”), various nonqualified retirement plans and international plans, which include certain defined benefit plans acquired in connection with the purchases of Champion Europe and Hanes Australasia. Benefits under the U.S Pension Plans were frozen effective December 31, 2005. Effective December 1, 2022, the Company spun-off the majority of participants in the Hanesbrands Inc. Pension Plan into a new, separate plan, the Hanesbrands Inc. Legacy Pension Plan. A small number of participants remained in the Hanesbrands Inc. Pension Plan, representing approximately 1% of the total participants and 1% of the total projected benefit obligation. The components of net periodic benefit cost and other amounts recognized in other comprehensive income (loss) of the Company’s noncontributory defined benefit pension plans were as follows: Years Ended December 31, January 1, January 2, Service cost $ 1,345 $ 1,488 $ 1,406 Interest cost 27,669 23,812 33,552 Expected return on assets (49,189) (45,923) (42,278) Settlement cost (6) 861 121 Amortization of: Prior service cost (6) (6) (6) Net actuarial loss 20,972 24,440 22,277 Net periodic benefit cost $ 785 $ 4,672 $ 15,072 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss) Net (gain) loss $ (130,000) $ (96,334) $ 38,484 Prior service credit 6 6 6 Total (gain) loss recognized in other comprehensive income (loss) (129,994) (96,328) 38,490 Total recognized in net periodic benefit cost and other comprehensive income (loss) $ (129,209) $ (91,656) $ 53,562 The funded status of the Company’s defined benefit pension plans at the respective year ends was as follows: December 31, January 1, Benefit obligation: Beginning of year $ 1,216,161 $ 1,299,943 Service cost 1,345 1,488 Interest cost 27,669 23,812 Benefits paid (64,786) (62,525) Settlements (125) (2,072) Impact of exchange rate change (2,603) (1,128) Actuarial gain (251,426) (43,325) Other (36) (32) End of year 926,199 1,216,161 Fair value of plan assets: Beginning of year 973,598 920,316 Actual return on plan assets (93,497) 73,567 Employer contributions 2,831 44,658 Benefits paid (64,786) (62,525) Settlements (125) (2,072) Impact of exchange rate change (1,741) (314) Other (36) (32) End of year 816,244 973,598 Funded status $ (109,955) $ (242,563) The actuarial gain in 2022 and 2021 included in benefit obligations was primarily driven by increases in the U.S. discount rate assumptions. As most of the Company’s pension plans are frozen, the accumulated benefit obligation (“ABO”) approximates the benefit obligation. The total benefit obligation and the benefit obligation and fair value of plan assets for the Company’s pension plans with benefit obligations in excess of plan assets are as follows: December 31, January 1, Benefit obligation $ 926,199 $ 1,216,161 Plans with benefit obligation in excess of plan assets: Benefit obligation 905,749 1,188,558 Fair value of plan assets 790,641 942,733 Amounts recognized in the Company’s Consolidated Balance Sheets consist of: December 31, January 1, Other noncurrent assets $ 5,153 $ 3,262 Accrued liabilities and other: Payroll and employee benefits (2,388) (2,225) Pension and postretirement benefits (112,720) (243,600) Accumulated other comprehensive loss (440,529) (570,523) Amounts recognized in accumulated other comprehensive loss consist of: December 31, January 1, Prior service cost $ (133) $ (139) Actuarial loss 440,662 570,662 Accumulated other comprehensive loss $ 440,529 $ 570,523 (a) Measurement Date and Assumptions A December 31 measurement date is used to value plan assets and obligations for the pension plans. In determining the discount rate, the Company utilizes a full yield curve approach in the calculation of the plan obligation and interest cost and service cost components of net periodic benefit cost. The specific spot rates along the yield curve are applied to the relevant projected cash flows, and single equivalent discount rates are shown for disclosure purposes. The expected long-term rate of return on plan assets was based on the Company’s investment policy target allocation of the asset portfolio among various asset classes and the expected real returns of each asset class over various periods of time. The weighted average actuarial assumptions used in measuring the net periodic benefit cost and plan obligations for the periods presented were as follows: December 31, January 1, January 2, Net periodic benefit cost: Discount rate 2.88 % 2.55 % 3.25 % Long-term rate of return on plan assets 5.24 4.95 4.97 Rate of compensation increase (1) 3.09 3.10 3.07 Interest crediting rate 5.50 5.50 5.50 Plan obligations: Discount rate 5.15 % 2.88 % 2.55 % Rate of compensation increase (1) 3.08 3.09 3.10 Interest crediting rate 5.50 5.50 5.50 (1) For December 31, 2022, January 1, 2022 and January 2, 2021, the compensation assumption only applies to certain international plans as the benefits of the U.S. pension plans are now all frozen. (b) Plan Assets, Expected Benefit Payments, and Funding The allocation of pension plan assets as of the respective period end measurement dates is as follows: December 31, January 1, Asset category: Hedge fund of funds 39 % 37 % Foreign equity securities 21 22 U.S. equity securities 19 21 Debt securities 10 11 Real estate 8 6 Commodities 2 3 Cash and other 1 0 The Company’s asset strategy and primary investment objective are to maximize the principal value of the plan assets to meet current and future benefit obligations to plan participants and their beneficiaries. To accomplish this goal, the assets of the plan are broadly diversified to protect against large investment losses and to reduce the likelihood of excessive volatility of returns. Diversification of assets is achieved through strategic allocations to various asset classes, as well as various investment styles within these asset classes, and by retaining multiple, third-party investment management firms with complementary investment styles and philosophies to implement these allocations. The Company has established a target asset allocation based upon analysis of risk/return trade-offs and correlations of asset mixes given long-term historical data, prospective capital market returns and forecasted liabilities of the plans. The target asset allocation approximates the actual asset allocation as of December 31, 2022. In addition to volatility protection, diversification enables the assets of the plan the best opportunity to provide adequate returns in order to meet the Company’s investment return objectives. These objectives include, over a rolling five The Company utilizes market data or assumptions that market participants would use in pricing the pension plan assets. The Level 1 assets consisted primarily of certain U.S. equity securities, certain foreign equity securities, certain debt securities and cash and cash equivalents. Certain foreign equity securities, debt securities, insurance contracts and commodity investments measured at their net asset value, which is determined based on inputs readily available in public markets, and investments in hedge funds of funds and real estate investments that are based on unobservable inputs about which little or no market data exists and are measured at a net asset value per share shall not be categorized within the fair value hierarchy. Refer to Note “Fair Value of Assets and Liabilities” for the Company’s complete disclosure of the fair value of pension plan assets. Expected benefit payments are as follows: $66,272 in 2023, $66,619 in 2024, $67,295 in 2025, $68,302 in 2026, $69,553 in 2027 and $340,853 in 2028 through 2032. The Company has no required cash contribution to its U.S. Pension Plans in 2023 based on a preliminary calculation by its actuary. The Company made no cash contributions to its U.S. Pension Plans in 2022. Prior to the plan spin-off described above, on January 4, 2021, the Company made a contribution of $40,000 to the U.S. Pension Plans. (c) Nonretirement Postemployment Benefit Plans Certain of the international plans, specifically those acquired in connection with the purchase of Champion Europe, are in substance nonretirement postemployment benefit plans, which are future liabilities funded through future operational results of the Company. However, for purposes of consolidation, the Company is including these plans within the defined benefit reporting. At December 31, 2022 and January 1, 2022, the total amounts accrued for these plans were $871 and $1,171, respectively and the total expense was $9, $8 and $16 for 2022, 2021 and 2020, respectively. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Income Taxes | Income Taxes The Company generated income (loss) from continuing operations before income tax expense of $352,738, $581,075, and $(142,227) for the years 2022, 2021 and 2020, respectively. The provision for income tax expense (benefit) computed by applying the U.S. statutory rate to income (loss) from continuing operations before income tax expense as reconciled to the actual provisions were: Years Ended December 31, January 1, January 2, Income (loss) from continuing operations before income tax expense: Domestic (45.0) % (3.3) % 445.1 % Foreign 145.0 103.3 (345.1) 100.0 % 100.0 % 100.0 % Tax expense at U.S. statutory rate 21.0 % 21.0 % 21.0 % State income tax (1.6) (0.7) 17.0 Tax on actual and planned remittances of foreign earnings (1.6) 1.5 5.4 Tax on foreign earnings due to U.S. tax reform including measurement period adjustments (1) — (0.3) 26.9 Tax on foreign earnings (U.S. tax reform - GILTI and FDII) 3.8 1.7 (2.3) Foreign taxes less than U.S. statutory rate (14.0) (12.3) 39.0 Statutory stock deduction and other foreign adjustments (2) 22.5 — (34.5) Employee benefits 1.0 0.3 (2.2) Changes in valuation allowance 101.1 1.9 (14.2) Release of unrecognized tax benefit reserves (1.1) (0.9) 13.2 State tax rate change 3.1 1.0 0.3 Tax provision adjustments and revisions to prior years' returns 3.6 (1.6) (1.0) Nondeductible expenses and tax exempt income, net (1.2) (0.4) 10.2 Nondeductible impairment charges — — (3.7) Domestic income tax credits (0.7) (0.4) 2.3 Other, net 1.3 (0.5) (0.1) Taxes at effective worldwide tax rates 137.2 % 10.3 % 77.3 % (1) In 2020, the Company continued to analyze the impacts of the Tax Cuts and Jobs Act (the “Tax Act”) and recently issued regulations that have been published to help taxpayers interpret and apply the legislation. As a result of its analysis, the Company changed its estimate of the tax liability due in connection with the one-time mandatory transition tax and recognized a $4,668 income tax benefit in 2021 and a $38,315 income tax benefit in 2020. (2) During the year ending January 2, 2021, the Company recorded $49,082 of tax expense due to recapture of previous net operating losses created by statutory impairment. This amount is offset in the change in valuation allowance section of the rate reconciliation. During the year ending December 31, 2022, the Company recorded a deferred tax liability related to tax impairments of subsidiary stock in Switzerland which created a net operating loss carryforward. Pursuant to Swiss tax law, the loss created is subject to recapture for which a deferred tax liability was recorded in excess of the deferred tax asset. Current and deferred tax provisions (benefits) were: Current Deferred Total Year ended December 31, 2022 Domestic $ 15,188 $ 201,112 $ 216,300 Foreign 83,607 95,558 179,165 State (2,712) 91,154 88,442 $ 96,083 $ 387,824 $ 483,907 Year ended January 1, 2022 Domestic $ (15,176) $ 6,934 $ (8,242) Foreign 66,844 1,421 68,265 State (2,948) 3,032 84 $ 48,720 $ 11,387 $ 60,107 Year ended January 2, 2021 Domestic $ (7,770) $ (136,221) $ (143,991) Foreign 46,701 34,066 80,767 State 6,256 (52,972) (46,716) $ 45,187 $ (155,127) $ (109,940) Years Ended December 31, January 1, January 2, Cash payments for income taxes $ 95,331 $ 95,011 $ 107,577 The deferred tax assets and liabilities at the respective year-ends were as follows: December 31, January 1, Deferred tax assets: Inventories $ 92,347 $ 64,425 Bad debt allowance 15,854 15,605 Accrued expenses 15,492 20,863 Employee benefits 55,687 104,845 Tax credits 10,859 4,804 Net operating loss and other tax carryforwards 562,326 410,921 Leasing 112,619 112,423 Property and equipment 6,094 4,707 Section 163(j) 50,695 46,729 Capitalized research costs 17,501 5,873 Other 1,029 — Gross deferred tax assets 940,503 791,195 Less valuation allowances (626,540) (306,221) Deferred tax assets 313,963 484,974 Deferred tax liabilities: Derivatives 13,781 10,303 Section 481(a) liability — 23,881 Leasing 101,558 99,470 Accrued tax on unremitted foreign earnings 26,128 38,812 Intangibles 41,331 43,917 Other — 392 Statutory impairment 247,360 — Prepaids 877 434 Deferred tax liabilities 431,035 217,209 Net deferred tax assets (liabilities) $ (117,072) $ 267,765 In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets are deductible, the Company believes it is more likely than not it will realize the benefits of these deductible differences, net of the existing valuation allowances. The changes in the Company’s valuation allowance for deferred tax assets are as follows: December 28, 2019 $ 188,554 Charged to income tax expense 14,959 Charged to other accounts (1) 1,341 January 2, 2021 $ 204,854 Charged to income tax expense 4,343 Charged to other accounts (1) 97,024 January 1, 2022 $ 306,221 Charged to income tax expense 356,740 Charged to other accounts (1) (36,421) December 31, 2022 $ 626,540 (1) Charges to other accounts include the effects of foreign currency translation, purchase accounting adjustments and changes to valuation allowances as a result of intraperiod tax allocations. As of December 31, 2022, the valuation allowance for deferred tax assets was $626,540, made up of $306,743 for foreign loss carryforwards, $21,232 for other foreign deferred tax assets, $63,619 for federal and state operating loss carryforwards, and $234,946 for other federal and state deferred tax assets. The net change in the total valuation allowance for 2022 was $320,319, which relates to an increase of $24,172 for foreign loss carryforwards, an increase of $9,166 for other foreign deferred tax assets, an increase of $52,035 for federal and state operating loss carryforwards and an increase of $234,946 for other federal and state deferred tax assets. The domestic net increase reflects a full valuation allowance recorded against federal and state deferred tax assets in 2022. As of December 31, 2022, the Company concluded that, based on its evaluation of all available positive and negative evidence, its U.S. federal and state deferred tax assets were no longer more likely than not realizable. In making this determination, the Company evaluated positive evidence, including its projections of future taxable income which demonstrate a long-term return to profitability in the U.S., and negative evidence, including recent tax losses incurred and expected near term tax losses in connection with its domestic operations and the lack of sufficient taxable temporary differences expected to reverse in future periods, and determined that the negative evidence outweighed the positive. At December 31, 2022, the Company had gross foreign net operating loss carryforwards of approximately $1,912,611 (on a tax return basis) which are subject to expiration as follows: Fiscal Year: 2023 $ 6,055 2024 3,921 2025 6,076 2026 2,320 2027 4,168 Thereafter 1,890,071 At December 31, 2022, the Company had domestic tax credit carryforwards totaling $10,859, which expire beginning after 2022. At December 31, 2022, the Company had gross federal and state interest carryforwards of approximately $209,536 and $151,718 (on a tax return basis), respectively, which carry forward indefinitely. At December 31, 2022, the Company had gross federal and state net operating loss carryforwards of approximately $173,305 and $1,018,011 (on a tax return basis), respectively, which expire beginning after 2022. During 2022, the Company recorded $696,028 of additional foreign net operating losses due to tax-deductible impairments in Switzerland and Luxembourg. These losses are subject to recapture in Switzerland and Luxembourg such that they will be taxable in a future year, therefore deferred tax liabilities were recorded. The Company believes it is reasonably possible that the deferred tax liability in Switzerland will reverse within the next twelve months due to expected actions by the Company in 2023. The Company has determined that a portion of the Company’s unremitted foreign earnings as of December 31, 2022, totaling approximately $269,019, are not permanently reinvested. The remainder of the Company’s foreign earnings will continue to be permanently reinvested to fund working capital requirements and operations abroad. As of December 31, 2022, the Company has accrued $26,128 of income taxes with respect to the $269,019 of foreign earnings the Company intends to remit in the future. These income tax effects include U.S. federal, state, foreign and withholding tax implications in accordance with the planned remittance of such foreign earnings. An estimate of income tax costs that may be incurred if the permanently reinvested portion of unremitted foreign earnings were in fact remitted is impractical to calculate. In 2022, 2021, and 2020, the Company recognized reductions of unrecognized tax benefits for tax positions of prior years of $311, $12,599, and $18,385, respectively. In 2022, 2021, and 2020, income tax benefits recognized in connection with the expiration of statutes of limitations were $7,191, $147, and $16,655, respectively. The Company believes it is reasonably possible that the amount of unrecognized tax benefits may decrease by $3,267 within the next 12 months due to expirations in statutes of limitations. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: Balance at December 28, 2019 (gross balance of $78,789) $ 74,385 Additions based on tax positions related to the current year 3,675 Additions based on tax positions of prior years 2,666 Settlements — Lapse of statute of limitations (16,655) Reductions for tax positions of prior years (18,385) Balance at January 2, 2021 (gross balance of $46,645) $ 45,686 Additions based on tax positions related to the current year 3,231 Additions based on tax positions of prior years 3,401 Settlements — Lapse of statute of limitations (147) Reductions for tax positions of prior years (12,599) Balance at January 1, 2022 (gross balance of $40,706) $ 39,572 Adjustments related to prior year ending balance 1,138 Additions based on tax positions related to the current year 2,857 Additions based on tax positions of prior years 798 Settlements — Lapse of statute of limitations (7,191) Reductions for tax positions of prior years (311) Balance at December 31, 2022 (gross balance of $37,818) $ 36,863 At December 31, 2022, the balance of the Company’s unrecognized tax benefits, which would, if recognized, affect the Company’s annual effective tax rate was $28,444. The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company recognized $81, $933 and $(5,206) in 2022, 2021 and 2020, respectively, for interest and penalties classified as income tax expense (benefit) in the Consolidated Statements of Income. At December 31, 2022 and January 1, 2022, the Company had a total of $6,303 and $5,865, respectively, of interest and penalties accrued related to unrecognized tax benefits. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The Company is a party to various pending legal proceedings, claims and environmental actions by government agencies. In accordance with the accounting rules for contingencies, the Company records a provision with respect to a claim, suit, investigation or proceeding when it is probable that a liability has been incurred and the amount of the loss can reasonably be estimated. Any provisions are reviewed at least quarterly and are adjusted to reflect the impact and status of settlements, rulings, advice of counsel and other information pertinent to the particular matter. The recorded liabilities for these items were not material to the consolidated financial statements of the Company in any of the years presented. Although the outcome of such items cannot be determined with certainty, the Company’s legal counsel and management are of the opinion that the final outcome of these matters will not have a material adverse impact on the consolidated financial position, results of operations or liquidity. Purchase Commitments In the ordinary course of business, the Company has entered into purchase commitments for raw materials, production and finished goods. These agreements, typically with terms ending within a year, require total payments of $403,316 in 2023, $6,219 in 2024 and $6,840 in 2025. License Agreements The Company is party to several royalty-bearing license agreements for the use of third-party trademarks in certain of its products. The license agreements typically require a minimum guarantee to be paid either at the commencement of the agreement, by a designated date during the term of the agreement or by the end of the agreement period. When payments are made in advance of when they are due, the Company records a prepayment and amortizes the expense in the “Cost of sales” line in the Consolidated Statements of Income uniformly over the guaranteed period. For guarantees required to be paid at the completion of the agreement, royalties are expensed through the “Cost of sales” line in the Consolidated Statements of Income as the related sales are made. The Company has reviewed all license agreements and has concluded that there are no liabilities recorded at inception of the agreements. During 2022, 2021 and 2020, the Company incurred royalty expense of approximately $103,204, $100,281 and $72,775, respectively. Minimum amounts due under the license agreements are approximately $66,215 in 2023, $49,117 in 2024, $29,190 in 2025, $26,190 in 2026, $18,379 in 2027 and $44,498 thereafter. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Stockholders' Equity | Stockholders’ Equity The Company is authorized to issue up to 2,000,000 shares of common stock, par value $0.01 per share, and up to 50,000 shares of preferred stock, par value $0.01 per share, and the Company’s Board of Directors may, without stockholder approval, increase or decrease the aggregate number of shares of stock or the number of shares of stock of any class or series that the Company is authorized to issue. At December 31, 2022 and January 1, 2022, 349,009 and 349,903 shares, respectively, of common stock were issued and outstanding and no shares of preferred stock were issued or outstanding. On February 2, 2022, the Company’s Board of Directors approved a new share repurchase program for up to $600,000 of shares to be repurchased in open market transactions or privately negotiated transactions, subject to market conditions, legal requirements and other factors. Additionally, management has been granted authority to establish a trading plan under Rule 10b5-1 of the Exchange Act in connection with share repurchases, which will allow the Company to repurchase shares in the open market during periods in which the stock trading window is otherwise closed for the Company and certain of the Company’s officers and employees pursuant to the Company’s insider trading policy. The new program replaced the Company’s previous share repurchase program for up to 40,000 shares that was originally approved on February 6, 2020. Unless terminated earlier by the Company’s Board of Directors, the new program will expire on December 28, 2024. Under the February 6, 2020 share repurchase program, the Company entered into transactions to repurchase 14,464 shares at a weighted average repurchase price of $13.83 per share for the year ended January 2, 2021. These shares were repurchased at a total cost of $200,269. The Company did not purchase any shares of the Company’s common stock under the February 6, 2020 share repurchase program during 2021. Under the new program, the Company entered into transactions to repurchase 1,577 shares at a weighted average repurchase price of $15.84 per share for the year ended December 31, 2022. The shares were repurchased at a total cost of $25,018 including broker’s commissions of $31. The Company did not repurchase any shares under the previous share repurchase program during 2022 through the expiration of the program on February 2, 2022. At December 31, 2022, the remaining repurchase authorization under the current share repurchase program totaled $575,013. Dividends In 2020 and 2021, the Company’s Board of Directors declared regular quarterly cash dividends of $0.15 per share of the Company’s outstanding common stock, which were paid in 2020 and 2021, respectively. During 2022, the Company’s Board of Directors declared regular quarterly cash dividends of $0.15 per share of the Company’s outstanding common stock, which were paid on March 8, 2022, May 31, 2022, September 14, 2022 and December 13, 2022. The Company’s Board of Directors eliminated the Company’s quarterly cash dividend as the Company recently shifted its capital allocation strategy to focus the use of all its free cash flow (cash from operations less capital expenditures) on reducing debt and bringing its leverage back to a range that is no greater than two to three times on a net debt-to-adjusted EBITDA basis. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 12 Months Ended |
Dec. 31, 2022 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive Loss The components of AOCI are as follows: Cumulative Translation Adjustment (1) Cash Flow Hedges Defined Benefit Plans Income Taxes Accumulated Other Comprehensive Loss Balance at January 2, 2021 $ (52,820) $ (26,538) $ (668,730) $ 181,129 $ (566,959) Amounts reclassified from accumulated other comprehensive loss — 34,554 25,011 (15,179) 44,386 Current-period other comprehensive income (loss) activity (81,181) (2,772) 74,558 (19,635) (29,030) Total other comprehensive income (loss) (81,181) 31,782 99,569 (34,814) 15,356 Balance at January 1, 2022 $ (134,001) $ 5,244 $ (569,161) $ 146,315 $ (551,603) Amounts reclassified from accumulated other comprehensive loss (13,473) 14,927 21,224 3,319 25,997 Current-period other comprehensive income (loss) activity (81,329) (11,462) 110,584 (4,195) 13,598 Total other comprehensive income (loss) (94,802) 3,465 131,808 (876) 39,595 Balance at December 31, 2022 $ (228,803) $ 8,709 $ (437,353) $ 145,439 $ (512,008) (1) Cumulative Translation Adjustment includes translation adjustments and net investment hedges. See Note “Financial Instruments and Risk Management” for additional disclosures about net investment hedges. The Company uses a portfolio approach to release the income tax effects in accumulated other comprehensive loss related to pension and postretirement benefits. Under this approach, the income tax effects are released from accumulated other comprehensive loss based on the pre-tax adjustments to pension liabilities or assets recognized within other comprehensive income. Any tax effects remaining in accumulated other comprehensive loss are released only when the entire portfolio of the pension and postretirement benefits is liquidated, sold or extinguished. The Company had the following reclassifications out of AOCI: Component of AOCI Location of Reclassification into Income Amount of Reclassification from AOCI Years Ended December 31, January 1, January 2, Write-off of cumulative translation associated with sale of business Income (loss) from discontinued operations, net of tax $ 13,473 $ — $ — Gain (loss) on forward foreign exchange contracts designated as cash flow hedges Cost of sales $ 11,336 $ (15,301) $ 10,069 Income tax (3,401) 4,105 (2,851) Income (loss) from discontinued operations, net of tax (232) (2,890) 4,314 Net of tax 7,703 (14,086) 11,532 Gain (loss) on cross-currency swap contracts designated as cash flow hedges Selling, general and administrative expenses (20,016) (12,155) — Interest expense, net (5,940) (3,556) — Income tax — 4,061 — Net of tax (25,956) (11,650) — Amortization of deferred actuarial loss and prior service cost Other expenses (20,809) (25,671) (22,261) Income tax 52 6,461 5,753 Income (loss) from discontinued operations, net of tax — 560 (698) Pension activity associated with sale of business Income (loss) from discontinued operations, net of tax (460) — — Net of tax (21,217) (18,650) (17,206) Total reclassifications $ (25,997) $ (44,386) $ (5,674) |
Financial Instruments and Risk
Financial Instruments and Risk Management | 12 Months Ended |
Dec. 31, 2022 | |
Disclosure Financial Instruments and Risk Management [Abstract] | |
Financial Instruments and Risk Management | Financial Instruments and Risk Management The Company uses forward foreign exchange contracts and cross-currency swap contracts to manage its exposures to movements in foreign exchange rates primarily related to the Euro, Australian dollar, Canadian dollar and Mexican peso. The Company also uses a combination of cross-currency swap contracts and long-term debt to manage its exposure to foreign currency risk associated with the Company’s net investment in certain European subsidiaries. Hedge Type December 31, January 1, U.S. dollar equivalent notional amount of derivative instruments: Forward foreign exchange contracts Cash Flow and $ 397,908 $ 308,071 Cross-currency swap contracts Cash Flow $ 352,920 $ 352,920 Cross-currency swap contracts Net Investment $ 335,940 $ 335,940 Fair Values of Derivative Instruments The fair values of derivative instruments related to forward foreign exchange contracts and cross-currency swap contracts recognized in the Consolidated Balance Sheets of the Company were as follows: Balance Sheet Location Fair Value December 31, January 1, Derivatives designated as hedging instruments: Forward foreign exchange contracts Other current assets $ 1,892 $ 2,898 Cross-currency swap contracts Other current assets 1,033 974 Forward foreign exchange contracts Other noncurrent assets 110 83 Cross-currency swap contracts Other noncurrent assets 16,477 1,979 Derivatives not designated as hedging instruments: Forward foreign exchange contracts Other current assets 5,402 5,439 Total derivative assets 24,914 11,373 Derivatives designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities and other: Other (1,263) (349) Cross-currency swap contracts Accrued liabilities and other: Other (252) (222) Forward foreign exchange contracts Other noncurrent liabilities (178) (14) Cross-currency swap contracts Other noncurrent liabilities (27,753) (11,387) Derivatives not designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities and other: Other (4,841) (331) Total derivative liabilities (34,287) (12,303) Net derivative liability $ (9,373) $ (930) Cash Flow Hedges The Company uses forward foreign exchange contracts and cross-currency swap contracts to reduce the effect of fluctuating foreign currencies on foreign currency-denominated transactions, foreign currency-denominated investments and other known foreign currency exposures. Gains and losses on these contracts are intended to offset losses and gains on the hedged transaction in an effort to reduce the earnings volatility resulting from fluctuating foreign currency exchange rates. On April 1, 2021, in connection with a reduction in the amount of the 3.5% Senior Notes designated in the European net investment hedge discussed below, the Company entered into three pay-fixed rate, receive-fixed rate cross-currency swap contracts with a total notional amount of €300,000. The Company designated these cross-currency swap contracts to hedge the undesignated portion of the foreign currency cash flow exposure related to the Company’s 3.5% Senior Notes, which had a carrying amount of €500,000 as of December 31, 2022. These cross-currency swap contracts, which mature on June 15, 2024, swap Euro-denominated interest payments for U.S. dollar-denominated interest payments, thereby economically converting €300,000 of the Company’s €500,000 fixed-rate 3.5% Senior Notes to a fixed-rate 4.7945% USD-denominated obligation. The Company expects to reclassify into earnings during the next 12 months a net loss from AOCI of approximately $1,457. The Company is hedging exposure to the variability in future foreign currency-denominated cash flows for forecasted transactions over the next 14 months and for long-term debt over the next 18 months. The effect of derivative instruments designated as cash flow hedges on the Consolidated Statements of Income and AOCI is as follows: Amount of Gain (Loss) Years Ended December 31, January 1, January 2, Forward foreign exchange contracts $ 10,843 $ 12,170 $ (15,643) Cross-currency swap contracts (22,305) (14,942) — Total $ (11,462) $ (2,772) $ (15,643) Location of Gain (Loss) Amount of Gain (Loss) Years Ended December 31, January 1, January 2, Forward foreign exchange contracts (1) Cost of sales $ 11,336 $ (15,301) $ 10,069 Forward foreign exchange contracts (1) Income (loss) from discontinued operations, net of tax (307) (3,542) 5,612 Cross-currency swap contracts (1) Selling, general and administrative expenses (20,016) (12,155) — Cross-currency swap contracts (1) Interest expense, net (5,940) (3,556) — Total $ (14,927) $ (34,554) $ 15,681 (1) The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. The following table presents the amounts in the Consolidated Statements of Income in which the effects of cash flow hedges are recorded: Years Ended December 31, January 1, January 2, Cost of sales $ 4,012,542 $ 4,149,541 $ 4,524,461 Selling, general and administrative expenses $ 1,701,563 $ 1,853,971 $ 1,560,034 Interest expense, net $ 157,073 $ 163,067 $ 164,238 Income (loss) from discontinued operations, net of tax $ 3,965 $ (443,744) $ (43,292) Net Investment Hedges In July 2019, the Company entered into two pay-fixed rate, receive-fixed rate cross-currency swap contracts with a total notional amount of €300,000 that were designated as hedges of a portion of the beginning balance of the Company’s net investment in certain European subsidiaries. These cross-currency swap contracts, which mature on May 15, 2024, swap U.S. dollar-denominated interest payments for Euro-denominated interest payments, thereby economically converting a portion of the Company’s fixed-rate 4.625% Senior Notes to a fixed-rate 2.3215% Euro-denominated obligation. In July 2019, the Company also designated the full amount of its 3.5% Senior Notes with a carrying value of €500,000, which is a nonderivative financial instrument, as a hedge of a portion of the beginning balance of the Company’s European net investment. As of April 1, 2021, the Company reduced the amount of its 3.5% Senior Notes designated in the European net investment hedge from €500,000 to €200,000. As of December 31, 2022 and January 1, 2022, the U.S. dollar equivalent carrying value of Euro-denominated long-term debt designated as a partial European net investment hedge was $214,110 and $227,454, respectively. The amount of after-tax gains (losses) included in AOCI in the Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges are as follows: Amount of Gain (Loss) Recognized in AOCI Years Ended December 31, January 1, January 2, Euro-denominated long-term debt $ 9,716 $ 24,928 $ (36,609) Cross-currency swap contracts 14,497 13,670 (14,404) Total $ 24,213 $ 38,598 $ (51,013) The effect of derivative and non-derivative instruments designated as net investment hedges on the Consolidated Statements of Income are as follows: Location of Gain (Loss) Reclassified from AOCI into Income Amount of Gain (Loss) Reclassified from AOCI into Income Years Ended December 31, January 1, January 2, Euro-denominated long-term debt Income (loss) from discontinued operations, net of tax $ (13,348) $ — $ — Cross-currency swap contracts Income (loss) from discontinued operations, net of tax (2,505) — — Cross-currency swap contracts (amounts excluded from effectiveness testing) Interest expense, net 8,368 7,389 7,637 Total $ (7,485) $ 7,389 $ 7,637 The following table presents the amounts in the Consolidated Statements of Income in which the amounts excluded from effectiveness testing for net investment hedges are recorded: Years Ended December 31, January 1, January 2, Income (loss) from discontinued operations, net of tax $ 3,965 $ (443,744) $ (43,292) Interest expense, net $ 157,073 $ 163,067 $ 164,238 Mark to Market Hedges Derivatives used in mark to market hedges are not designated as hedges under the accounting standards. The Company uses forward foreign exchange derivative contracts as hedges against the impact of foreign exchange fluctuations on existing accounts receivable and payable balances and intercompany lending transactions denominated in foreign currencies. Forward foreign exchange derivative contracts are recorded as mark to market hedges when the hedged item is a recorded asset or liability that is revalued in each accounting period. Any gains or losses resulting from changes in fair value are recognized directly into earnings. Gains or losses on these contracts largely offset the net remeasurement gains or losses on the related assets and liabilities. The effect of derivative instruments not designated as hedges on the Consolidated Statements of Income is as follows: Location of Gain (Loss) Amount of Gain (Loss) Recognized in Income Years Ended December 31, January 1, January 2, Forward foreign exchange contracts Cost of sales $ (16,557) $ 24,087 $ (16,163) Forward foreign exchange contracts Selling, general and (290) 2,784 (2,029) Forward foreign exchange contracts Income (loss) from discontinued operations, net of tax — 4,706 (3,707) Total $ (16,847) $ 31,577 $ (21,899) |
Fair Value of Assets and Liabil
Fair Value of Assets and Liabilities | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Assets and Liabilities | Fair Value of Assets and Liabilities Fair value is an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability. A three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value, is utilized for disclosing the fair value of the Company’s assets and liabilities. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs about which little or no market data exists, therefore requiring an entity to develop its own assumptions. Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques: • Market approach — prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. • Cost approach — amount that would be required to replace the service capacity of an asset or replacement cost. • Income approach — techniques to convert future amounts to a single present amount based on market expectations, including present value techniques, option-pricing and other models. The Company primarily applies the market approach for commodity derivatives and for all defined benefit plan investment assets and the income approach for interest rate and foreign currency derivatives for recurring fair value measurements and attempts to utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The determination of fair values incorporates various factors that include not only the credit standing of the counterparties involved and the impact of credit enhancements, but also the impact of the Company’s nonperformance risk on its liabilities. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels. As of December 31, 2022 and January 1, 2022, the Company held certain financial assets and liabilities that are required to be measured at fair value on a recurring basis. These consisted of the Company’s derivative instruments related to forward foreign exchange derivative contracts, cross-currency swap derivative contracts, defined benefit pension plan investment assets and deferred compensation plan liabilities. The fair values of forward foreign exchange derivative contracts are determined using the cash flows of the forward contracts, discount rates to account for the passage of time and current foreign exchange market data which are all based on inputs readily available in public markets and are categorized as Level 2. The fair values of cross-currency swap derivative contracts are determined using the cash flows of the swap contracts, discount rates to account for the passage of time, current foreign exchange and interest rate market data and credit risk, which are all based on inputs readily available in public markets and are categorized as Level 2. The fair value of deferred compensation plan liabilities is based on readily available current market data and is categorized as Level 2. The fair values of defined benefit pension plan investment assets include: certain U.S. equity securities, certain foreign equity securities, cash and cash equivalents and debt securities that are determined based on quoted prices in public markets categorized as Level 1; insurance contracts that are determined based on inputs readily available in public markets or can be derived from information available in publicly quoted markets categorized as Level 2; certain foreign equity securities, debt securities and commodity investments measured at their net asset value, which is determined based on inputs readily available in public markets; and investments in hedge fund of funds and real estate investments that are based on unobservable inputs about which little or no market data exists and are measured at a net asset value. Assets valued utilizing a net asset value are not required to be classified within the fair value hierarchy. There were no changes during 2022 to the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis. As of and for the year ended December 31, 2022, the Company did not have any non-financial assets or liabilities that were required to be measured at fair value on a recurring basis or non-recurring basis. The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities within continuing operations accounted for at fair value on a recurring basis. Assets (Liabilities) at Fair Value as of December 31, 2022 Total Quoted Prices In Significant Significant Defined benefit pension plan investment assets: U.S. equity securities $ 158,305 $ 158,305 $ — $ — Foreign equity securities 33,713 33,713 — — Debt securities 81,812 81,812 — — Cash and other 11,045 11,045 — — Total plan assets in the fair value hierarchy 284,875 284,875 — — Plan assets measured at net asset value: (1) Hedge fund of funds 313,521 Foreign equity securities 135,076 Debt securities 670 Real estate 65,364 Commodities 16,738 Total plan assets measured at net asset value 531,369 Total plan assets 816,244 Derivative contracts: Forward foreign exchange contracts - assets 7,404 — 7,404 — Cross-currency swap contracts - assets 17,510 — 17,510 — Forward foreign exchange contracts - liabilities (6,282) — (6,282) — Cross-currency swap contracts - liabilities (28,005) — (28,005) — Total derivative contracts (9,373) — (9,373) — Deferred compensation plan liability (16,096) — (16,096) — Total $ 790,775 $ 284,875 $ (25,469) $ — (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in the tables above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. Assets (Liabilities) at Fair Value as of January 1, 2022 Total Quoted Prices In Significant Significant Defined benefit pension plan investment assets: U.S. equity securities $ 201,111 $ 201,111 $ — $ — Foreign equity securities 47,099 47,099 — — Debt securities 24,125 24,125 — — Cash and other 1,597 1,597 — — Total plan assets in the fair value hierarchy 273,932 273,932 — — Plan assets measured at net asset value: (1) Hedge fund of funds 356,289 Foreign equity securities 170,741 Debt securities 87,284 Real estate 57,479 Commodities 27,873 Total plan assets measured at net asset value 699,666 Total plan assets 973,598 Derivative contracts: Forward foreign exchange contracts - assets 8,420 — 8,420 — Cross-currency swap contracts - assets 2,953 — 2,953 — Forward foreign exchange contracts - liabilities (694) — (694) — Cross-currency swap contracts - liabilities (11,609) — (11,609) — Total derivative contracts (930) — (930) — Deferred compensation plan liability (20,916) — (20,916) — Total $ 951,752 $ 273,932 $ (21,846) $ — (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in the tables above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. Fair Value of Financial Instruments The carrying amounts of cash and cash equivalents, trade accounts receivable and accounts payable approximated fair value as of December 31, 2022 and January 1, 2022. The fair value of debt, which is classified as a Level 2 liability, was $3,697,856 and $3,504,412 as of December 31, 2022 and January 1, 2022, respectively. Debt had a carrying value of $3,872,275 and $3,368,634 as of December 31, 2022 and January 1, 2022, respectively. The fair values were estimated using quoted market prices as provided in secondary markets, which consider the Company’s credit risk and market related conditions. |
Business Segment Information
Business Segment Information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Business Segment Information | Business Segment Information The Company’s operations are managed and reported in three operating segments, each of which is a reportable segment for financial reporting purposes: Innerwear, Activewear and International. These segments are organized principally by product category and geographic location. Each segment has its own management team that is responsible for the operations of the segment’s businesses, but the segments share a common supply chain and media and marketing platforms. Other consists of the Company’s U.S.-based outlet stores, U.S. Sheer Hosiery business and certain sales from its supply chain to the European Innerwear business. In the fourth quarter of 2021, the Company reached the decision to divest its U.S. Sheer Hosiery business, including the L’eggs brand, as part of its strategy to streamline its portfolio under its Full Potential plan. See Note “Assets and Liabilities Held for Sale” for additional information. The Company considers its chief executive officer to be the Company’s chief operating decision maker. The Company’s chief operating decision maker manages business operations, evaluates performance and allocates resources based on the segments’ net revenues and operating income. The Company reports inventories by segment as that information is used by the chief operating decision maker in assessing segment performance. The Company does not report its other assets by segment as that information is not used by the chief operating decision maker in assessing segment performance. The types of products and services from which each reportable segment derives its revenues are as follows: • Innerwear includes sales in the United States of basic branded apparel products that are replenishment in nature under the product categories of men’s underwear, women’s panties, children’s underwear and socks, and intimate apparel, which includes bras and shapewear. Innerwear also includes sales of PPE including products such as cloth face coverings and gowns in 2020. • Activewear includes sales in the United States of branded products that are primarily seasonal in nature to both retailers and wholesalers, as well as licensed sports apparel and licensed logo apparel. • International primarily includes sales of our innerwear and activewear products, including PPE in 2020, outside the United States, primarily in Australia, Europe, Asia, Latin America and Canada. The Company evaluates the operating performance of its segments based upon segment operating profit, which is defined as operating profit before general corporate expenses, restructuring and other action-related charges and amortization of intangibles. The accounting policies of the segments are consistent with those described in Note “Summary of Significant Accounting Policies.” Years Ended December 31, January 1, January 2, Net sales: Innerwear $ 2,429,966 $ 2,719,788 $ 2,978,009 Activewear 1,555,062 1,679,639 1,184,413 International 1,914,268 2,066,249 1,711,432 Other 334,354 335,564 253,307 Total net sales $ 6,233,650 $ 6,801,240 $ 6,127,161 Years Ended December 31, January 1, January 2, Segment operating profit: Innerwear $ 388,586 $ 573,852 $ 718,923 Activewear 153,710 236,400 67,643 International 283,036 339,317 249,718 Other 17,019 30,922 (10,140) Total segment operating profit 842,351 1,180,491 1,026,144 Items not included in segment operating profit: General corporate expenses (232,975) (219,984) (218,424) Restructuring and other action-related charges (59,858) (131,710) (734,196) Amortization of intangibles (29,973) (31,069) (30,858) Total operating profit 519,545 797,728 42,666 Other expenses (9,734) (53,586) (20,655) Interest expense, net (157,073) (163,067) (164,238) Income (loss) from continuing operations before income tax expense $ 352,738 $ 581,075 $ (142,227) The Company incurred restructuring and other action-related charges that were reported in the following lines in the Consolidated Statements of Income: Years Ended December 31, January 1, January 2, Cost of sales $ 17,025 $ 10,098 $ 670,618 Selling, general and administrative expenses 42,833 121,612 63,578 Total included in operating profit 59,858 131,710 734,196 Other expenses — 45,699 — Total included in income (loss) from continuing operations before income tax expense 59,858 177,409 734,196 Income tax (expense) benefit (413,766) 53,665 205,342 Total restructuring and other action-related charges $ 473,624 $ 123,744 $ 528,854 The components of restructuring and other action-related charges were as follows: Years Ended December 31, January 1, January 2, Full Potential plan: Professional services $ 23,994 $ 44,617 $ — Supply chain segmentation 17,982 5,419 — Technology 11,922 4,617 — Operating model 8,221 23,191 — Impairment of intangible assets — 7,302 — (Gain) loss on sale of business and classification of assets held for sale (3,535) 38,364 — Other 1,274 8,200 — Inventory SKU rationalization — — 192,704 PPE inventory write-off — — 362,913 PPE vendor commitments — — 26,400 Supply chain actions — — 19,636 Program exit costs — — 9,854 Other restructuring costs — — 7,763 COVID-19 related charges: Supply chain re-startup — — 48,608 Bad debt — — 9,418 Inventory — — 14,869 Goodwill — — 25,173 Write-off of acquisition tax asset — — 16,858 Total included in operating profit 59,858 131,710 734,196 Early extinguishment and refinancing of debt included in other expenses — 45,699 — Total included in income (loss) from continuing operations before income tax expense 59,858 177,409 734,196 Discrete tax (expense) benefit (422,918) 27,147 69,628 Tax effect on actions 9,152 26,518 135,714 Total included in income tax (expense) benefit (413,766) 53,665 205,342 Total restructuring and other action-related charges $ 473,624 $ 123,744 $ 528,854 Restructuring and other action-related charges within operating profit included $59,858 and $131,710 of charges related to the implementation of the Company’s Full Potential plan in the year ended December 31, 2022 and January 1, 2022, respectively. Full Potential plan charges in the year ended December 31, 2022 included charges related to supply chain segmentation of $17,982 to position the Company’s manufacturing network to align with revenue growth opportunities of its Full Potential plan demand trends which is reflected in the “Cost of sales” line of the Consolidated Statements of Income. In the fourth quarter of 2021, the Company determined that its U.S. Sheer Hosiery business met held-for-sale accounting criteria and recorded a non-cash charge related to the Full Potential plan of $38,364 to record a valuation allowance against the net assets held for sale to write down the carrying value of the disposal group to the estimated fair value less costs of disposal. In the year ended December 31, 2022, the Company recorded a non-cash gain of $3,535, to adjust the valuation allowance related to the U.S. Sheer Hosiery business resulting from a decrease in carrying value due to changes in working capital. These valuation allowance adjustments are reflected in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. Additionally, Full Potential plan charges in the year ended January 1, 2022 included impairment charges of $7,302, which are reflected in the “Selling, general and administrative expenses” line of the Consolidated Statements of Income, related to the full impairment of an indefinite-lived trademark related to a specific brand within the European Innerwear business that was excluded from the disposal group as it was not marketed for sale. In the third quarter of 2021, the Company recorded a Full Potential plan charge of $16,000 for an action to resize its U.S. corporate office workforce through a voluntary retirement program which was reflected in the “Selling, general and administrative expenses” line of the Consolidated Statements of Income and in the “Operating model” line of the restructuring and other action-related charges table above. At January 1, 2022, the accrual for employee termination and other benefits related to the Company’s 2021 voluntary retirement program was $15,688. During the year ended December 31, 2022, the Company approved actions to position the Company’s manufacturing network to align with revenue growth opportunities of its Full Potential plan demand trends and to reduce corporate headcount which resulted in charges of $16,770 for employee termination and other benefits for employees affected by the actions. Of these charges, $7,170 is reflected in the “Cost of sales” line in the Consolidated Statements of Income and in the Supply chain segmentation line in the restructuring and other action-related charges table above and $9,600 related to corporate headcount reductions is reflected in the “Selling, general and administrative expenses” line of the Consolidated Statements of Income and in the “Operating model” line in the restructuring and other action-related table. During the year ended December 31, 2022, benefit payments and other adjustments of $16,288, have been made, resulting in an ending accrual for the actions noted above of $16,170 which is included in the “Accrued liabilities” line of the Consolidated Balance Sheets at December 31, 2022. In the fourth quarter of 2022, the Company recorded a non-cash discrete tax charge of $422,918 to reflect a full valuation allowance against the Company’s U.S. federal and state deferred tax assets. As of December 31, 2022, the Company concluded that, based on its evaluation of all available positive and negative evidence, its U.S. federal and state deferred tax assets were no longer more likely than not realizable. In making this determination, the Company evaluated positive evidence, including its projections of future taxable income which demonstrate a long-term return to profitability in the U.S., and negative evidence, including recent tax losses incurred and expected near term tax losses in connection with its domestic operations and the lack of sufficient taxable temporary differences expected to reverse in future periods, and determined that the negative evidence outweighed the positive. In the fourth quarter of 2021, the Company also recorded a charge of $45,699 in restructuring and other action-related charges related to the refinancing of its Senior Secured Credit Facility and the redemption of the 5.375% Senior Notes. The charge, which is reported in the “Other expenses” line in the Consolidated Statements of Income, included a payment of $34,840 for a make-whole premium in connection with the redemption of the 5.375% Senior Notes, a non-cash charge of $8,899 for the write-off of unamortized debt issuance costs related to the redemption of the 5.375% Senior Notes and the refinancing of the Senior Secured Credit Facility and $1,960 in fees related to the refinancing. See Note “Debt”. In the fourth quarter of 2020, the Company began the implementation of its Full Potential plan which included a number of actions to simplify its business including streamlining its portfolio and SKU rationalization. Specifically, the Company no longer viewed PPE as a future growth opportunity for the Company. Therefore, the Company recorded a charge of $362,913 to write down its entire PPE inventory balance to its estimated net realizable value and a charge of $26,400 to accrue for vendor commitments for PPE materials that were paid in 2021. Additionally, the Company commenced an initiative to reduce 20% of its SKUs in inventory in order to streamline product offerings while also implementing a formal lifecycle management process. As a result, the Company recorded a charge of $192,704 to write down inventory to its estimated net realizable value taking into account these initiatives. In the fourth quarter of 2020, the Company also recorded a charge to write off an acquisition tax asset. Additionally, in 2020, restructuring and other action-related charges included $48,608 of supply chain re-start up charges primarily related to incremental costs incurred, such as freight and sourcing premiums, to expedite product to meet customer demand following the extended shut-down of parts of the Company’s manufacturing network as a result of the COVID-19 pandemic and $49,460 of asset write-down charges recorded as a result of the ongoing effects of the COVID-19 pandemic. Restructuring and other action-related charges in 2020 also included charges for supply chain actions to reduce overhead costs principally within the Western Hemisphere network and charges associated with exiting the C9 Champion mass program and the DKNY intimate apparel license in 2019. December 31, 2022 Innerwear Activewear International Other Unallocated Total Assets Assets: Inventories $ 918,104 $ 665,500 $ 364,231 $ 31,837 $ — $ 1,979,672 Assets held for sale — — — — 13,327 13,327 All other assets — — — — 4,510,877 4,510,877 Total assets $ 6,503,876 January 1, 2022 Innerwear Activewear International Other Unallocated Total Assets Assets: Inventories $ 829,093 $ 447,297 $ 279,379 $ 28,246 $ — $ 1,584,015 Assets held for sale — — — — 327,157 327,157 All other assets — — — — 5,160,264 5,160,264 Total assets $ 7,071,436 Years Ended December 31, January 1, January 2, Depreciation and amortization expense: Innerwear $ 26,518 $ 25,816 $ 27,407 Activewear 24,200 23,562 23,621 International 19,670 22,476 24,307 Other 3,341 4,578 5,520 73,729 76,432 80,855 Corporate 32,538 33,698 34,112 Total depreciation and amortization expense $ 106,267 $ 110,130 $ 114,967 Sales to Walmart were substantially in the Innerwear and Activewear segments. Sales to Walmart represented 16%, 17% and 16% of total net sales in 2022, 2021 and 2020, respectively. |
Geographic Area Information
Geographic Area Information | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Geographic Area Information | Geographic Area Information Years Ended or at December 31, January 1, January 2, Sales Property, Net Sales Property, Net Sales Property, Net Americas $ 4,532,595 $ 325,957 $ 4,995,230 $ 325,188 $ 4,544,651 $ 351,841 Asia Pacific 1,149,954 85,966 1,257,037 85,538 1,085,822 92,582 Europe 534,892 30,481 530,440 30,675 482,630 33,398 Other 16,209 — 18,533 — 14,058 — $ 6,233,650 $ 442,404 $ 6,801,240 $ 441,401 $ 6,127,161 $ 477,821 The net sales by geographic region are attributed by customer location. The property by geographic region includes assets held and used, which are recognized within the “Property, net” line in the Consolidated Balance Sheets. |
Quarterly Financial Data
Quarterly Financial Data | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Quarterly Financial Data | Quarterly Financial Data (Unaudited)The following table presents the summarized unaudited quarterly financial data of the Company for the fourth quarter ended December 31, 2022 and January 1, 2022. See the Company’s Condensed Consolidated Statements of Income in its Quarterly Reports on Form 10-Q for the quarters ended April 2, 2022, July 2, 2022 and October 1, 2022 for additional quarterly information related to 2022 and 2021. Quarters Ended December 31, January 1, Net sales $ 1,473,286 $ 1,752,349 Cost of sales 971,309 1,084,621 Gross profit 501,977 667,728 Selling, general and administrative expenses 441,642 512,162 Operating profit 60,335 155,566 Other expenses 3,646 47,359 Interest expense, net 49,665 35,307 Income from continuing operations before income tax expense 7,024 72,900 Income tax expense 425,132 4,946 Income (loss) from continuing operations (418,108) 67,954 Loss from discontinued operations, net of tax — (7,921) Net income (loss) $ (418,108) $ 60,033 Earnings (loss) per share - basic: Continuing operations $ (1.19) $ 0.19 Discontinued operations — (0.02) Net income (loss) $ (1.19) $ 0.17 Earnings (loss) per share - diluted: Continuing operations $ (1.19) $ 0.19 Discontinued operations — (0.02) Net income (loss) $ (1.19) $ 0.17 |
Basis of Presentation (Policies
Basis of Presentation (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Fiscal period policy | The Company’s fiscal year ends on the Saturday closest to December 31. All references to “2022”, “2021” and “2020” relate to the 52-week fiscal year ended on December 31, 2022 and January 1, 2022, and the 53-week fiscal year ended on January 2, 2021, respectively. Two subsidiaries of the Company close one day after the Company’s consolidated year end. The difference in reporting of financial information for these subsidiaries did not have a material impact on the Company’s financial condition, results of operations or cash flows. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Consolidation | ConsolidationThe accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation, except for certain intercompany sales and related profit and receivables from the Company’s supply chain to the European Innerwear business, which is classified as discontinued operations in the consolidated financial statements and was sold on March 5, 2022. See Note “Assets and Liabilities Held for Sale” for additional information. |
Use of Estimates | Use of EstimatesThe preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make use of estimates and assumptions that affect the reported amount of assets and liabilities, certain financial statement disclosures at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results may vary from these estimates. |
Foreign Currency Translation | Foreign Currency TranslationForeign currency-denominated assets and liabilities are translated into U.S. dollars at exchange rates existing at the respective balance sheet dates. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of accumulated other comprehensive loss (“AOCI”) within stockholders’ equity. The Company translates the results of operations of its foreign operations at the average exchange rates during the respective periods. Gains and losses resulting from foreign currency transactions are included in both the “Cost of sales” and “Selling, general and administrative expenses” lines in the Consolidated Statements of Income. |
Sales Recognition and Incentives | Sales Recognition and Incentives The Company recognizes revenue when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. The Company records a sales reduction for returns and allowances based upon historical return experience. The Company earns royalty revenues through license agreements with manufacturers of other consumer products that incorporate certain of the Company’s brands. The Company accrues revenue earned under these contracts based upon reported sales from the licensee. The Company offers a variety of sales incentives to resellers and consumers of its products, and the policies regarding the recognition and display of these incentives within the Consolidated Statements of Income are as follows: Discounts, Coupons, and Rebates The Company provides customers with discounts and rebates that are explicitly stated in the Company’s contracts and are recorded as a reduction of revenue in the period the product revenue is recognized. The cost of these incentives is estimated using a number of factors, including historical utilization and redemption rates. The Company includes incentives offered in the form of free products in the determination of cost of sales. For all variable consideration, where appropriate, the Company estimates the amount using the expected value, which takes into consideration historical experience, current contractual requirements, specific known market events and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates of the amount of consideration to which the customer is entitled based on the terms of the contracts. Volume-Based Incentives Volume-based incentives involve rebates or refunds of cash that are redeemable only if the customer completes a specified number of sales transactions. Under these incentive programs, the Company estimates the anticipated rebate to be paid and allocates a portion of the estimated cost of the rebate to each underlying sales transaction with the customer. The Company records volume-based incentives as a reduction of revenue. Cooperative Advertising Under cooperative advertising arrangements, the Company agrees to reimburse the retailer for a portion of the costs incurred by the retailer to advertise and promote certain of the Company’s products. The Company recognizes the cost of cooperative advertising programs in the period in which the advertising and promotional activity takes place as a reduction of revenue. Fixtures and Racks Store fixtures and racks are periodically used by resellers to display Company products. The Company expenses the cost of these fixtures and racks in the period in which they are delivered to the resellers. The Company includes the costs of fixtures and racks incurred by resellers and charged back to the Company in the determination of net sales. Fixtures and racks purchased by the Company and provided to resellers are included in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. Product Returns The Company generally offers customers a limited right of return for a purchased product. The Company estimates the amount of its product sales that may be returned by its customers and records this as a reduction of revenue in the period the related product revenue is recognized. |
Advertising Expense | Advertising ExpenseAdvertising represents one of several brand building methods used by the Company. Advertising costs, which include the development and production of advertising materials and the communication of these materials through various forms of media, are expensed in the period the advertising first takes place. The Company recognized advertising expense in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income of $208,881, $208,998 and $113,586 in 2022, 2021 and 2020, respectively. |
Shipping and Handling Costs | Shipping and Handling CostsRevenue received for shipping and handling costs is included in net sales and was $13,578, $19,461 and $18,943 in 2022, 2021 and 2020, respectively. Shipping costs, which comprise payments to third-party shippers, and handling costs, which consist of warehousing costs in the Company’s various distribution facilities, were $415,989, $447,131 and $389,252 in 2022, 2021 and 2020, respectively. The Company recognizes shipping, handling and distribution costs in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. |
Research and Development | Research and DevelopmentResearch and development costs are expensed as incurred and are included in the “Selling, general and administrative expenses” line in the Consolidated Statements of Income. Research and development includes expenditures for new product, technological improvements for existing products and process innovation, which primarily consist of salaries, consulting and supplies attributable to time spent on research and development activities. Additional costs include depreciation and maintenance for research and development equipment and facilities. Research and development expense was $38,911, $39,320 and $37,367 in 2022, 2021 and 2020, respectively. |
Defined Contribution Benefit Plans | Defined Contribution Benefit PlansThe Company sponsors 401(k) plans as well as other defined contribution benefit plans. Expense for these plans was $26,296, $37,979 and $34,720 in 2022, 2021 and 2020, respectively. |
Cash and Cash Equivalents | Cash and Cash Equivalents All highly liquid investments with an original maturity of three months or less at the time of purchase are considered to be cash equivalents. Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included within “Other current assets” in the Consolidated Balance Sheets. As of January 2, 2021, an indemnification escrow balance of A$1,517 (U.S. $1,166) related to the Company’s 2018 acquisition of BNT Holdco Pty Limited was held in one of the Company’s bank accounts and classified as restricted cash in the “Other current assets” line in the Consolidated Balance Sheets. This balance was paid to the sellers in the second quarter of 2021. The Company had no restricted cash as of December 31, 2022 and January 1, 2022. |
Accounts Receivable Valuation | Accounts Receivable ValuationAccounts receivable are stated at their net realizable value. The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the accounts receivable portfolio. Trade receivables are evaluated on a collection (pool) basis and aggregated on the basis of similar risk characteristics which are determined on the basis of historical losses, the aging of trade receivables, industry trends, and its customers’ financial strength, credit standing and payment and default history. |
Inventory Valuation | Inventory ValuationInventories are stated at the estimated lower of cost or net realizable value. Cost is determined by the first-in, first-out, or “FIFO”, method for inventories. Obsolete, damaged, and excess inventory is carried at the net realizable value, which is determined by assessing historical recovery rates, current market conditions and future marketing and sales plans. Rebates, discounts and other cash consideration received from a vendor related to inventory purchases are reflected as reductions in the cost of the related inventory item and are therefore reflected in cost of sales when the related inventory item is sold. |
Property | Property Property is stated at historical cost and depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. Machinery and equipment is depreciated over periods ranging from one Property is tested for recoverability whenever events or changes in circumstances indicate that its carrying value may not be recoverable. Such events include significant adverse changes in the business climate, several periods of operating or cash flow losses, forecasted continuing losses or a current expectation that an asset or an asset group will be disposed of before the end of its useful life. Recoverability of property is evaluated by a comparison of the carrying amount of an asset or asset group to future net undiscounted cash flows expected to be generated by the asset or asset group. If these comparisons indicate that an asset is not recoverable, the impairment loss recognized is the amount by which the carrying amount of the asset exceeds the estimated fair value. When an impairment loss is recognized for assets to be held and used, the adjusted carrying amount of those assets is depreciated over its remaining useful life. Restoration of a previously recognized impairment loss is not permitted under GAAP. |
Leases | Leases The Company accounts for leases under the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)”. The Company determines whether an arrangement is a lease at inception. At inception, a right of use asset and lease liability is recorded. The Company has operating leases for real estate (primarily retail stores and operating facilities) and certain equipment. The Company’s finance leases are not material. Leases with a term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The exercise of lease renewal options is at the Company’s sole discretion. In general, for leased retail real estate, the Company will not include renewal options in the underlying lease term. However, if a situation arises where the lessor has control over the option periods, then the Company will include these periods within the lease term. The depreciable life of assets and leasehold improvements are limited by the expected lease term. Certain of the Company’s lease agreements include rental payments based on a percentage of retail sales over contractual levels and others include rental payments adjusted periodically for inflation. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. In light of temporary store closures related to the COVID-19 pandemic, the Company took actions in 2020, 2021 and 2022 with respect to certain of its existing leases, including withholding rent payments and engaging with landlords to obtain rent deferrals and other rent concessions. Consistent with updated guidance from the FASB in April 2020, the Company elected to treat agreed-upon payment deferrals that resulted in the total payments required by the modified contract being substantially the same as total payments required by the contract as if there were no modifications to the lease contract. The Company elected to treat other agreed-upon rent concessions, which resulted in reduced minimum lease payments, as variable lease payments. For any agreed-upon rent concessions, which change the payment terms from minimum rental amounts to amounts |
Trademarks and Other Identifiable Intangible Assets | Trademarks and Other Identifiable Intangible Assets The primary identifiable intangible assets of the Company are trademarks, licensing agreements, customer and distributor relationships and computer software. Identifiable intangible assets with finite lives are amortized and those with indefinite lives are not amortized. The estimated useful life of a finite-lived intangible asset is based upon a number of factors, including the effects of demand, competition, expected changes in distribution channels and the level of maintenance expenditures required to obtain future cash flows. Trademarks determined to have finite lives are generally amortized over periods ranging from 10 to 20 years, license agreements are generally amortized over periods ranging from three one Identifiable intangible assets that are subject to amortization are evaluated for impairment using a process similar to that used in evaluating elements of property. Identifiable intangible assets not subject to amortization are assessed for impairment at least annually, as of the first day of the third fiscal quarter, and as triggering events occur. The impairment test for identifiable intangible assets not subject to amortization consists of comparing the fair value of the intangible asset, which is determined using the income approach, to its carrying value. If the carrying value exceeds the fair value of the asset, an impairment loss is recognized in an amount equal to such excess. Fair values of intangible assets are primarily based on future cash flows projected to be generated from that asset. In performing the discounted cash flow analysis, management makes various judgments, estimates and assumptions, the most significant of which are the assumptions related to revenue growth rates, operating profit margin rates, terminal growth rates, and discount rates. Rates used to discount cash flows are dependent upon interest rates and the cost of capital at a point in time. There are inherent uncertainties related to these factors and management’s judgment in applying them to the analysis of intangible asset impairment. The Company capitalizes internal software development costs incurred during the application development stage, which include the actual costs to purchase software from vendors and generally include personnel and related costs for employees who were directly associated with the enhancement and implementation of purchased computer software. Additions to computer software are included in the “Capital expenditures” line in the Consolidated Statements of Cash Flows. |
Goodwill | Goodwill Goodwill is the amount by which the purchase price exceeds the fair value of the assets acquired and liabilities assumed in a business combination. When a business combination is completed, the assets acquired and liabilities assumed are assigned to the reporting unit or units of the Company given responsibility for managing, controlling and generating returns on these assets and liabilities. In many instances, all of the acquired assets and assumed liabilities are assigned to a single reporting unit and in these cases, all of the goodwill is assigned to the same reporting unit. In those situations in which the acquired assets and liabilities are allocated to more than one reporting unit, the goodwill to be assigned to each reporting unit is determined in a manner similar to how the amount of goodwill recognized in a business combination is determined. Goodwill is not amortized; however, it is assessed for impairment at least annually, as of the first day of the third quarter, and as triggering events occur. In evaluating the recoverability of goodwill, the Company estimates the fair value of its reporting units, which is determined using the income approach, and compares it to the carrying value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to such excess. Fair values of reporting units are primarily based on future cash flows projected to be generated from that business. In performing the discounted cash flow analysis, management makes various judgments, estimates and assumptions, the most significant of which are the assumptions related to revenue growth rates, operating profit margin rates, terminal growth rates, and discount rates. Rates used to discount cash flows are dependent upon interest rates and the cost of capital at a point in time. There are inherent uncertainties related to these factors and management’s judgment in applying them to the analysis of goodwill impairment. |
Cloud Computing Arrangements | Cloud Computing Arrangements The Company’s cloud computing arrangements (“CCA”) include software licenses purchased from external vendors. Software license costs, implementation costs incurred during the application development stage and other costs meeting certain criteria are capitalized while all other costs are expensed as incurred. These assets are included in computer software in the “Trademarks and other identifiable intangibles, net” line in the Consolidated Balance Sheets and amortize on a straight-line basis over their assessed useful lives. See Note “Intangible Assets and Goodwill” for additional information. If a CCA does not include the purchase of a software license, the arrangement is accounted for as a service contract and the fees associated with the hosting service are expensed as incurred. These costs are included in prepaid assets in the “Other current assets” line in the Consolidated Balance Sheets. Implementation costs incurred during the application development stage as well as costs meeting certain criteria are capitalized and expensed on a straight-line basis over the term of the hosting contract. These assets are included in the “Other noncurrent assets” line in the Consolidated Balance Sheets. As of December 31, 2022, net capitalized CCA assets were $53,637. Changes in these assets are included in the “Other assets” line within operating activities in the Consolidated Statements of Cash Flows. |
Insurance Reserves | Insurance Reserves The Company is self-insured for property, workers’ compensation, medical and other casualty programs up to certain stop-loss limits. Undiscounted liabilities for self-insured exposures are accrued at the present value of the expected aggregate losses below those limits and are based on a number of assumptions, including historical trends, actuarial assumptions and economic conditions. |
Stock-Based Compensation | Stock-Based CompensationThe Company established the Hanesbrands Inc. Omnibus Incentive Plan (As Amended and Restated), (the “Omnibus Incentive Plan”) to award stock options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, performance shares and cash to its employees, non-employee directors and employees of its subsidiaries to promote the interests of the Company, incent performance and retain employees. Stock-based compensation is estimated at the grant date based on the award’s fair value and is recognized as expense over the requisite service period. The Company estimates forfeitures for stock-based awards granted that are not expected to vest. |
Income Taxes | Income Taxes Deferred taxes are recognized for the future tax effects of temporary differences between financial and income tax reporting using tax rates in effect for the years in which the differences are expected to reverse. Given continuing losses in certain jurisdictions in which the Company operates on a separate return basis, a valuation allowance has been established for the deferred tax assets in these specific locations. The Company periodically estimates the probable tax obligations using historical experience in tax jurisdictions and informed judgment. There are inherent uncertainties related to the interpretation of tax regulations in the jurisdictions in which the Company transacts business. The judgments and estimates made at a point in time may change based on the outcome of tax audits, as well as changes to, or further interpretations of, regulations. Income tax expense is adjusted in the period in which these events occur, and these adjustments are included in the Company’s Consolidated Statements of Income. If such changes take place, there is a risk that the Company’s effective tax rate may increase or decrease in any period. A company must recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company continues to use a portfolio approach to release the income tax effects in accumulated other comprehensive loss related to pension and postretirement benefits. Under this approach, the income tax effects are released from accumulated other comprehensive loss based on the pre-tax adjustments to pension liabilities or assets recognized within other comprehensive income. Any tax effects remaining in accumulated other comprehensive loss are released only when the entire portfolio of the pension and postretirement benefits is liquidated, sold or extinguished. |
Financial Instruments | Financial Instruments The Company uses forward foreign exchange contracts and cross-currency swap contracts to manage its exposures to movements in foreign exchange rates. The Company also uses a combination of cross-currency swap contracts and long-term debt to manage its exposure to foreign currency risk associated with the Company’s net investment in certain European subsidiaries. The use of these derivative and nonderivative financial instruments modifies the Company’s exposure to these risks with the goal of reducing the risk or cost to the Company. The Company does not use derivatives for trading purposes and is not a party to leveraged derivative contracts. Depending on the nature of the underlying risk being hedged, these derivative and nonderivative financial instruments are accounted for either as cash flow, net investment or mark to market hedges against changes in the value of the hedged item. Derivatives are recorded in the Consolidated Balance Sheets at fair value. The fair value is based upon either market quotes for actively traded instruments or independent bids for nonexchange traded instruments. The accounting for changes in fair value of a derivative instrument depends on whether the instrument has been designated and qualifies as part of a hedging relationship. The Company determines whether a derivative instrument meets the criteria for cash flow or net investment hedge accounting treatment on the date the derivative is executed. Derivatives accounted for as mark to market hedges are not designated as hedges for accounting purposes. The Company formally documents its hedge relationships, including identifying the hedging instruments and the hedged items, as well as its risk management objectives and strategies for undertaking the hedge transaction. This process includes linking financial instruments to the hedged assets, liabilities, firm commitments, forecasted transactions or net investments. The Company may be exposed to credit losses in the event of nonperformance by individual counterparties or the entire group of counterparties to the Company’s derivative contracts. Risk of nonperformance by counterparties is mitigated by dealing with highly rated counterparties and by diversifying across counterparties. Cash Flow Hedges For a cash flow hedge, the Company formally assesses, both at inception and on at least a quarterly basis thereafter, whether the designated derivative instrument is highly effective in offsetting changes in cash flows of the hedged item. The change in the fair value of a derivative instrument that is designated and highly effective as a cash flow hedge is recorded as a deferred gain or loss in the “Accumulated other comprehensive loss” line in the Consolidated Balance Sheets. When the hedged item affects the income statement, the deferred gain or loss on the derivative instrument is reclassified from AOCI and recorded on the same line in the Consolidated Statements of Income as the hedged item. The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. If it is determined that a designated derivative instrument ceases to be a highly effective cash flow hedge, or if the anticipated transaction is no longer likely to occur, the Company discontinues hedge accounting, and any deferred gain or loss is reclassified from AOCI and recorded on the same line in the Consolidated Statements of Income as the hedged item. Cash flows from derivatives designated as cash flow hedges are classified in the same category as the item being hedged in the Consolidated Statements of Cash Flows. Net Investment Hedges For a net investment hedge, the Company formally assesses, both at inception and on a quarterly basis thereafter, whether the designated financial instrument is highly effective as an economic hedge of foreign exchange risk associated with the hedged net investment. The change in the fair value of a derivative instrument or the change in the carrying value of a nonderivative financial instrument that is designated and highly effective as a net investment hedge is recorded as a deferred gain or loss in the cumulative translation adjustment component of AOCI, offsetting the translation gain or loss for the net investment being hedged. The Company assesses net investment hedge effectiveness and measures net investment hedge results for both derivative and nonderivative hedging instruments on an after-tax basis. The interest component of a cross-currency swap derivative contract designated in a highly effective net investment hedge is excluded from the assessment of hedge effectiveness and is initially recorded in the cumulative translation adjustment component of AOCI. This excluded component is amortized in earnings using a systematic and rational method over the term of the cross-currency swap derivative contract and recorded in the “Interest expense, net” line in the Consolidated Statements of Income. If a net investment hedging relationship ceases to be highly effective, the Company discontinues hedge accounting, and any future change in the fair value of the derivative hedging instrument or future change in the carrying value of the nonderivative hedging instrument is recorded in the “Other expenses” line in the Consolidated Statements of Income, which is where the gain or loss on the sale or substantial liquidation of the underlying net investment would be recorded. However, any deferred gain or loss previously recorded in the cumulative translation adjustment component of AOCI will remain in AOCI until the hedged net investment is sold or substantially liquidated, at which time the cumulative deferred gain or loss is reclassified from AOCI and recorded in the “Other expenses” line in the Consolidated Statements of Income. Cash flows from the periodic and final settlements of the cross-currency swap contracts are reported as cash flows from investing activities in the Consolidated Statements of Cash Flows because the hedged item is a net investment in foreign subsidiaries, and the cash paid or received from acquiring or selling the subsidiaries would typically be classified as investing. Mark to Market Hedges A derivative instrument whose change in fair value is used to hedge against changes in the value of a hedged item, but which is not designated as a hedge under the accounting standards, is accounted for as a mark to market hedge. These derivatives are recorded at fair value in the Consolidated Balance Sheets when the hedged item is recorded as an asset or liability and then are revalued each accounting period. Changes in the fair value of derivatives accounted for as mark to market hedges are reported in the “Cost of sales” and “Selling, general and administrative expenses” lines in the Consolidated Statements of Income. Cash flows from derivatives not designated as hedges are classified as cash flows from operating activities in the Consolidated Statements of Cash Flows. |
Assets and Liabilities Acquired in Business Combinations | Assets and Liabilities Acquired in Business CombinationsBusiness combinations are accounted for using the purchase method, which requires the Company to allocate the cost of an acquired business to the acquired assets and assumed liabilities based on their estimated fair values at the acquisition date. The Company recognizes the excess of an acquired business’ cost over the fair value of acquired assets and assumed liabilities as goodwill. Fair values are determined using the income approach based on market participant assumptions focusing on future cash flow projections and accepted industry standards. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01, “Reference Rate Reform: Scope.” The new accounting rules provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform. In December 2022, the FASB deferred the expiration date of Topic 848 with the issuance of ASU 2022-06, “Reference Rate Reform: Deferral of the Sunset Date of Topic 848.” The new accounting rules extend the relief in Topic 848 beyond the cessation date of USD LIBOR. The new accounting rules must be adopted by the fourth quarter of 2024. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows and disclosures. Business Combinations In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.” The new accounting rules require entities to apply “Revenue from Contracts with Customers (Topic 606)” to recognize and measure contract assets and contract liabilities in a business combination. The new accounting rules will be effective for the Company in the first quarter of 2023, including interim periods. The adoption impact of the new accounting rules will depend on the magnitude of future acquisitions. Derivatives and Hedging In March 2022, the FASB issued ASU 2022-01, “Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method.” The new accounting rules allow entities to expand the use of the portfolio layer method to all financial assets and designate multiple hedged layers within a single closed portfolio. The new accounting rules also clarify guidance related to hedge basis adjustments and the related disclosures for these adjustments. The new accounting rules will be effective for the Company in the first quarter of 2023, including interim periods. The Company does not currently have any fair value hedging programs that leverage the portfolio layer method, therefore, the Company does not expect the new accounting rules to have an impact on our near term financial condition, results of operations, cash flows or disclosures. Supplier Finance Program Obligations In September 2022, the FASB issued ASU 2022-04, “Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” The new accounting rules create certain disclosure requirements for a buyer in a supplier finance program. The new accounting rules require qualitative and quantitative disclosures including key terms of the program, balance sheet presentation of related amounts, and the obligation amount the buyer has confirmed as valid to the finance provider, including a rollforward of the obligation. Only the amount of the obligation outstanding is required to be disclosed in interim periods. The accounting rules do not impact the recognition, measurement, or financial statement presentation of supplier finance program obligations. The new accounting rules will be effective for the Company in the first quarter of 2023, including interim periods. While the new accounting rules will not have an impact on our financial condition, results of operations or cash flows, the Company is currently evaluating the impact the new accounting rules will have on the disclosures included in the notes to the consolidated financial statements beginning with the first quarter of 2023. |
Revenue Recognition (Policies)
Revenue Recognition (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue recognition, policy | Revenue is recognized when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. Variable consideration includes trade discounts, rebates, volume-based incentives, cooperative advertising and product returns, which are offered within contracts between the Company and its customers, employing the practical expedient for contract costs. Incidental items that are immaterial to the context of the contract are recognized as expense at the transaction date. |
Assets and Liabilities Held f_2
Assets and Liabilities Held for Sale (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets and Liabilities Held for Sale | December 31, January 1, U.S. Sheer Hosiery business - continuing operations $ 13,327 $ 5,426 European Innerwear business - discontinued operations — 321,731 Total current assets held for sale $ 13,327 $ 327,157 U.S. Sheer Hosiery business - continuing operations $ 13,327 $ 5,426 European Innerwear business - discontinued operations — 311,476 Total current liabilities held for sale $ 13,327 $ 316,902 |
Discontinued Operations Tables | The operating results of the discontinued operations only reflect revenues and expenses that are directly attributable to the European Innerwear business. Discontinued operations does not include any allocation of corporate overhead expense or interest expense. The key components from discontinued operations related to the European Innerwear business are as follows: Years Ended December 31, January 1, January 2, Net sales $ 101,314 $ 546,558 $ 598,322 Cost of sales 60,415 294,383 352,758 Gross profit 40,899 252,175 245,564 Selling, general and administrative expenses 54,689 274,408 261,410 Impairment of intangible assets and goodwill — 155,745 20,319 Loss on sale of business and classification of assets held for sale 373 273,995 — Operating loss (14,163) (451,973) (36,165) Other expenses 283 2,178 2,477 Interest expense, net 10 613 2,253 Loss from discontinued operations before income tax expense (benefit) (14,456) (454,764) (40,895) Income tax expense (benefit) (18,421) (11,020) 2,397 Net income (loss) from discontinued operations, net of tax $ 3,965 $ (443,744) $ (43,292) Assets and liabilities of discontinued operations classified as held for sale in the Consolidated Balance Sheets as of December 31, 2022 and January 1, 2022 consist of the following: December 31, January 1, Cash and cash equivalents $ — $ 24,352 Trade accounts receivable, net — 87,353 Inventories — 141,653 Other current assets — 21,926 Property, net — 62,659 Right-of-use assets — 32,603 Trademarks and other identifiable intangibles, net (1) — 205,204 Deferred tax assets — 4,174 Other noncurrent assets — 4,127 Allowance to adjust assets to estimated fair value, less costs of disposal — (262,320) Total assets of discontinued operations $ — $ 321,731 Accounts payable $ — $ 84,327 Accrued liabilities — 122,620 Lease liabilities — 6,562 Notes payable — 329 Lease liabilities - noncurrent — 27,426 Pension and postretirement benefits — 38,325 Other noncurrent liabilities — 31,887 Total liabilities of discontinued operations $ — $ 311,476 (1) The “Trademarks and other identifiable intangibles, net” line in the table above includes $161,693 of indefinite-lived trademarks as of January 1, 2022. The cash flows related to discontinued operations have not been segregated and are included in the Consolidated Statements of Cash Flows. The following table presents cash flow and non-cash information related to discontinued operations: Years Ended December 31, January 1, January 2, Depreciation $ — $ 2,608 $ 11,650 Amortization $ — $ 1,460 $ 5,829 Capital expenditures $ 715 $ 8,462 $ 4,160 Impairment of intangible assets and goodwill $ — $ 155,745 $ 20,319 Loss on sale of business and classification of assets held for sale $ 373 $ 273,995 $ — Capital expenditures included in accounts payable at end of period $ — $ 1,079 $ 3,767 Right-of-use assets obtained in exchange for lease obligations $ — $ 8,672 $ 3,738 |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents the Company’s revenues disaggregated by the customer’s method of purchase: Years Ended December 31, January 1, January 2, Third-party brick-and-mortar wholesale $ 4,348,424 $ 4,777,623 $ 4,334,088 Consumer-directed 1,885,226 2,023,617 1,793,073 Total net sales $ 6,233,650 $ 6,801,240 $ 6,127,161 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Reconciliation of Basic to Diluted Weighted Average Shares Outstanding | The reconciliation of basic to diluted weighted average shares outstanding is as follows: Years Ended December 31, January 1, January 2, Basic weighted average shares outstanding 349,970 351,028 352,766 Effect of potentially dilutive securities: Stock options — 16 — Restricted stock units — 1,031 — Employee stock purchase plan and other — 3 — Diluted weighted average shares outstanding 349,970 352,078 352,766 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following securities were excluded from the diluted earnings per share calculation because their effect would be anti-dilutive: Years Ended December 31, January 1, January 2, Stock options 252 167 219 Restricted stock units 1,907 32 621 Employee stock purchase plan and other 8 — 5 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-based Payment Arrangement, Assumptions for Option-Pricing Model Used in Determining Fair Value of Stock Options Granted | The following table includes the assumptions for the Black-Scholes option-pricing model used in determining the fair value of these options granted during 2020. Year Ended January 2, Dividend yield 5.00 % Risk-free interest rate 0.31 % Volatility 39.97 % Expected term (years) 6 |
Summary of Changes in Stock Options Outstanding | A summary of the changes in stock options outstanding to the Company’s employees is presented below: Shares Weighted- Aggregate Weighted- Options outstanding at December 28, 2019 471 $ 6.79 $ 3,786 0.94 Granted 250 17.18 Exercised (471) 6.79 Options outstanding at January 2, 2021 250 $ 17.18 $ 22 9.59 Granted — — Exercised — — Options outstanding at January 1, 2022 250 $ 17.18 $ 200 8.59 Granted — — Exercised — — Options outstanding at December 31, 2022 250 $ 17.18 $ — 7.59 Options exercisable at December 31, 2022 167 $ 15.75 $ — 7.59 |
Summary of Changes in Restricted Stock Unit Awards Outstanding | A summary of the changes in the restricted stock unit awards outstanding is presented below: Shares Weighted- Aggregate Weighted- Nonvested share units outstanding at December 28, 2019 1,867 $ 16.93 $ 27,692 1.50 Granted — non-performanced based 1,006 14.26 Granted — performanced based 1,124 14.40 Vested (803) 19.08 Forfeited (83) 15.53 Nonvested share units outstanding at January 2, 2021 3,111 $ 14.64 $ 45,361 1.32 Granted — non-performanced based 970 16.11 Granted — performanced based (149) 16.22 Vested (1,694) 14.87 Forfeited (117) 15.36 Nonvested share units outstanding at January 1, 2022 2,121 $ 16.53 $ 35,455 1.18 Granted — non-performanced based 1,178 15.39 Granted — performanced based 1,624 16.98 Vested (829) 15.92 Forfeited (435) 16.84 Nonvested share units outstanding at December 31, 2022 3,659 $ 16.46 $ 23,268 1.24 |
Summary of Compensation Expense and Deferred Tax Benefit from Share-based Payment Awards | For all share-based payments under the Omnibus Incentive Plan and outside the Omnibus Incentive Plan in 2020, the Company recognized compensation expense and deferred tax benefits as follows: Years Ended December 31, January 1, January 2, Compensation expense included in continuing operations $ 23,357 $ 16,065 $ 18,202 Compensation expense included in discontinued operations (200) 225 462 Total compensation expense $ 23,157 $ 16,290 $ 18,664 Deferred tax benefit recognized in continuing operations $ — $ 2,499 $ 1,808 |
Trade Accounts Receivable (Tabl
Trade Accounts Receivable (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Allowances for Trade Accounts Receivable | The changes in the Company’s allowance for doubtful accounts and allowance for chargebacks and other deductions are as follows: Allowance Allowance Total Balance at December 28, 2019 $ 16,277 $ 10,213 $ 26,490 Charged to expenses 31,661 14,631 46,292 Deductions, write-offs and adjustments (14,986) (9,864) (24,850) Currency translation 651 162 813 Balance at January 2, 2021 $ 33,603 $ 15,142 $ 48,745 Charged to expenses 2,279 24,501 26,780 Deductions, write-offs and adjustments 2,663 (15,245) (12,582) Currency translation (707) (288) (995) Balance at January 1, 2022 $ 37,838 $ 24,110 $ 61,948 Charged to expenses 6,721 20,432 27,153 Deductions, write-offs and adjustments (19,753) (16,180) (35,933) Currency translation (658) (487) (1,145) Balance at December 31, 2022 $ 24,148 $ 27,875 $ 52,023 |
Inventories (Tables)
Inventories (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Inventories | Inventories consisted of the following: December 31, January 1, Raw materials $ 69,279 $ 68,683 Work in process 107,904 110,246 Finished goods 1,802,489 1,405,086 $ 1,979,672 $ 1,584,015 |
Property, Net (Tables)
Property, Net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Summary of Property | Property is summarized as follows: December 31, January 1, Land $ 26,209 $ 26,368 Buildings and improvements 430,043 430,235 Machinery and equipment 994,829 998,891 Construction in progress 50,895 42,375 1,501,976 1,497,869 Less accumulated depreciation 1,059,572 1,056,468 Property, net $ 442,404 $ 441,401 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Supplemental Cash Flow and Non-cash Information | The following table presents supplemental cash flow and non-cash information related to leases: Years Ended December 31, January 1, January 2, Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from leases $ 146,439 $ 157,138 $ 179,591 Right-of-use assets obtained in exchange for lease obligations - non-cash activity $ 81,571 $ 59,864 $ 47,349 |
Supplemental Lease Information | The following table presents supplemental information related to lease terms and discount rates: Years Ended December 31, January 1, January 2, Weighted average remaining lease term 5.0 years 4.7 years 5.0 years Weighted average discount rate 4.77 % 4.55 % 4.65 % |
Maturities of Operating Lease Liabilities | The following table presents maturities of operating lease liabilities as of December 31, 2022: 2023 $ 127,996 2024 108,165 2025 75,007 2026 71,011 2027 48,370 Thereafter 69,034 Total lease payments 499,583 Less interest 58,145 $ 441,438 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Intangible Assets and Related Accumulated Amortization | The primary components of the Company’s intangible assets and the related accumulated amortization are as follows: Gross Accumulated Net Book Year ended December 31, 2022: Intangible assets subject to amortization: Trademarks and brand names $ 40,128 $ 28,633 $ 11,495 Licensing agreements 89,523 68,205 21,318 Customer and distributor relationships 122,283 81,099 41,184 Computer software 109,209 72,626 36,583 Other intangibles 5,160 5,043 117 $ 366,303 $ 255,606 110,697 Intangible assets not subject to amortization: Trademarks 1,142,746 Perpetual licensing agreements and other 2,250 Net book value of intangible assets $ 1,255,693 Gross Accumulated Net Book Year ended January 1, 2022: Intangible assets subject to amortization: Trademarks and brand names $ 43,187 $ 29,678 $ 13,509 Licensing agreements 92,370 65,828 26,542 Customer and distributor relationships 132,971 78,647 54,324 Computer software 97,464 62,064 35,400 Other intangibles 3,984 3,720 264 $ 369,976 $ 239,937 130,039 Intangible assets not subject to amortization: Trademarks 1,087,881 Perpetual licensing agreements and other 2,250 Net book value of intangible assets $ 1,220,170 |
Goodwill | Goodwill and the changes in those amounts during the period are as follows: Innerwear Activewear International Other Total Net book value at January 2, 2021 $ 406,853 $ 316,384 $ 433,201 $ 2,500 $ 1,158,938 Currency translation — — (25,843) — (25,843) Net book value at January 1, 2022 $ 406,853 $ 316,384 $ 407,358 $ 2,500 $ 1,133,095 Currency translation — — (24,188) — (24,188) Net book value at December 31, 2022 $ 406,853 $ 316,384 $ 383,170 $ 2,500 $ 1,108,907 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | A summary of the Company’s debt is presented below: Interest Rate as of December 31, Principal Amount December 31, January 1, Maturity Date Senior Secured Credit Facility: Revolving Loan Facility 5.83% $ 352,500 $ — November 2026 Term Loan A 5.92% 975,000 1,000,000 November 2026 4.875% Senior Notes 4.88% 900,000 900,000 May 2026 4.625% Senior Notes 4.63% 900,000 900,000 May 2024 3.5% Senior Notes 3.50% 535,275 568,634 June 2024 Accounts Receivable Securitization Facility 5.09% 209,500 — June 2023 3,872,275 3,368,634 Less long-term debt issuance costs 13,198 17,543 Less current maturities 247,000 25,000 $ 3,612,077 $ 3,326,091 |
Defined Benefit Pension Plans (
Defined Benefit Pension Plans (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Components of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Loss | The components of net periodic benefit cost and other amounts recognized in other comprehensive income (loss) of the Company’s noncontributory defined benefit pension plans were as follows: Years Ended December 31, January 1, January 2, Service cost $ 1,345 $ 1,488 $ 1,406 Interest cost 27,669 23,812 33,552 Expected return on assets (49,189) (45,923) (42,278) Settlement cost (6) 861 121 Amortization of: Prior service cost (6) (6) (6) Net actuarial loss 20,972 24,440 22,277 Net periodic benefit cost $ 785 $ 4,672 $ 15,072 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss) Net (gain) loss $ (130,000) $ (96,334) $ 38,484 Prior service credit 6 6 6 Total (gain) loss recognized in other comprehensive income (loss) (129,994) (96,328) 38,490 Total recognized in net periodic benefit cost and other comprehensive income (loss) $ (129,209) $ (91,656) $ 53,562 |
Funded Status of Company's Defined Benefit Pension Plans | The funded status of the Company’s defined benefit pension plans at the respective year ends was as follows: December 31, January 1, Benefit obligation: Beginning of year $ 1,216,161 $ 1,299,943 Service cost 1,345 1,488 Interest cost 27,669 23,812 Benefits paid (64,786) (62,525) Settlements (125) (2,072) Impact of exchange rate change (2,603) (1,128) Actuarial gain (251,426) (43,325) Other (36) (32) End of year 926,199 1,216,161 Fair value of plan assets: Beginning of year 973,598 920,316 Actual return on plan assets (93,497) 73,567 Employer contributions 2,831 44,658 Benefits paid (64,786) (62,525) Settlements (125) (2,072) Impact of exchange rate change (1,741) (314) Other (36) (32) End of year 816,244 973,598 Funded status $ (109,955) $ (242,563) |
Accumulated Benefit Obligation and Fair Value of Plan Assets with Accumulated Benefit Obligations in Excess of Plan Assets | As most of the Company’s pension plans are frozen, the accumulated benefit obligation (“ABO”) approximates the benefit obligation. The total benefit obligation and the benefit obligation and fair value of plan assets for the Company’s pension plans with benefit obligations in excess of plan assets are as follows: December 31, January 1, Benefit obligation $ 926,199 $ 1,216,161 Plans with benefit obligation in excess of plan assets: Benefit obligation 905,749 1,188,558 Fair value of plan assets 790,641 942,733 |
Amounts Recognized in Company's Consolidated Balance Sheets | Amounts recognized in the Company’s Consolidated Balance Sheets consist of: December 31, January 1, Other noncurrent assets $ 5,153 $ 3,262 Accrued liabilities and other: Payroll and employee benefits (2,388) (2,225) Pension and postretirement benefits (112,720) (243,600) Accumulated other comprehensive loss (440,529) (570,523) |
Amounts Recognized in Accumulated Other Comprehensive Loss | Amounts recognized in accumulated other comprehensive loss consist of: December 31, January 1, Prior service cost $ (133) $ (139) Actuarial loss 440,662 570,662 Accumulated other comprehensive loss $ 440,529 $ 570,523 |
Weighted Average Actuarial Assumptions Used in Measuring Net Periodic Benefit Cost and Plan Obligation | The weighted average actuarial assumptions used in measuring the net periodic benefit cost and plan obligations for the periods presented were as follows: December 31, January 1, January 2, Net periodic benefit cost: Discount rate 2.88 % 2.55 % 3.25 % Long-term rate of return on plan assets 5.24 4.95 4.97 Rate of compensation increase (1) 3.09 3.10 3.07 Interest crediting rate 5.50 5.50 5.50 Plan obligations: Discount rate 5.15 % 2.88 % 2.55 % Rate of compensation increase (1) 3.08 3.09 3.10 Interest crediting rate 5.50 5.50 5.50 (1) For December 31, 2022, January 1, 2022 and January 2, 2021, the compensation assumption only applies to certain international plans as the benefits of the U.S. pension plans are now all frozen. |
Allocation of Pension Plan Assets | The allocation of pension plan assets as of the respective period end measurement dates is as follows: December 31, January 1, Asset category: Hedge fund of funds 39 % 37 % Foreign equity securities 21 22 U.S. equity securities 19 21 Debt securities 10 11 Real estate 8 6 Commodities 2 3 Cash and other 1 0 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Provision for Income Tax Computed by Applying U.S. Statutory Rate to Income Before Taxes as Reconciled to Actual Provisions | The provision for income tax expense (benefit) computed by applying the U.S. statutory rate to income (loss) from continuing operations before income tax expense as reconciled to the actual provisions were: Years Ended December 31, January 1, January 2, Income (loss) from continuing operations before income tax expense: Domestic (45.0) % (3.3) % 445.1 % Foreign 145.0 103.3 (345.1) 100.0 % 100.0 % 100.0 % Tax expense at U.S. statutory rate 21.0 % 21.0 % 21.0 % State income tax (1.6) (0.7) 17.0 Tax on actual and planned remittances of foreign earnings (1.6) 1.5 5.4 Tax on foreign earnings due to U.S. tax reform including measurement period adjustments (1) — (0.3) 26.9 Tax on foreign earnings (U.S. tax reform - GILTI and FDII) 3.8 1.7 (2.3) Foreign taxes less than U.S. statutory rate (14.0) (12.3) 39.0 Statutory stock deduction and other foreign adjustments (2) 22.5 — (34.5) Employee benefits 1.0 0.3 (2.2) Changes in valuation allowance 101.1 1.9 (14.2) Release of unrecognized tax benefit reserves (1.1) (0.9) 13.2 State tax rate change 3.1 1.0 0.3 Tax provision adjustments and revisions to prior years' returns 3.6 (1.6) (1.0) Nondeductible expenses and tax exempt income, net (1.2) (0.4) 10.2 Nondeductible impairment charges — — (3.7) Domestic income tax credits (0.7) (0.4) 2.3 Other, net 1.3 (0.5) (0.1) Taxes at effective worldwide tax rates 137.2 % 10.3 % 77.3 % (1) In 2020, the Company continued to analyze the impacts of the Tax Cuts and Jobs Act (the “Tax Act”) and recently issued regulations that have been published to help taxpayers interpret and apply the legislation. As a result of its analysis, the Company changed its estimate of the tax liability due in connection with the one-time mandatory transition tax and recognized a $4,668 income tax benefit in 2021 and a $38,315 income tax benefit in 2020. |
Current and Deferred Tax Provisions (Benefits) | Current and deferred tax provisions (benefits) were: Current Deferred Total Year ended December 31, 2022 Domestic $ 15,188 $ 201,112 $ 216,300 Foreign 83,607 95,558 179,165 State (2,712) 91,154 88,442 $ 96,083 $ 387,824 $ 483,907 Year ended January 1, 2022 Domestic $ (15,176) $ 6,934 $ (8,242) Foreign 66,844 1,421 68,265 State (2,948) 3,032 84 $ 48,720 $ 11,387 $ 60,107 Year ended January 2, 2021 Domestic $ (7,770) $ (136,221) $ (143,991) Foreign 46,701 34,066 80,767 State 6,256 (52,972) (46,716) $ 45,187 $ (155,127) $ (109,940) |
Cash Payments For Income Taxes | Years Ended December 31, January 1, January 2, Cash payments for income taxes $ 95,331 $ 95,011 $ 107,577 |
Deferred Tax Assets and Liabilities | The deferred tax assets and liabilities at the respective year-ends were as follows: December 31, January 1, Deferred tax assets: Inventories $ 92,347 $ 64,425 Bad debt allowance 15,854 15,605 Accrued expenses 15,492 20,863 Employee benefits 55,687 104,845 Tax credits 10,859 4,804 Net operating loss and other tax carryforwards 562,326 410,921 Leasing 112,619 112,423 Property and equipment 6,094 4,707 Section 163(j) 50,695 46,729 Capitalized research costs 17,501 5,873 Other 1,029 — Gross deferred tax assets 940,503 791,195 Less valuation allowances (626,540) (306,221) Deferred tax assets 313,963 484,974 Deferred tax liabilities: Derivatives 13,781 10,303 Section 481(a) liability — 23,881 Leasing 101,558 99,470 Accrued tax on unremitted foreign earnings 26,128 38,812 Intangibles 41,331 43,917 Other — 392 Statutory impairment 247,360 — Prepaids 877 434 Deferred tax liabilities 431,035 217,209 Net deferred tax assets (liabilities) $ (117,072) $ 267,765 |
Summary of Changes in Valuation Allowance | The changes in the Company’s valuation allowance for deferred tax assets are as follows: December 28, 2019 $ 188,554 Charged to income tax expense 14,959 Charged to other accounts (1) 1,341 January 2, 2021 $ 204,854 Charged to income tax expense 4,343 Charged to other accounts (1) 97,024 January 1, 2022 $ 306,221 Charged to income tax expense 356,740 Charged to other accounts (1) (36,421) December 31, 2022 $ 626,540 (1) Charges to other accounts include the effects of foreign currency translation, purchase accounting adjustments and changes to valuation allowances as a result of intraperiod tax allocations. |
Net Operating Loss Carryforwards | At December 31, 2022, the Company had gross foreign net operating loss carryforwards of approximately $1,912,611 (on a tax return basis) which are subject to expiration as follows: Fiscal Year: 2023 $ 6,055 2024 3,921 2025 6,076 2026 2,320 2027 4,168 Thereafter 1,890,071 |
Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: Balance at December 28, 2019 (gross balance of $78,789) $ 74,385 Additions based on tax positions related to the current year 3,675 Additions based on tax positions of prior years 2,666 Settlements — Lapse of statute of limitations (16,655) Reductions for tax positions of prior years (18,385) Balance at January 2, 2021 (gross balance of $46,645) $ 45,686 Additions based on tax positions related to the current year 3,231 Additions based on tax positions of prior years 3,401 Settlements — Lapse of statute of limitations (147) Reductions for tax positions of prior years (12,599) Balance at January 1, 2022 (gross balance of $40,706) $ 39,572 Adjustments related to prior year ending balance 1,138 Additions based on tax positions related to the current year 2,857 Additions based on tax positions of prior years 798 Settlements — Lapse of statute of limitations (7,191) Reductions for tax positions of prior years (311) Balance at December 31, 2022 (gross balance of $37,818) $ 36,863 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Loss (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Schedule of Accumulated Other Comprehensive Loss | The components of AOCI are as follows: Cumulative Translation Adjustment (1) Cash Flow Hedges Defined Benefit Plans Income Taxes Accumulated Other Comprehensive Loss Balance at January 2, 2021 $ (52,820) $ (26,538) $ (668,730) $ 181,129 $ (566,959) Amounts reclassified from accumulated other comprehensive loss — 34,554 25,011 (15,179) 44,386 Current-period other comprehensive income (loss) activity (81,181) (2,772) 74,558 (19,635) (29,030) Total other comprehensive income (loss) (81,181) 31,782 99,569 (34,814) 15,356 Balance at January 1, 2022 $ (134,001) $ 5,244 $ (569,161) $ 146,315 $ (551,603) Amounts reclassified from accumulated other comprehensive loss (13,473) 14,927 21,224 3,319 25,997 Current-period other comprehensive income (loss) activity (81,329) (11,462) 110,584 (4,195) 13,598 Total other comprehensive income (loss) (94,802) 3,465 131,808 (876) 39,595 Balance at December 31, 2022 $ (228,803) $ 8,709 $ (437,353) $ 145,439 $ (512,008) (1) Cumulative Translation Adjustment includes translation adjustments and net investment hedges. See Note “Financial Instruments and Risk Management” for additional disclosures about net investment hedges. |
Schedule of Reclassifications Out of Accumulated Other Comprehensive Loss | The Company had the following reclassifications out of AOCI: Component of AOCI Location of Reclassification into Income Amount of Reclassification from AOCI Years Ended December 31, January 1, January 2, Write-off of cumulative translation associated with sale of business Income (loss) from discontinued operations, net of tax $ 13,473 $ — $ — Gain (loss) on forward foreign exchange contracts designated as cash flow hedges Cost of sales $ 11,336 $ (15,301) $ 10,069 Income tax (3,401) 4,105 (2,851) Income (loss) from discontinued operations, net of tax (232) (2,890) 4,314 Net of tax 7,703 (14,086) 11,532 Gain (loss) on cross-currency swap contracts designated as cash flow hedges Selling, general and administrative expenses (20,016) (12,155) — Interest expense, net (5,940) (3,556) — Income tax — 4,061 — Net of tax (25,956) (11,650) — Amortization of deferred actuarial loss and prior service cost Other expenses (20,809) (25,671) (22,261) Income tax 52 6,461 5,753 Income (loss) from discontinued operations, net of tax — 560 (698) Pension activity associated with sale of business Income (loss) from discontinued operations, net of tax (460) — — Net of tax (21,217) (18,650) (17,206) Total reclassifications $ (25,997) $ (44,386) $ (5,674) |
Financial Instruments and Ris_2
Financial Instruments and Risk Management (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Disclosure Financial Instruments and Risk Management [Abstract] | |
Schedule of Notional Amounts of Outstanding Derivative Positions | Hedge Type December 31, January 1, U.S. dollar equivalent notional amount of derivative instruments: Forward foreign exchange contracts Cash Flow and $ 397,908 $ 308,071 Cross-currency swap contracts Cash Flow $ 352,920 $ 352,920 Cross-currency swap contracts Net Investment $ 335,940 $ 335,940 |
Fair Values of Derivative Instruments | The fair values of derivative instruments related to forward foreign exchange contracts and cross-currency swap contracts recognized in the Consolidated Balance Sheets of the Company were as follows: Balance Sheet Location Fair Value December 31, January 1, Derivatives designated as hedging instruments: Forward foreign exchange contracts Other current assets $ 1,892 $ 2,898 Cross-currency swap contracts Other current assets 1,033 974 Forward foreign exchange contracts Other noncurrent assets 110 83 Cross-currency swap contracts Other noncurrent assets 16,477 1,979 Derivatives not designated as hedging instruments: Forward foreign exchange contracts Other current assets 5,402 5,439 Total derivative assets 24,914 11,373 Derivatives designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities and other: Other (1,263) (349) Cross-currency swap contracts Accrued liabilities and other: Other (252) (222) Forward foreign exchange contracts Other noncurrent liabilities (178) (14) Cross-currency swap contracts Other noncurrent liabilities (27,753) (11,387) Derivatives not designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities and other: Other (4,841) (331) Total derivative liabilities (34,287) (12,303) Net derivative liability $ (9,373) $ (930) |
Effect of Cash Flow Hedge Derivative Instruments | The effect of derivative instruments designated as cash flow hedges on the Consolidated Statements of Income and AOCI is as follows: Amount of Gain (Loss) Years Ended December 31, January 1, January 2, Forward foreign exchange contracts $ 10,843 $ 12,170 $ (15,643) Cross-currency swap contracts (22,305) (14,942) — Total $ (11,462) $ (2,772) $ (15,643) Location of Gain (Loss) Amount of Gain (Loss) Years Ended December 31, January 1, January 2, Forward foreign exchange contracts (1) Cost of sales $ 11,336 $ (15,301) $ 10,069 Forward foreign exchange contracts (1) Income (loss) from discontinued operations, net of tax (307) (3,542) 5,612 Cross-currency swap contracts (1) Selling, general and administrative expenses (20,016) (12,155) — Cross-currency swap contracts (1) Interest expense, net (5,940) (3,556) — Total $ (14,927) $ (34,554) $ 15,681 (1) The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. The following table presents the amounts in the Consolidated Statements of Income in which the effects of cash flow hedges are recorded: Years Ended December 31, January 1, January 2, Cost of sales $ 4,012,542 $ 4,149,541 $ 4,524,461 Selling, general and administrative expenses $ 1,701,563 $ 1,853,971 $ 1,560,034 Interest expense, net $ 157,073 $ 163,067 $ 164,238 Income (loss) from discontinued operations, net of tax $ 3,965 $ (443,744) $ (43,292) |
Effect of Net Investment Hedge Derivative Instruments | The amount of after-tax gains (losses) included in AOCI in the Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges are as follows: Amount of Gain (Loss) Recognized in AOCI Years Ended December 31, January 1, January 2, Euro-denominated long-term debt $ 9,716 $ 24,928 $ (36,609) Cross-currency swap contracts 14,497 13,670 (14,404) Total $ 24,213 $ 38,598 $ (51,013) The effect of derivative and non-derivative instruments designated as net investment hedges on the Consolidated Statements of Income are as follows: Location of Gain (Loss) Reclassified from AOCI into Income Amount of Gain (Loss) Reclassified from AOCI into Income Years Ended December 31, January 1, January 2, Euro-denominated long-term debt Income (loss) from discontinued operations, net of tax $ (13,348) $ — $ — Cross-currency swap contracts Income (loss) from discontinued operations, net of tax (2,505) — — Cross-currency swap contracts (amounts excluded from effectiveness testing) Interest expense, net 8,368 7,389 7,637 Total $ (7,485) $ 7,389 $ 7,637 The following table presents the amounts in the Consolidated Statements of Income in which the amounts excluded from effectiveness testing for net investment hedges are recorded: Years Ended December 31, January 1, January 2, Income (loss) from discontinued operations, net of tax $ 3,965 $ (443,744) $ (43,292) Interest expense, net $ 157,073 $ 163,067 $ 164,238 |
Effect of Mark to Market Hedge Derivative Instruments | The effect of derivative instruments not designated as hedges on the Consolidated Statements of Income is as follows: Location of Gain (Loss) Amount of Gain (Loss) Recognized in Income Years Ended December 31, January 1, January 2, Forward foreign exchange contracts Cost of sales $ (16,557) $ 24,087 $ (16,163) Forward foreign exchange contracts Selling, general and (290) 2,784 (2,029) Forward foreign exchange contracts Income (loss) from discontinued operations, net of tax — 4,706 (3,707) Total $ (16,847) $ 31,577 $ (21,899) |
Fair Value of Assets and Liab_2
Fair Value of Assets and Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Assets and Liabilities Measured on Recurring Basis | The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities within continuing operations accounted for at fair value on a recurring basis. Assets (Liabilities) at Fair Value as of December 31, 2022 Total Quoted Prices In Significant Significant Defined benefit pension plan investment assets: U.S. equity securities $ 158,305 $ 158,305 $ — $ — Foreign equity securities 33,713 33,713 — — Debt securities 81,812 81,812 — — Cash and other 11,045 11,045 — — Total plan assets in the fair value hierarchy 284,875 284,875 — — Plan assets measured at net asset value: (1) Hedge fund of funds 313,521 Foreign equity securities 135,076 Debt securities 670 Real estate 65,364 Commodities 16,738 Total plan assets measured at net asset value 531,369 Total plan assets 816,244 Derivative contracts: Forward foreign exchange contracts - assets 7,404 — 7,404 — Cross-currency swap contracts - assets 17,510 — 17,510 — Forward foreign exchange contracts - liabilities (6,282) — (6,282) — Cross-currency swap contracts - liabilities (28,005) — (28,005) — Total derivative contracts (9,373) — (9,373) — Deferred compensation plan liability (16,096) — (16,096) — Total $ 790,775 $ 284,875 $ (25,469) $ — (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in the tables above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. Assets (Liabilities) at Fair Value as of January 1, 2022 Total Quoted Prices In Significant Significant Defined benefit pension plan investment assets: U.S. equity securities $ 201,111 $ 201,111 $ — $ — Foreign equity securities 47,099 47,099 — — Debt securities 24,125 24,125 — — Cash and other 1,597 1,597 — — Total plan assets in the fair value hierarchy 273,932 273,932 — — Plan assets measured at net asset value: (1) Hedge fund of funds 356,289 Foreign equity securities 170,741 Debt securities 87,284 Real estate 57,479 Commodities 27,873 Total plan assets measured at net asset value 699,666 Total plan assets 973,598 Derivative contracts: Forward foreign exchange contracts - assets 8,420 — 8,420 — Cross-currency swap contracts - assets 2,953 — 2,953 — Forward foreign exchange contracts - liabilities (694) — (694) — Cross-currency swap contracts - liabilities (11,609) — (11,609) — Total derivative contracts (930) — (930) — Deferred compensation plan liability (20,916) — (20,916) — Total $ 951,752 $ 273,932 $ (21,846) $ — (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in the tables above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets. |
Business Segment Information (T
Business Segment Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Net Sales | Years Ended December 31, January 1, January 2, Net sales: Innerwear $ 2,429,966 $ 2,719,788 $ 2,978,009 Activewear 1,555,062 1,679,639 1,184,413 International 1,914,268 2,066,249 1,711,432 Other 334,354 335,564 253,307 Total net sales $ 6,233,650 $ 6,801,240 $ 6,127,161 |
Segment Operating Profit | Years Ended December 31, January 1, January 2, Segment operating profit: Innerwear $ 388,586 $ 573,852 $ 718,923 Activewear 153,710 236,400 67,643 International 283,036 339,317 249,718 Other 17,019 30,922 (10,140) Total segment operating profit 842,351 1,180,491 1,026,144 Items not included in segment operating profit: General corporate expenses (232,975) (219,984) (218,424) Restructuring and other action-related charges (59,858) (131,710) (734,196) Amortization of intangibles (29,973) (31,069) (30,858) Total operating profit 519,545 797,728 42,666 Other expenses (9,734) (53,586) (20,655) Interest expense, net (157,073) (163,067) (164,238) Income (loss) from continuing operations before income tax expense $ 352,738 $ 581,075 $ (142,227) |
Restructuring and other action-related charges | The Company incurred restructuring and other action-related charges that were reported in the following lines in the Consolidated Statements of Income: Years Ended December 31, January 1, January 2, Cost of sales $ 17,025 $ 10,098 $ 670,618 Selling, general and administrative expenses 42,833 121,612 63,578 Total included in operating profit 59,858 131,710 734,196 Other expenses — 45,699 — Total included in income (loss) from continuing operations before income tax expense 59,858 177,409 734,196 Income tax (expense) benefit (413,766) 53,665 205,342 Total restructuring and other action-related charges $ 473,624 $ 123,744 $ 528,854 The components of restructuring and other action-related charges were as follows: Years Ended December 31, January 1, January 2, Full Potential plan: Professional services $ 23,994 $ 44,617 $ — Supply chain segmentation 17,982 5,419 — Technology 11,922 4,617 — Operating model 8,221 23,191 — Impairment of intangible assets — 7,302 — (Gain) loss on sale of business and classification of assets held for sale (3,535) 38,364 — Other 1,274 8,200 — Inventory SKU rationalization — — 192,704 PPE inventory write-off — — 362,913 PPE vendor commitments — — 26,400 Supply chain actions — — 19,636 Program exit costs — — 9,854 Other restructuring costs — — 7,763 COVID-19 related charges: Supply chain re-startup — — 48,608 Bad debt — — 9,418 Inventory — — 14,869 Goodwill — — 25,173 Write-off of acquisition tax asset — — 16,858 Total included in operating profit 59,858 131,710 734,196 Early extinguishment and refinancing of debt included in other expenses — 45,699 — Total included in income (loss) from continuing operations before income tax expense 59,858 177,409 734,196 Discrete tax (expense) benefit (422,918) 27,147 69,628 Tax effect on actions 9,152 26,518 135,714 Total included in income tax (expense) benefit (413,766) 53,665 205,342 Total restructuring and other action-related charges $ 473,624 $ 123,744 $ 528,854 |
Assets | December 31, 2022 Innerwear Activewear International Other Unallocated Total Assets Assets: Inventories $ 918,104 $ 665,500 $ 364,231 $ 31,837 $ — $ 1,979,672 Assets held for sale — — — — 13,327 13,327 All other assets — — — — 4,510,877 4,510,877 Total assets $ 6,503,876 January 1, 2022 Innerwear Activewear International Other Unallocated Total Assets Assets: Inventories $ 829,093 $ 447,297 $ 279,379 $ 28,246 $ — $ 1,584,015 Assets held for sale — — — — 327,157 327,157 All other assets — — — — 5,160,264 5,160,264 Total assets $ 7,071,436 |
Depreciation and Amortization Expense | Years Ended December 31, January 1, January 2, Depreciation and amortization expense: Innerwear $ 26,518 $ 25,816 $ 27,407 Activewear 24,200 23,562 23,621 International 19,670 22,476 24,307 Other 3,341 4,578 5,520 73,729 76,432 80,855 Corporate 32,538 33,698 34,112 Total depreciation and amortization expense $ 106,267 $ 110,130 $ 114,967 |
Geographic Area Information (Ta
Geographic Area Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Sales and Long Lived Assets by Geographical Area | Years Ended or at December 31, January 1, January 2, Sales Property, Net Sales Property, Net Sales Property, Net Americas $ 4,532,595 $ 325,957 $ 4,995,230 $ 325,188 $ 4,544,651 $ 351,841 Asia Pacific 1,149,954 85,966 1,257,037 85,538 1,085,822 92,582 Europe 534,892 30,481 530,440 30,675 482,630 33,398 Other 16,209 — 18,533 — 14,058 — $ 6,233,650 $ 442,404 $ 6,801,240 $ 441,401 $ 6,127,161 $ 477,821 |
Quarterly Financial Data (Table
Quarterly Financial Data (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Text Block [Abstract] | |
Quarterly Information | Quarters Ended December 31, January 1, Net sales $ 1,473,286 $ 1,752,349 Cost of sales 971,309 1,084,621 Gross profit 501,977 667,728 Selling, general and administrative expenses 441,642 512,162 Operating profit 60,335 155,566 Other expenses 3,646 47,359 Interest expense, net 49,665 35,307 Income from continuing operations before income tax expense 7,024 72,900 Income tax expense 425,132 4,946 Income (loss) from continuing operations (418,108) 67,954 Loss from discontinued operations, net of tax — (7,921) Net income (loss) $ (418,108) $ 60,033 Earnings (loss) per share - basic: Continuing operations $ (1.19) $ 0.19 Discontinued operations — (0.02) Net income (loss) $ (1.19) $ 0.17 Earnings (loss) per share - diluted: Continuing operations $ (1.19) $ 0.19 Discontinued operations — (0.02) Net income (loss) $ (1.19) $ 0.17 |
Basis of Presentation (Details)
Basis of Presentation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Ransomware Attack [Member] | |||
Ransomware Recovery Costs Net [Line Items] | |||
Ransomware Recovery Costs Net | $ 15,427 | ||
Total included in operating profit | |||
Restructuring and Other Action-Related Charges | |||
Restructuring and other action-related charges | 59,858 | $ 131,710 | $ 734,196 |
Total included in operating profit | PPE inventory write-off | Full Potential plan | |||
Restructuring and Other Action-Related Charges | |||
Restructuring and other action-related charges | 0 | 0 | 362,913 |
Total included in operating profit | PPE vendor commitments | Full Potential plan | |||
Restructuring and Other Action-Related Charges | |||
Restructuring and other action-related charges | 0 | 0 | 26,400 |
Total included in operating profit | Inventory SKU rationalization | Full Potential plan | |||
Restructuring and Other Action-Related Charges | |||
Restructuring and other action-related charges | 0 | 0 | 192,704 |
Cost of sales | |||
Restructuring and Other Action-Related Charges | |||
Restructuring and other action-related charges | 17,025 | 10,098 | 670,618 |
Cost of sales | Ransomware Attack [Member] | |||
Ransomware Recovery Costs Net [Line Items] | |||
Ransomware Recovery Costs Net | 14,168 | ||
Selling, general and administrative expenses | |||
Restructuring and Other Action-Related Charges | |||
Restructuring and other action-related charges | 42,833 | $ 121,612 | $ 63,578 |
Selling, general and administrative expenses | Ransomware Attack [Member] | |||
Ransomware Recovery Costs Net [Line Items] | |||
Ransomware Recovery Costs Net | $ 1,259 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Additional Information (Detail) $ in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Jan. 02, 2021 USD ($) | Jan. 02, 2021 AUD ($) | |
Summary of Significant Accounting Policies | ||||||
Advertising expense | $ 208,881 | $ 208,998 | $ 113,586 | |||
Net sales | $ 1,473,286 | $ 1,752,349 | 6,233,650 | 6,801,240 | 6,127,161 | |
Shipping and handling costs | 415,989 | 447,131 | 389,252 | |||
Research and development expense | 38,911 | 39,320 | 37,367 | |||
Defined contribution benefit plans | 26,296 | 37,979 | 34,720 | |||
Restricted cash | 0 | $ 0 | $ 0 | 0 | 1,166 | |
BNT Holdco Pty Limited | ||||||
Summary of Significant Accounting Policies | ||||||
Restricted cash | 1,166 | $ 1,517 | ||||
Trademarks | Minimum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 10 years | |||||
Trademarks | Maximum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 20 years | |||||
Licensing agreements | Minimum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 3 years | |||||
Licensing agreements | Maximum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 15 years | |||||
Computer software and other intangibles | Minimum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 1 year | |||||
Computer software and other intangibles | Maximum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 13 years | |||||
Cloud Computing Arrangement Software [Member] | ||||||
Summary of Significant Accounting Policies | ||||||
Net capitalized CCA assets | $ 53,637 | $ 53,637 | ||||
Customer and distributor relationships | Maximum | ||||||
Summary of Significant Accounting Policies | ||||||
Finite-lived intangible assets amortization period | 15 years | |||||
Machinery and Equipment | Minimum | ||||||
Summary of Significant Accounting Policies | ||||||
Estimated useful life | 1 year | |||||
Machinery and Equipment | Maximum | ||||||
Summary of Significant Accounting Policies | ||||||
Estimated useful life | 15 years | |||||
Buildings and Improvements | Maximum | ||||||
Summary of Significant Accounting Policies | ||||||
Estimated useful life | 40 years | |||||
Shipping and Handling | ||||||
Summary of Significant Accounting Policies | ||||||
Net sales | $ 13,578 | $ 19,461 | $ 18,943 |
Assets and Liabilities Held f_3
Assets and Liabilities Held for Sale - Balance Sheet (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Current assets of discontinued operations | $ 13,327 | $ 327,157 |
Current liabilities of discontinued operations | 13,327 | 316,902 |
Continuing Operations, Disposal Group, Held-for-sale | U.S. Sheer Hosiery Business | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Current assets of discontinued operations | 13,327 | 5,426 |
Current liabilities of discontinued operations | 13,327 | 5,426 |
Discontinued Operations, Held-for-sale | European Innerwear Business | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Current assets of discontinued operations | 0 | 321,731 |
Current liabilities of discontinued operations | $ 0 | $ 311,476 |
Assets and Liabilities Held f_4
Assets and Liabilities Held for Sale - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
(Gain) loss on sale of business and classification of assets held for sale | $ (3,162) | $ 312,359 | $ 0 | |
Selling, general and administrative expenses | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Impairment of intangible assets, Continuing Operations | 7,302 | |||
U.S. Sheer Hosiery Business | Selling, general and administrative expenses | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Goodwill, impairment loss | 25,173 | |||
Continuing Operations, Disposal Group, Held-for-sale | U.S. Sheer Hosiery Business | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
(Gain) loss on sale of business and classification of assets held for sale | (3,535) | |||
Continuing Operations, Disposal Group, Held-for-sale | U.S. Sheer Hosiery Business | Selling, general and administrative expenses | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
(Gain) Loss on Sale of Business and Classification of Assets Held For Sale | 38,364 | |||
Discontinued Operations, Held-for-sale | European Innerwear Business | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Impairment of intangible assets and goodwill, Discontinued Operations | 0 | 155,745 | 20,319 | |
(Gain) loss on sale of business and classification of assets held for sale | $ 7,253 | $ 373 | $ 273,995 | $ 0 |
Discontinued Operations - Incom
Discontinued Operations - Income Statement (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
(Gain) loss on sale of business and classification of assets held for sale | $ (3,162) | $ 312,359 | $ 0 | ||
Net income (loss) from discontinued operations, net of tax | $ 0 | $ (7,921) | 3,965 | (443,744) | (43,292) |
Discontinued Operations, Held-for-sale | European Innerwear Business | |||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Net sales | 101,314 | 546,558 | 598,322 | ||
Cost of sales | 60,415 | 294,383 | 352,758 | ||
Gross profit | 40,899 | 252,175 | 245,564 | ||
Selling, general and administrative expenses | 54,689 | 274,408 | 261,410 | ||
Impairment of intangible assets and goodwill | 0 | 155,745 | 20,319 | ||
(Gain) loss on sale of business and classification of assets held for sale | $ 7,253 | 373 | 273,995 | 0 | |
Operating income (loss) | (14,163) | (451,973) | (36,165) | ||
Other expenses | 283 | 2,178 | 2,477 | ||
Interest expense, net | 10 | 613 | 2,253 | ||
Income (loss) from discontinued operations before income tax expense | (14,456) | (454,764) | (40,895) | ||
Income tax expense (benefit) | (18,421) | (11,020) | 2,397 | ||
Net income (loss) from discontinued operations, net of tax | $ 3,965 | $ (443,744) | $ (43,292) |
Discontinued Operations - Asset
Discontinued Operations - Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Current assets of discontinued operations | $ 13,327 | $ 327,157 | |
Current liabilities of discontinued operations | 13,327 | 316,902 | |
Trademarks | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Intangible assets not subject to amortization | 1,142,746 | 1,087,881 | |
Discontinued Operations, Held-for-sale | European Innerwear Business | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Cash and cash equivalents | 0 | 24,352 | $ 8,822 |
Trade accounts receivable, net | 0 | 87,353 | |
Inventories | 0 | 141,653 | |
Other current assets | 0 | 21,926 | |
Property, net | 0 | 62,659 | |
Right-of-use assets | 0 | 32,603 | |
Trademarks and other identifiable intangibles, net | 0 | 205,204 | |
Deferred tax assets | 0 | 4,174 | |
Other noncurrent assets | 0 | 4,127 | |
Allowance to adjust assets to estimated fair value, less costs of disposal | 0 | (262,320) | |
Current assets of discontinued operations | 0 | 321,731 | |
Accounts payable | 0 | 84,327 | |
Accrued liabilities | 0 | 122,620 | |
Lease liabilities | 0 | 6,562 | |
Notes payable | 0 | 329 | |
Lease liabilities - noncurrent | 0 | 27,426 | |
Pension and postretirement benefits | 0 | 38,325 | |
Other noncurrent liabilities | 0 | 31,887 | |
Current liabilities of discontinued operations | $ 0 | 311,476 | |
Discontinued Operations, Held-for-sale | European Innerwear Business | Trademarks | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Intangible assets not subject to amortization | $ 161,693 |
Discontinued Operations - Cash
Discontinued Operations - Cash Flows (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
(Gain) loss on sale of business and classification of assets held for sale | $ (3,162) | $ 312,359 | $ 0 | |
Discontinued Operations, Held-for-sale | European Innerwear Business | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Depreciation | 0 | 2,608 | 11,650 | |
Amortization | 0 | 1,460 | 5,829 | |
Capital expenditures | 715 | 8,462 | 4,160 | |
Impairment of intangible assets and goodwill | 0 | 155,745 | 20,319 | |
(Gain) loss on sale of business and classification of assets held for sale | $ 7,253 | 373 | 273,995 | 0 |
Capital expenditures included in accounts payable at end of period | 0 | 1,079 | 3,767 | |
Right-of-use assets obtained in exchange for lease obligations | $ 0 | $ 8,672 | $ 3,738 |
Revenue Recognition (Details)
Revenue Recognition (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disaggregation of Revenue | |||||
Net sales | $ 1,473,286 | $ 1,752,349 | $ 6,233,650 | $ 6,801,240 | $ 6,127,161 |
Third-party brick-and-mortar wholesale | |||||
Disaggregation of Revenue | |||||
Net sales | 4,348,424 | 4,777,623 | 4,334,088 | ||
Consumer-directed | |||||
Disaggregation of Revenue | |||||
Net sales | $ 1,885,226 | $ 2,023,617 | 1,793,073 | ||
Government contract | Third-party brick-and-mortar wholesale | |||||
Disaggregation of Revenue | |||||
Net sales | $ 518,309 |
Earnings Per Share - Reconcilia
Earnings Per Share - Reconciliation of Basic to Diluted Weighted Average Shares (Detail) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Reconciliation of basic to diluted weighted average shares | |||
Basic weighted average shares outstanding | 349,970 | 351,028 | 352,766 |
Diluted weighted average shares outstanding | 349,970 | 352,078 | 352,766 |
Stock options | |||
Effect of potentially dilutive securities: | |||
Incremental common shares attributable to dilutive effect of share-based payment arrangements | 0 | 16 | 0 |
Restricted stock units | |||
Effect of potentially dilutive securities: | |||
Incremental common shares attributable to dilutive effect of share-based payment arrangements | 0 | 1,031 | 0 |
Employee stock purchase plan and other | |||
Effect of potentially dilutive securities: | |||
Incremental common shares attributable to dilutive effect of share-based payment arrangements | 0 | 3 | 0 |
Earnings Per Share - Anti-Dilut
Earnings Per Share - Anti-Dilutive Securities (Detail) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Stock options | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted earnings per share | 252 | 167 | 219 |
Restricted stock units | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted earnings per share | 1,907 | 32 | 621 |
Employee stock purchase plan and other | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of diluted earnings per share | 8 | 0 | 5 |
Stock Based Compensation - Summ
Stock Based Compensation - Summary of Changes in Stock Options Outstanding (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Dec. 28, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||||
Options outstanding, Shares, Beginning Balance | 250 | 250 | 471 | |
Granted, shares | 0 | 0 | 250 | |
Exercised, shares | 0 | 0 | (471) | |
Options outstanding, Shares, Ending Balance | 250 | 250 | 250 | 471 |
Options exercisable, Shares, Ending Balance | 167 | |||
Options outstanding, Weighted-Average Exercise Price, Beginning Balance | $ 17.18 | $ 17.18 | $ 6.79 | |
Weighted-Average Exercise Price, Grants | 0 | 0 | 17.18 | |
Weighted-Average Exercise Price, Exercised | 0 | 0 | 6.79 | |
Options outstanding, Weighted Average Exercise Price, Ending Balance | 17.18 | $ 17.18 | $ 17.18 | $ 6.79 |
Weighted-Average Exercise Price, Exercisable | $ 15.75 | |||
Options Outstanding, Aggregate Intrinsic Value | $ 0 | $ 200 | $ 22 | $ 3,786 |
Options Exercisable, Aggregate Intrinsic Value | $ 0 | |||
Option Outstanding, Weighted-Average Remaining Contractual Term (Years) | 7 years 7 months 2 days | 8 years 7 months 2 days | 9 years 7 months 2 days | 11 months 8 days |
Option Exercisable, Weighted-Average Remaining Contractual Term (Years) | 7 years 7 months 2 days |
Stock Based Compensation - Su_2
Stock Based Compensation - Summary of Changes in Restricted Stock Unit Awards Outstanding (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Dec. 28, 2019 | |
Restricted Stock Units (RSUs) | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||
Nonvested share units outstanding, Beginning Balance | 2,121 | 3,111 | 1,867 | |
Vested, Shares | (829) | (1,694) | (803) | |
Forfeited, Shares | (435) | (117) | (83) | |
Nonvested share units outstanding, Ending Balance | 3,659 | 2,121 | 3,111 | 1,867 |
Weighted Average Grant Date Fair Value, Share units, Beginning Balance | $ 16.53 | $ 14.64 | $ 16.93 | |
Weighted Average Grant Date Fair Value, Vested | 15.92 | 14.87 | 19.08 | |
Weighted Average Grant Date Fair Value, Forfeited | 16.84 | 15.36 | 15.53 | |
Weighted Average Grant Date Fair Value, Share units, Ending Balance | $ 16.46 | $ 16.53 | $ 14.64 | $ 16.93 |
Aggregate Intrinsic Value | $ 23,268 | $ 35,455 | $ 45,361 | $ 27,692 |
Weighted-Average Remaining Contractual Term (Years) | 1 year 2 months 26 days | 1 year 2 months 4 days | 1 year 3 months 25 days | 1 year 6 months |
Non-Performanced Based | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 1,178 | 970 | 1,006 | |
Weighted Average Grant Date Fair Value, Granted | $ 15.39 | $ 16.11 | $ 14.26 | |
Performanced Based | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Performanced Based Restricted Stock Units, Grants in Period | 1,624 | (149) | 1,124 | |
Weighted Average Grant Date Fair Value, Granted | $ 16.98 | $ 16.22 | $ 14.40 |
Stock Based Compensation - Addi
Stock Based Compensation - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation expense from share-based payment awards | $ 23,157 | $ 16,290 | $ 18,664 |
Total unrecognized compensation cost related to non-vested stock-based compensation arrangements | 23,329 | ||
Unrecognized compensation cost related to non-vested stock-based compensation arrangements expected to be recognized in 2023 | 16,349 | ||
Unrecognized compensation cost related to non-vested stock-based compensation arrangements expected to be recognized in 2024 | 6,097 | ||
Unrecognized compensation cost related to non-vested stock-based compensation arrangements expected to be recognized in 2025 | 883 | ||
Continuing Operations | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation expense from share-based payment awards | 23,357 | 16,065 | 18,202 |
Deferred tax benefit from share-based payment awards | 0 | 2,499 | 1,808 |
Discontinued Operations | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation expense from share-based payment awards | $ (200) | 225 | $ 462 |
Share Based Compensation Arrangement | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Common stock shares authorized for awards granted | 11,000 | ||
Common stock shares authorized for awards of Stock Options and Restricted Stock Units | 74,220 | ||
Number of shares available for future grants | 14,033 | ||
Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Ratable vesting period of Stock Options, years | 3 years | ||
Exercise term of Stock Options, years | 10 years | ||
Number of shares granted outside of the Omnibus Plan | 250 | ||
Ratable vesting period of Stock Options granted outside of the Omnibus Plan, years | 3 years | ||
Exercise term of Stock Options granted outside of the Omnibus Plan, years | 10 years | ||
Dividend yield | 5% | ||
Risk-free interest rate | 0.31% | ||
Volatility | 39.97% | ||
Expected term (years) | 6 years | ||
Total intrinsic value of options exercised | $ 0 | $ 3,299 | |
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares granted outside of the Omnibus Plan | 225 | ||
Fair value of Restricted Stock Units shares vested | $ 13,199 | $ 25,201 | $ 15,325 |
Minimum percentage of target of performanced-based Restricted Stock Units granted | 0% | ||
Maximum percentage of target of performanced-based Restricted Stock Units granted | 200% | ||
Restricted Stock Units (RSUs) | Non-performanced based | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares granted outside of the Omnibus Plan | 119 | ||
Restricted Stock Units (RSUs) | Performanced-based | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares granted outside of the Omnibus Plan | 106 | ||
Restricted Stock Units (RSUs) | Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period of Restricted Stock Units, years | 1 year | ||
Restricted Stock Units (RSUs) | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period of Restricted Stock Units, years | 3 years |
Trade Accounts Receivable - All
Trade Accounts Receivable - Allowances for Trade Accounts Receivable (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Accounts Receivable, Allowance for Doubtful Accounts, Chargebacks and Other Deductions [Roll Forward] | |||
Beginning Balance | $ 61,948 | $ 48,745 | $ 26,490 |
Charged to expenses | 27,153 | 26,780 | 46,292 |
Deductions, write-offs and adjustments | (35,933) | (12,582) | (24,850) |
Currency translation | (1,145) | (995) | 813 |
Ending Balance | 52,023 | 61,948 | 48,745 |
Allowance for Doubtful Accounts | |||
Accounts Receivable, Allowance for Doubtful Accounts, Chargebacks and Other Deductions [Roll Forward] | |||
Beginning Balance | 37,838 | 33,603 | 16,277 |
Charged to expenses | 6,721 | 2,279 | 31,661 |
Deductions, write-offs and adjustments | (19,753) | 2,663 | (14,986) |
Currency translation | (658) | (707) | 651 |
Ending Balance | 24,148 | 37,838 | 33,603 |
Allowance for Chargebacks and Other Deductions | |||
Accounts Receivable, Allowance for Doubtful Accounts, Chargebacks and Other Deductions [Roll Forward] | |||
Beginning Balance | 24,110 | 15,142 | 10,213 |
Charged to expenses | 20,432 | 24,501 | 14,631 |
Deductions, write-offs and adjustments | (16,180) | (15,245) | (9,864) |
Currency translation | (487) | (288) | 162 |
Ending Balance | $ 27,875 | $ 24,110 | $ 15,142 |
Trade Accounts Receivable - Add
Trade Accounts Receivable - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Trade Accounts Receivable [Abstract] | |||
Funding Fees For Sales Of Accounts Receivable | $ 8,823 | $ 3,312 | $ 4,932 |
Inventories Disclosure (Detail)
Inventories Disclosure (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Inventories Disclosure [Abstract] | ||
Raw materials | $ 69,279 | $ 68,683 |
Work in process | 107,904 | 110,246 |
Finished goods | 1,802,489 | 1,405,086 |
Total Inventories | $ 1,979,672 | $ 1,584,015 |
Summary of Property (Detail)
Summary of Property (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 |
Property, Net - Summary Of Property [Abstract] | |||
Land | $ 26,209 | $ 26,368 | |
Buildings and improvements | 430,043 | 430,235 | |
Machinery and equipment | 994,829 | 998,891 | |
Construction in progress | 50,895 | 42,375 | |
Property, gross | 1,501,976 | 1,497,869 | |
Less accumulated depreciation | 1,059,572 | 1,056,468 | |
Property, net | $ 442,404 | $ 441,401 | $ 477,821 |
Property, Net Narrative (Detail
Property, Net Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Property, Plant and Equipment [Abstract] | |||
Capital expenditures included in accounts payable | $ 10,549 | $ 23,085 | $ 14,164 |
Leases (Details)
Leases (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Lessee, Lease, Description [Line Items] | |||
Lease cost | $ 239,854 | $ 236,139 | $ 218,506 |
Variable cost | $ 82,165 | $ 77,496 | $ 69,210 |
Minimum | |||
Lessee, Lease, Description [Line Items] | |||
Remaining lease terms | 1 month | ||
Option to terminate, period | 1 year | ||
Maximum | |||
Lessee, Lease, Description [Line Items] | |||
Option to extend, term | 15 years | ||
Remaining lease terms | 35 years |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow and Non-Cash Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Leases [Abstract] | |||
Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from leases | $ 146,439 | $ 157,138 | $ 179,591 |
Right-of-use assets obtained in exchange for lease obligations - non-cash activity | $ 81,571 | $ 59,864 | $ 47,349 |
Leases - Supplemental Lease Inf
Leases - Supplemental Lease Information (Details) | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 |
Leases [Abstract] | |||
Weighted average remaining lease term | 5 years | 4 years 8 months 12 days | 5 years |
Weighted average discount rate | 4.77% | 4.55% | 4.65% |
Leases - Maturities of Operatin
Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Leases [Abstract] | |
2023 | $ 127,996 |
2024 | 108,165 |
2025 | 75,007 |
2026 | 71,011 |
2027 | 48,370 |
Thereafter | 69,034 |
Total lease payments | 499,583 |
Less interest | 58,145 |
Total operating lease liabilities | 441,438 |
Lessor, Operating Lease, Lease Not yet Commenced, Assumption and Judgment, Value of Underlying Asset, Amount | $ 55,240 |
Intangible Assets and Goodwil_2
Intangible Assets and Goodwill - Intangible Assets and Related Accumulated Amortization (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Jul. 02, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Gross | $ 366,303 | $ 369,976 | ||
Accumulated Amortization | 255,606 | 239,937 | ||
Net Book Value | 110,697 | 130,039 | ||
Net book value of intangible assets | 1,255,693 | 1,220,170 | ||
Purchase of trademarks | 103,000 | 0 | $ 0 | |
Trademarks and brand names | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Gross | 40,128 | 43,187 | ||
Accumulated Amortization | 28,633 | 29,678 | ||
Net Book Value | 11,495 | 13,509 | ||
Purchase of trademarks | $ 102,500 | |||
Licensing agreements | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Gross | 89,523 | 92,370 | ||
Accumulated Amortization | 68,205 | 65,828 | ||
Net Book Value | 21,318 | 26,542 | ||
Customer and distributor relationships | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Gross | 122,283 | 132,971 | ||
Accumulated Amortization | 81,099 | 78,647 | ||
Net Book Value | 41,184 | 54,324 | ||
Computer software | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Gross | 109,209 | 97,464 | ||
Accumulated Amortization | 72,626 | 62,064 | ||
Net Book Value | 36,583 | 35,400 | ||
Other intangibles | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Gross | 5,160 | 3,984 | ||
Accumulated Amortization | 5,043 | 3,720 | ||
Net Book Value | 117 | 264 | ||
Trademarks | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Intangible assets not subject to amortization | 1,142,746 | 1,087,881 | ||
Perpetual licensing agreements and other | ||||
Finite And Indefinite Lived Intangible Assets [Line Items] | ||||
Intangible assets not subject to amortization | $ 2,250 | $ 2,250 |
Intangible Assets and Goodwil_3
Intangible Assets and Goodwill - Goodwill (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Jan. 01, 2022 | |
Intangible Assets and Goodwill [Line Items] | ||
Goodwill, Beginning Balance | $ 1,133,095 | $ 1,158,938 |
Currency translation | (24,188) | (25,843) |
Goodwill, Ending Balance | 1,108,907 | 1,133,095 |
Innerwear | ||
Intangible Assets and Goodwill [Line Items] | ||
Goodwill, Beginning Balance | 406,853 | 406,853 |
Currency translation | 0 | 0 |
Goodwill, Ending Balance | 406,853 | 406,853 |
Activewear | ||
Intangible Assets and Goodwill [Line Items] | ||
Goodwill, Beginning Balance | 316,384 | 316,384 |
Currency translation | 0 | 0 |
Goodwill, Ending Balance | 316,384 | 316,384 |
International | ||
Intangible Assets and Goodwill [Line Items] | ||
Goodwill, Beginning Balance | 407,358 | 433,201 |
Currency translation | (24,188) | (25,843) |
Goodwill, Ending Balance | 383,170 | 407,358 |
Other | ||
Intangible Assets and Goodwill [Line Items] | ||
Goodwill, Beginning Balance | 2,500 | 2,500 |
Currency translation | 0 | 0 |
Goodwill, Ending Balance | $ 2,500 | $ 2,500 |
Intangible Assets and Goodwil_4
Intangible Assets and Goodwill - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Intangible Assets and Goodwill [Line Items] | |||
Amortization expense in Continuing Operations for intangible assets subject to amortization | $ 29,973 | $ 31,069 | $ 30,858 |
Estimated amortization expense, 2023 | 29,728 | ||
Estimated amortization expense, 2024 | 25,338 | ||
Estimated amortization expense, 2025 | 21,602 | ||
Estimated amortization expense, 2026 | 12,234 | ||
Estimated amortization expense, 2027 | 5,261 | ||
Purchase of trademarks | $ 103,000 | 0 | 0 |
Selling, general and administrative expenses | |||
Intangible Assets and Goodwill [Line Items] | |||
Impairment of intangible assets, Continuing Operations | $ 7,302 | ||
U.S. Sheer Hosiery | Selling, general and administrative expenses | |||
Intangible Assets and Goodwill [Line Items] | |||
Goodwill, impairment loss | $ 25,173 |
Debt - Summary of Debt (Details
Debt - Summary of Debt (Details) - USD ($) $ in Thousands | 3 Months Ended | |||||
Apr. 01, 2023 | Dec. 31, 2022 | May 20, 2022 | Jan. 01, 2022 | Apr. 01, 2021 | Jul. 10, 2019 | |
Debt Instrument [Line Items] | ||||||
Long-term debt, gross | $ 3,872,275 | $ 3,368,634 | ||||
Long-term Debt, Excluding Current Maturities [Abstract] | ||||||
Less long-term debt issuance costs | 13,198 | 17,543 | ||||
Less current maturities | 247,000 | 25,000 | ||||
Long-term debt | $ 3,612,077 | 3,326,091 | ||||
Subsequent Event | ||||||
Debt Instrument [Line Items] | ||||||
Expected refinancing of 4.625% and 3.5% senior notes | $ 1,435,275 | |||||
Revolving Loan Facility | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 5.83% | |||||
Long-term debt, gross | $ 352,500 | 0 | ||||
Term Loan A | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 5.92% | |||||
Long-term debt, gross | $ 975,000 | 1,000,000 | ||||
5.375% Senior Notes | ||||||
Debt Instrument [Line Items] | ||||||
Long-term debt, gross | $ 700,000 | |||||
4.875% Senior Notes | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 4.88% | |||||
Long-term debt, gross | $ 900,000 | 900,000 | ||||
4.625% Senior Notes | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 4.63% | 4.625% | ||||
Long-term debt, gross | $ 900,000 | 900,000 | ||||
3.5% Senior Notes | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 3.50% | 3.50% | ||||
Long-term debt, gross | $ 535,275 | 568,634 | ||||
Accounts Receivable Securitization Facility | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 5.09% | |||||
Long-term debt, gross | $ 209,500 | $ 0 |
Debt - Description of Debt Term
Debt - Description of Debt Terms (Detail) € in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||||||
Nov. 19, 2021 USD ($) | Dec. 28, 2024 | Sep. 28, 2024 | Jun. 29, 2024 | Mar. 30, 2024 USD ($) | Dec. 31, 2022 USD ($) | Dec. 30, 2023 USD ($) | Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Jan. 02, 2021 USD ($) | Dec. 30, 2017 USD ($) | Dec. 31, 2016 EUR (€) | Dec. 31, 2022 EUR (€) | May 20, 2022 USD ($) | Jan. 01, 2022 EUR (€) | |
Debt Instrument [Line Items] | |||||||||||||||
Repayments on Term Loan Facilities | $ 25,000 | $ 925,000 | $ 0 | ||||||||||||
Loss on extinguishment of debt | 0 | 43,739 | 0 | ||||||||||||
Long-term debt, gross | $ 3,872,275 | 3,872,275 | 3,368,634 | ||||||||||||
Borrowings on Senior Notes | 0 | 0 | 700,000 | ||||||||||||
Borrowings on Term Loan Facilities | $ 0 | 1,000,000 | $ 0 | ||||||||||||
Senior Secured Credit Facility | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Senior Secured Credit Facility Commitment | $ 2,000,000 | ||||||||||||||
Applicable commitment fee margin | 0.25% | ||||||||||||||
Line of Credit Facility, Dividend Restrictions | 75,000 | 350,000 | |||||||||||||
Limit on incremental secured indebtedness | $ 1,750 | ||||||||||||||
Senior Secured Credit Facility | Subsequent Event | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Line of Credit Facility, Dividend Restrictions | 350,000 | 350,000 | 350,000 | 75,000 | 75,000 | ||||||||||
Limit on incremental secured indebtedness | $ 1,750 | $ 1,750 | |||||||||||||
Senior Secured Credit Facility | Minimum | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Leverage Ratio for Interest Rate and Commitment Fee | 2.25 | ||||||||||||||
Applicable commitment fee margin | 0.15% | ||||||||||||||
Senior Secured Credit Facility | Maximum | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Leverage Ratio for Interest Rate and Commitment Fee | 4.50 | ||||||||||||||
Leverage Ratio for Additional Borrowings | 3.50 | ||||||||||||||
Applicable commitment fee margin | 0.25% | ||||||||||||||
Senior Secured Credit Facility | LIBOR Based Loan | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Variable rate on base rate | 1.50% | ||||||||||||||
Senior Secured Credit Facility | LIBOR Based Loan | Minimum | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Variable rate on base rate | 1% | ||||||||||||||
Senior Secured Credit Facility | LIBOR Based Loan | Maximum | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Variable rate on base rate | 1.75% | ||||||||||||||
Senior Secured Credit Facility | Base Rate Loan | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Variable rate on base rate | 0.50% | ||||||||||||||
Senior Secured Credit Facility | Base Rate Loan | Minimum | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Variable rate on base rate | 0% | ||||||||||||||
Senior Secured Credit Facility | Base Rate Loan | Maximum | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Variable rate on base rate | 0.75% | ||||||||||||||
Revolving Loan Facility | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Maximum Borrowing Capacity | $ 1,000,000 | 1,000,000 | $ 1,000,000 | ||||||||||||
Remaining borrowing capacity | 642,546 | 642,546 | |||||||||||||
Standby and trade letters of credit issued | 4,954 | 4,954 | |||||||||||||
Long-term debt, gross | 352,500 | 352,500 | 0 | ||||||||||||
Term Loan A | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Increase in Term Loan Borrowing Capacity | $ 390,625 | ||||||||||||||
Quarterly repayment percentage, years one and two | 2.50% | ||||||||||||||
Quarterly repayment percentage, years three and four | 5% | ||||||||||||||
Quarterly repayment percentage, year five | 7.50% | ||||||||||||||
Long-term debt, gross | 975,000 | 975,000 | 1,000,000 | ||||||||||||
Borrowings on Term Loan Facilities | $ 1,000,000 | ||||||||||||||
Term Loan B | Excess Cash Flow Prepayment | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments on Term Loan Facilities | 238,936 | ||||||||||||||
Term Loan B | Voluntary Prepayment | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Repayments on Term Loan Facilities | 61,064 | ||||||||||||||
5.375% Senior Notes | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Long-term debt, gross | $ 700,000 | ||||||||||||||
4.875% Senior Notes | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Long-term debt, gross | 900,000 | 900,000 | 900,000 | ||||||||||||
4.625% Senior Notes | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Long-term debt, gross | 900,000 | 900,000 | 900,000 | ||||||||||||
2016 New Senior Notes, Combined | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Borrowings on Senior Notes | $ 1,773,000 | ||||||||||||||
Debt Instrument, Redemption Price, Percentage | 100% | ||||||||||||||
3.5% Senior Notes, Euro Value | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Long-term debt, gross | € | € 500,000 | € 500,000 | |||||||||||||
Borrowings on Senior Notes | € | € 492,500 | ||||||||||||||
3.5% Senior Notes | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Long-term debt, gross | 535,275 | 535,275 | 568,634 | ||||||||||||
Debt Instrument, Redemption Price, Percentage | 100% | ||||||||||||||
Accounts Receivable Securitization Facility | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Maximum Borrowing Capacity | 225,000 | 225,000 | 175,000 | ||||||||||||
Remaining borrowing capacity | 13,193 | 13,193 | |||||||||||||
Current Borrowing Capacity | 222,693 | 222,693 | |||||||||||||
Long-term debt, gross | 209,500 | 209,500 | 0 | ||||||||||||
Redemption of 5.375% Senior Notes and Refinancing of Senior Secured Credit Facility | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Refinancing fees incurred | 9,729 | ||||||||||||||
Capitalized debt issuance cost | 7,769 | ||||||||||||||
Redemption of 5.375% Senior Notes and Refinancing of Senior Secured Credit Facility | Other expenses | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Make-whole premium | 34,840 | ||||||||||||||
Write-off of unamortized debt issuance costs | 8,899 | ||||||||||||||
Debt issuance costs expensed | 1,960 | ||||||||||||||
Loss on extinguishment of debt | $ 45,699 | ||||||||||||||
Other International Debt | |||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||
Remaining borrowing capacity | $ 32,266 | $ 32,266 |
Debt - Future Principal Payment
Debt - Future Principal Payments (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Maturities of Long-Term Debt [Abstract] | |
Future principal payment, 2023 | $ 247,000 |
Future principal payment, 2024 | 1,485,275 |
Future principal payment, 2025 | 62,500 |
Future principal payment, 2026 | $ 2,077,500 |
Debt - Additional Disclosures (
Debt - Additional Disclosures (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||||
Dec. 28, 2024 | Sep. 28, 2024 | Jun. 29, 2024 | Mar. 30, 2024 | Dec. 30, 2023 | Sep. 30, 2023 | Jul. 01, 2023 | Apr. 01, 2023 | Dec. 31, 2022 USD ($) | Oct. 01, 2022 | Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Jan. 02, 2021 USD ($) | |
Debt Instrument [Line Items] | |||||||||||||
Payments of capitalized debt issuance costs within Continuing Operations | $ 3,159 | $ 8,346 | $ 15,010 | ||||||||||
Amortization of debt issuance costs in Continuing Operations | 7,300 | 12,305 | 11,349 | ||||||||||
Amortization of debt issuance costs | 7,300 | 12,305 | 11,565 | ||||||||||
Long-term debt issuance cost in other noncurrent assets | $ 6,831 | 6,831 | |||||||||||
Long-term debt issuance costs in long-term debt | $ 13,198 | $ 13,198 | 17,543 | ||||||||||
Senior Secured Credit Facility | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Maximum Leverage Ratio | 5.25 | ||||||||||||
Interest Coverage Ratio | 2.60 | 3 | |||||||||||
Subsequent Event | Senior Secured Credit Facility | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Maximum Leverage Ratio | 4.50 | 4.50 | 4.50 | 5 | 5.25 | 6.75 | 7.25 | 6.75 | |||||
Interest Coverage Ratio | 2.75 | 2.75 | 2.75 | 2.50 | 2 | 2 | 2 | 2.60 | |||||
Minimum | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt issuance costs amortization period, in years | 1 year | ||||||||||||
Maximum | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Debt issuance costs amortization period, in years | 10 years | ||||||||||||
Debt Payable to Banks | |||||||||||||
Debt Instrument [Line Items] | |||||||||||||
Cash paid for interest related to debt | $ 150,452 | $ 161,202 | $ 157,094 |
Defined Benefit Pension Plans -
Defined Benefit Pension Plans - Components of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Income (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disclosure Defined Benefit Pension Plans Components Of Net Periodic Benefit Cost And Other Amounts Recognized In Other Comprehensive Loss [Abstract] | |||
Service cost | $ 1,345 | $ 1,488 | $ 1,406 |
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | 1,345 | 1,488 | 1,406 |
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss) | |||
Net (gain) loss | (130,000) | (96,334) | 38,484 |
Prior service credit | 6 | 6 | 6 |
Total (gain) loss recognized in other comprehensive income (loss) | (129,994) | (96,328) | 38,490 |
Total recognized in net periodic benefit cost and other comprehensive income (loss) | (129,209) | (91,656) | 53,562 |
Pension Plan | |||
Disclosure Defined Benefit Pension Plans Components Of Net Periodic Benefit Cost And Other Amounts Recognized In Other Comprehensive Loss [Abstract] | |||
Interest cost | 27,669 | 23,812 | 33,552 |
Expected return on assets | (49,189) | (45,923) | (42,278) |
Settlement cost | 6 | (861) | (121) |
Amortization of: | |||
Prior service cost | (6) | (6) | (6) |
Net actuarial loss | 20,972 | 24,440 | 22,277 |
Net periodic benefit cost | 785 | 4,672 | 15,072 |
Defined Benefit Plan Disclosure [Line Items] | |||
Interest cost | 27,669 | 23,812 | 33,552 |
Defined Benefit Plan, Expected Return (Loss) on Plan Assets | 49,189 | 45,923 | 42,278 |
Settlement cost | (6) | 861 | 121 |
Prior service cost | (6) | (6) | (6) |
Defined Benefit Plan, Amortization of Gain (Loss) | (20,972) | (24,440) | (22,277) |
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) | $ 785 | $ 4,672 | $ 15,072 |
Defined Benefit Pension Plans_2
Defined Benefit Pension Plans - Funded Status of Company's Defined Benefit Pension Plans (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Benefit obligation: | |||
Beginning of year | $ 1,216,161 | $ 1,299,943 | |
Service cost | 1,345 | 1,488 | $ 1,406 |
Benefits paid | (64,786) | (62,525) | |
Settlements | (125) | (2,072) | |
Impact of exchange rate change | (2,603) | (1,128) | |
Actuarial gain | (251,426) | (43,325) | |
Other | (36) | (32) | |
End of year | 926,199 | 1,216,161 | 1,299,943 |
Fair value of plan assets: | |||
Beginning of year | 973,598 | 920,316 | |
Actual return on plan assets | (93,497) | 73,567 | |
Employer contributions | 2,831 | 44,658 | |
Benefits paid | (64,786) | (62,525) | |
Settlements | (125) | (2,072) | |
Impact of exchange rate change | (1,741) | (314) | |
Other | (36) | (32) | |
End of year | 816,244 | 973,598 | 920,316 |
Funded status | (109,955) | (242,563) | |
Pension Plan | |||
Benefit obligation: | |||
Interest cost | 27,669 | 23,812 | 33,552 |
Defined Benefit Plan Disclosure [Line Items] | |||
Interest cost | $ 27,669 | $ 23,812 | $ 33,552 |
Defined Benefit Pension Plans_3
Defined Benefit Pension Plans - Accumulated Benefit Obligation and Fair Value of Plan Assets with Accumulated Benefit Obligations in Excess of Plan Assets (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 |
Disclosure Defined Benefit Pension Plans Accumulated Benefit Obligation And Fair Value Of Plan Assets With Accumulated Benefit Obligations In Excess Of Plan Assets [Abstract] | |||
Benefit obligation | $ 926,199 | $ 1,216,161 | $ 1,299,943 |
Plans with benefit obligation in excess of plan assets: | |||
Benefit obligation | 905,749 | 1,188,558 | |
Fair value of plan assets | $ 790,641 | $ 942,733 |
Defined Benefit Pension Plans_4
Defined Benefit Pension Plans - Amounts Recognized in Company's Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Disclosure Defined Benefit Pension Plans Amounts Recognized In Companys Consolidated Balance Sheets [Abstract] | ||
Other noncurrent assets | $ 5,153 | $ 3,262 |
Accrued liabilities and other: Payroll and employee benefits | (2,388) | (2,225) |
Pension and postretirement benefits | (112,720) | (243,600) |
Accumulated other comprehensive loss | $ (440,529) | $ (570,523) |
Defined Benefit Pension Plans_5
Defined Benefit Pension Plans - Amounts Recognized in Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Disclosure Defined Benefit Pension Plans Amounts Recognized In Accumulated Other Comprehensive Loss [Abstract] | ||
Prior service cost | $ (133) | $ (139) |
Actuarial loss | 440,662 | 570,662 |
Accumulated other comprehensive loss | $ 440,529 | $ 570,523 |
Defined Benefit Pension Plans_6
Defined Benefit Pension Plans - Weighted Average Actuarial Assumptions Used in Measuring Net Periodic Benefit Cost and Plan Obligation (Detail) | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Net periodic benefit cost: | |||
Discount rate | 2.88% | 2.55% | 3.25% |
Long-term rate of return on plan assets | 5.24% | 4.95% | 4.97% |
Rate of compensation increase | 3.09% | 3.10% | 3.07% |
Interest crediting rate | 5.50% | 5.50% | 5.50% |
Plan obligations: | |||
Discount rate | 5.15% | 2.88% | 2.55% |
Rate of compensation increase | 3.08% | 3.09% | 3.10% |
Interest crediting rate | 5.50% | 5.50% | 5.50% |
Defined Benefit Pension Plans_7
Defined Benefit Pension Plans - Allocation of Pension Plan Assets (Detail) | Dec. 31, 2022 | Jan. 01, 2022 |
Hedge Fund of Funds | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 39% | 37% |
Foreign Equity Securities | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 21% | 22% |
U.S. Equity Securities | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 19% | 21% |
Debt Securities | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 10% | 11% |
Real Estate | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 8% | 6% |
Commodities | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 2% | 3% |
Cash and other | ||
Pension Plans, Postretirement and Other Employee Benefits [Line Items] | ||
Pension plan assets allocation percentage | 1% | 0% |
Defined Benefit Pension Plans_8
Defined Benefit Pension Plans - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Jan. 04, 2021 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disclosure Defined Benefit Pension Plans Additional Information [Abstract] | ||||
Target return period | 5 years | |||
Expected benefit payments, 2023 | $ 66,272 | |||
Expected benefit payments, 2024 | 66,619 | |||
Expected benefit payments, 2025 | 67,295 | |||
Expected benefit payments, 2026 | 68,302 | |||
Expected benefit payments, 2027 | 69,553 | |||
Expected benefit payments, 2028 through 2032 | 340,853 | |||
Contribution to U.S. Pension Plan | $ 40,000 | |||
Required cash contributions to the Company's U.S. pension plan, 2023 | 0 | |||
Nonretirement postemployment benefit plans liability | 871 | $ 1,171 | ||
Nonretirement postemployment benefit plans expense | $ 9 | 8 | $ 16 | |
Required cash contributions to the Company's U.S. pension plan , prior year | $ 0 |
Income Taxes - Provision for In
Income Taxes - Provision for Income Tax Computed by Applying U.S. Statutory Rate to Income Before Taxes as Reconciled to Actual Provisions (Detail) | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disclosure Income Taxes Provision For Income Tax Computed By Applying U S Statutory Rate To Income Before Taxes As Reconciled To Actual Provisions [Abstract] | |||
Domestic | (45.00%) | (3.30%) | 445.10% |
Foreign | 145% | 103.30% | (345.10%) |
Total | 100% | 100% | 100% |
Tax expense at U.S. statutory rate | 21% | 21% | 21% |
State income tax | (1.60%) | (0.70%) | 17% |
Tax on actual and planned remittances of foreign earnings | (1.60%) | 1.50% | 5.40% |
Tax on foreign earnings due to U.S. tax reform including measurement period adjustments | 0% | (0.30%) | 26.90% |
Tax on foreign earnings (U.S. tax reform - GILTI and FDII) | 3.80% | 1.70% | (2.30%) |
Foreign taxes less than U.S. statutory rate | (14.00%) | (12.30%) | 39% |
Statutory stock deduction and other foreign adjustments | 22.50% | 0% | (34.50%) |
Employee benefits | 1% | 0.30% | (2.20%) |
Changes in valuation allowance | 101.10% | 1.90% | (14.20%) |
Release of unrecognized tax benefit reserves | (1.10%) | (0.90%) | 13.20% |
State tax rate change | 3.10% | 1% | 0.30% |
Tax provision adjustments and revisions to prior years' returns | 3.60% | (1.60%) | (1.00%) |
Nondeductible expenses and tax exempt income, net | (1.20%) | (0.40%) | 10.20% |
Nondeductible impairment charges | 0% | 0% | (3.70%) |
Domestic income tax credits | (0.70%) | (0.40%) | 2.30% |
Other, net | 1.30% | (0.50%) | (0.10%) |
Taxes at effective worldwide tax rates | 137.20% | 10.30% | 77.30% |
Income taxes - Current and Defe
Income taxes - Current and Deferred Tax Provisions (Benefits) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disclosure Income Taxes Current And Deferred Tax Provisions Benefits [Abstract] | |||||
Current, domestic | $ 15,188 | $ (15,176) | $ (7,770) | ||
Current, foreign | 83,607 | 66,844 | 46,701 | ||
Current, state | (2,712) | (2,948) | 6,256 | ||
Current, Total | 96,083 | 48,720 | 45,187 | ||
Deferred, domestic | 201,112 | 6,934 | (136,221) | ||
Deferred, foreign | 95,558 | 1,421 | 34,066 | ||
Deferred, state | 91,154 | 3,032 | (52,972) | ||
Deferred, Total | 387,824 | 11,387 | (155,127) | ||
Total, domestic | 216,300 | (8,242) | (143,991) | ||
Total, foreign | 179,165 | 68,265 | 80,767 | ||
Total, state | 88,442 | 84 | (46,716) | ||
Total, Current and Deferred tax provisions (benefits) | $ 425,132 | $ 4,946 | $ 483,907 | $ 60,107 | $ (109,940) |
Income Taxes - Cash Tax Payment
Income Taxes - Cash Tax Payments Made by Company Primarily in Foreign Jurisdictions (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disclosure Income Taxes Cash Tax Payments Made By Company Primarily In Foreign Jurisdictions [Abstract] | |||
Cash payments for income taxes | $ 95,331 | $ 95,011 | $ 107,577 |
Income Taxes - Deferred Tax Ass
Income Taxes - Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Dec. 28, 2019 |
Deferred tax assets: | ||||
Inventories | $ 92,347 | $ 64,425 | ||
Bad debt allowance | 15,854 | 15,605 | ||
Accrued expenses | 15,492 | 20,863 | ||
Employee benefits | 55,687 | 104,845 | ||
Tax credits | 10,859 | 4,804 | ||
Net operating loss and other tax carryforwards | 562,326 | 410,921 | ||
Leasing | 112,619 | 112,423 | ||
Property and equipment | 6,094 | 4,707 | ||
Section 163(j) | 50,695 | 46,729 | ||
Capitalized research costs | 17,501 | 5,873 | ||
Other | 1,029 | 0 | ||
Gross deferred tax assets | 940,503 | 791,195 | ||
Less valuation allowances | (626,540) | (306,221) | $ (204,854) | $ (188,554) |
Deferred tax assets | 313,963 | 484,974 | ||
Deferred tax liabilities: | ||||
Derivatives | 13,781 | 10,303 | ||
Section 481(a) liability | 0 | 23,881 | ||
Leasing | 101,558 | 99,470 | ||
Accrued tax on unremitted foreign earnings | 26,128 | 38,812 | ||
Intangibles | 41,331 | 43,917 | ||
Other | 0 | 392 | ||
Statutory impairment | 247,360 | 0 | ||
Prepaids | 877 | 434 | ||
Deferred tax liabilities | (431,035) | (217,209) | ||
Deferred tax assets (liabilities), net | $ (117,072) | $ 267,765 |
Income Taxes - Summary of chang
Income Taxes - Summary of changes in Valuation Allowance (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Dec. 28, 2019 | |
Valuation Allowance [Line Items] | ||||
Valuation allowance for deferred tax assets | $ 626,540 | $ 306,221 | $ 204,854 | $ 188,554 |
Net change in the total valuation allowance, including foreign currency fluctuations | 320,319 | |||
Charged to income tax expense | ||||
Valuation Allowance [Line Items] | ||||
Net change in the total valuation allowance, including foreign currency fluctuations | 356,740 | 4,343 | 14,959 | |
Charged to other accounts | ||||
Valuation Allowance [Line Items] | ||||
Net change in the total valuation allowance, including foreign currency fluctuations | $ (36,421) | $ 97,024 | $ 1,341 |
Income Taxes - Foreign Net Oper
Income Taxes - Foreign Net Operating Loss Carryforwards (Detail) - Foreign Tax Authority $ in Thousands | Dec. 31, 2022 USD ($) |
Operating Loss Carryforwards [Line Items] | |
2023 | $ 6,055 |
2024 | 3,921 |
2025 | 6,076 |
2026 | 2,320 |
2027 | 4,168 |
Thereafter | $ 1,890,071 |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Dec. 28, 2019 | |
Disclosure Income Taxes Reconciliation Of Beginning And Ending Amount Of Unrecognized Tax Benefits [Abstract] | ||||
Unrecognized Tax Benefits, Gross | $ 37,818 | $ 40,706 | $ 46,645 | $ 78,789 |
Beginning Balance | 39,572 | 45,686 | 74,385 | |
Adjustments related to prior year ending balance | 1,138 | |||
Additions based on tax positions related to the current year | 2,857 | 3,231 | 3,675 | |
Additions based on tax positions of prior years | 798 | 3,401 | 2,666 | |
Settlements | 0 | 0 | 0 | |
Lapse of statute of limitations | (7,191) | (147) | (16,655) | |
Reductions for tax positions of prior years | (311) | (12,599) | (18,385) | |
Ending Balance | $ 36,863 | $ 39,572 | $ 45,686 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Dec. 28, 2019 | |
Additional Income Tax Information [Line Items] | ||||||
Income (loss) from continuing operations before income tax expense | $ 7,024 | $ 72,900 | $ 352,738 | $ 581,075 | $ (142,227) | |
Income tax expense (benefit) | (425,132) | (4,946) | (483,907) | (60,107) | 109,940 | |
Valuation allowance for deferred tax assets | 626,540 | 306,221 | 626,540 | 306,221 | 204,854 | $ 188,554 |
Net increase (decrease) in the total valuation allowance, including foreign currency fluctuations | 320,319 | |||||
Unremitted foreign earnings not permanently reinvested | 269,019 | 269,019 | ||||
Accrued income taxes with respect to foreign earnings the Company intends to remit in the future | 26,128 | 26,128 | ||||
Recognized reduction related to realization of unrecognized tax benefit resulting from prior year tax positions | 311 | 12,599 | 18,385 | |||
Recognized benefit related to realization of unrecognized tax benefit resulting from expiration of statutes of limitations | 7,191 | 147 | 16,655 | |||
Reduction in amount of unrecognized tax benefits that is reasonably possible due to expirations in statutes of limitations | 3,267 | $ 3,267 | ||||
Period of unrecognized tax benefits reduction that is reasonably possible due to expirations in statutes of limitations | 12 months | |||||
Unrecognized tax benefits, which would, if recognized, affect the annual effective tax rate | 28,444 | $ 28,444 | ||||
Interest and penalties classified as income tax expense (benefit) in the Consolidated Statement of Income | 81 | 933 | (5,206) | |||
Interest and penalties accrued related to unrecognized tax benefits | 6,303 | $ 5,865 | 6,303 | 5,865 | ||
Charged to other accounts | ||||||
Additional Income Tax Information [Line Items] | ||||||
Net increase (decrease) in the total valuation allowance, including foreign currency fluctuations | (36,421) | 97,024 | 1,341 | |||
Foreign Tax Authority | ||||||
Additional Income Tax Information [Line Items] | ||||||
Net operating loss carryforwards, approximately, for foreign jurisdictions | 1,912,611 | 1,912,611 | ||||
Foreign Tax Authority | Operating loss carryforward | ||||||
Additional Income Tax Information [Line Items] | ||||||
Valuation allowance for deferred tax assets | 306,743 | 306,743 | ||||
Net increase (decrease) in the total valuation allowance, including foreign currency fluctuations | 24,172 | |||||
Foreign Tax Authority | Other foreign deferred tax assets | ||||||
Additional Income Tax Information [Line Items] | ||||||
Valuation allowance for deferred tax assets | 21,232 | 21,232 | ||||
Net increase (decrease) in the total valuation allowance, including foreign currency fluctuations | 9,166 | |||||
Federal | ||||||
Additional Income Tax Information [Line Items] | ||||||
Tax credit carryforwards | 10,859 | 10,859 | ||||
Federal interest carryforwards | 209,536 | 209,536 | ||||
Net operating loss carryforwards | 173,305 | 173,305 | ||||
State | ||||||
Additional Income Tax Information [Line Items] | ||||||
State interest carryforwards | 151,718 | 151,718 | ||||
Net operating loss carryforwards | 1,018,011 | 1,018,011 | ||||
Federal and State | Operating loss carryforward | ||||||
Additional Income Tax Information [Line Items] | ||||||
Valuation allowance for deferred tax assets | 63,619 | 63,619 | ||||
Net increase (decrease) in the total valuation allowance, including foreign currency fluctuations | 52,035 | |||||
Federal and State | Other Federal and State Deferred Tax Assets [Member] | ||||||
Additional Income Tax Information [Line Items] | ||||||
Valuation allowance for deferred tax assets | 234,946 | 234,946 | ||||
Net increase (decrease) in the total valuation allowance, including foreign currency fluctuations | 234,946 | |||||
Switzerland and Luxembourg | ||||||
Additional Income Tax Information [Line Items] | ||||||
Net operating loss carryforwards, approximately, for foreign jurisdictions | $ 696,028 | $ 696,028 | ||||
One-time provisional transition | Tax Cuts and Jobs Act | ||||||
Additional Income Tax Information [Line Items] | ||||||
Income tax expense (benefit) | $ (4,668) | (38,315) | ||||
Recapture of statutory impairment net operating losses | ||||||
Additional Income Tax Information [Line Items] | ||||||
Income tax expense (benefit) | $ (49,082) |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Disclosure Commitments And Contingencies Additional Information [Abstract] | |||
Purchase commitments due in 2022 | $ 403,316 | ||
Purchase commitments due in 2023 | 6,219 | ||
Purchase commitments due in 2024 | 6,840 | ||
Royalty expense | 103,204 | $ 100,281 | $ 72,775 |
Minimum amounts due under license agreements, 2022 | 66,215 | ||
Minimum amounts due under license agreements, 2023 | 49,117 | ||
Minimum amounts due under license agreements, 2024 | 29,190 | ||
Minimum amounts due under license agreements, 2025 | 26,190 | ||
Minimum amounts due under license agreements, 2026 | 18,379 | ||
Minimum amounts under license agreements due thereafter | $ 44,498 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||||||||
Dec. 13, 2022 | Sep. 14, 2022 | May 31, 2022 | Mar. 08, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | Feb. 02, 2022 | Feb. 06, 2020 | |
Class of Stock [Line Items] | |||||||||
Common stock, shares authorized | 2,000,000,000 | 2,000,000,000 | |||||||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||||||
Common stock, shares issued | 349,009,147 | 349,903,253 | |||||||
Common stock, shares outstanding | 349,009,147 | 349,903,253 | |||||||
Preferred stock, shares authorized | 50,000,000 | 50,000,000 | |||||||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||||||
Preferred stock, shares issued | 0 | 0 | |||||||
Preferred stock, shares outstanding | 0 | 0 | |||||||
Common stock repurchased, Cost | $ 25,018 | $ 200,269 | |||||||
Quarterly dividends declared, common stock, per share | $ 0.15 | $ 0.15 | |||||||
Quarterly dividends paid, common stock, per share | $ 0.15 | $ 0.15 | $ 0.15 | $ 0.15 | $ 0.15 | $ 0.15 | |||
2020 Share Repurchase Plan | |||||||||
Class of Stock [Line Items] | |||||||||
Repurchase of common stock, Authority granted | 40,000,000 | ||||||||
Common Stock, Repurchased | 14,464,000 | ||||||||
Shares Acquired Weighted Average Cost Per Share | $ 13.83 | ||||||||
Common stock repurchased, Cost | $ 200,269 | ||||||||
2022 Share Repurchase Plan | |||||||||
Class of Stock [Line Items] | |||||||||
Common Stock, Repurchased | 1,577,000 | ||||||||
Shares Acquired Weighted Average Cost Per Share | $ 15.84 | ||||||||
Common stock repurchased, Cost | $ 25,018 | ||||||||
Share Repurchase Program, Authorized Amount | $ 600,000 | ||||||||
Payments for Stock Repurchased, Broker's Commissions | 31 | ||||||||
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $ 575,013 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Loss - Rollforward (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning Balance, net of tax | $ (551,603) | ||
Total other comprehensive income (loss), net of tax | 39,595 | $ 15,356 | $ 50,689 |
Ending Balance, net of tax | (512,008) | (551,603) | |
Cumulative Translation Adjustment | |||
Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Beginning Balance, before tax | (134,001) | (52,820) | |
Amounts reclassified from accumulated other comprehensive loss, before tax | (13,473) | 0 | |
Current-period other comprehensive income (loss) activity, before tax | (81,329) | (81,181) | |
Total other comprehensive income (loss), before tax | (94,802) | (81,181) | |
Ending Balance, before tax | (228,803) | (134,001) | (52,820) |
Cash Flow Hedges | |||
Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Beginning Balance, before tax | 5,244 | (26,538) | |
Amounts reclassified from accumulated other comprehensive loss, before tax | 14,927 | 34,554 | |
Current-period other comprehensive income (loss) activity, before tax | (11,462) | (2,772) | |
Total other comprehensive income (loss), before tax | 3,465 | 31,782 | |
Ending Balance, before tax | 8,709 | 5,244 | (26,538) |
Defined Benefit Plans | |||
Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward] | |||
Beginning Balance, before tax | (569,161) | (668,730) | |
Amounts reclassified from accumulated other comprehensive loss, before tax | 21,224 | 25,011 | |
Current-period other comprehensive income (loss) activity, before tax | 110,584 | 74,558 | |
Total other comprehensive income (loss), before tax | 131,808 | 99,569 | |
Ending Balance, before tax | (437,353) | (569,161) | (668,730) |
Income Taxes | |||
Accumulated Other Comprehensive Income (Loss), Tax [Roll Forward] | |||
Beginning Balance, tax | 146,315 | 181,129 | |
Amounts reclassified from accumulated other comprehensive loss, tax | 3,319 | (15,179) | |
Current-period other comprehensive income (loss) activity, tax | (4,195) | (19,635) | |
Total other comprehensive income (loss), tax | (876) | (34,814) | |
Ending Balance, tax | 145,439 | 146,315 | 181,129 |
Accumulated Other Comprehensive Loss | |||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
Beginning Balance, net of tax | (551,603) | (566,959) | |
Amounts reclassified from accumulated other comprehensive loss, net of tax | 25,997 | 44,386 | |
Current-period other comprehensive income (loss) activity, net of tax | 13,598 | (29,030) | |
Total other comprehensive income (loss), net of tax | 39,595 | 15,356 | 50,689 |
Ending Balance, net of tax | $ (512,008) | $ (551,603) | $ (566,959) |
Accumulated Other Comprehensi_4
Accumulated Other Comprehensive Loss - Reclassifications (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Cost of sales | $ 971,309 | $ 1,084,621 | $ 4,012,542 | $ 4,149,541 | $ 4,524,461 |
Selling, general and administrative expenses | 441,642 | 512,162 | 1,701,563 | 1,853,971 | 1,560,034 |
Interest expense, net | 49,665 | 35,307 | 157,073 | 163,067 | 164,238 |
Other expenses | 3,646 | 47,359 | 9,734 | 53,586 | 20,655 |
Income tax expense (benefit) | (425,132) | (4,946) | (483,907) | (60,107) | 109,940 |
Income (loss) from discontinued operations, net of tax | 0 | (7,921) | 3,965 | (443,744) | (43,292) |
Net income (loss) | $ (418,108) | $ 60,033 | (127,204) | 77,224 | (75,579) |
Reclassification out of Accumulated Other Comprehensive Income | |||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Net income (loss) | (25,997) | (44,386) | (5,674) | ||
Reclassification out of Accumulated Other Comprehensive Income | Amortization of deferred actuarial loss and prior service cost | |||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Other expenses | (20,809) | (25,671) | (22,261) | ||
Income tax expense (benefit) | 52 | 6,461 | 5,753 | ||
Income (loss) from discontinued operations, net of tax | 0 | 560 | (698) | ||
Net income (loss) | (21,217) | (18,650) | (17,206) | ||
Reclassification out of Accumulated Other Comprehensive Income | Cumulative Translation Adjustment | |||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Income (loss) from discontinued operations, net of tax | 13,473 | 0 | 0 | ||
Reclassification out of Accumulated Other Comprehensive Income | Pension Activity Associated with Sale of Business | |||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Income (loss) from discontinued operations, net of tax | (460) | 0 | 0 | ||
Forward foreign exchange contract | Reclassification out of Accumulated Other Comprehensive Income | Gain (loss) on derivative instruments designated as cash flow hedges | |||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Cost of sales | 11,336 | (15,301) | 10,069 | ||
Income tax expense (benefit) | (3,401) | 4,105 | (2,851) | ||
Income (loss) from discontinued operations, net of tax | (232) | (2,890) | 4,314 | ||
Net income (loss) | 7,703 | (14,086) | 11,532 | ||
Cross-currency swap contract | Reclassification out of Accumulated Other Comprehensive Income | Gain (loss) on derivative instruments designated as cash flow hedges | |||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | |||||
Selling, general and administrative expenses | (20,016) | (12,155) | 0 | ||
Interest expense, net | (5,940) | (3,556) | 0 | ||
Income tax expense (benefit) | 0 | 4,061 | 0 | ||
Net income (loss) | $ (25,956) | $ (11,650) | $ 0 |
Financial Instruments and Ris_3
Financial Instruments and Risk Management - Notional Amounts of Derivative Instruments (Details) € in Thousands, $ in Thousands | Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Jan. 01, 2022 USD ($) | Jan. 01, 2022 EUR (€) | Apr. 01, 2021 EUR (€) | Jan. 02, 2021 EUR (€) | Jul. 10, 2019 EUR (€) |
Forward foreign exchange contract | Cash Flow and Mark to Market Hedges | |||||||
Derivative [Line Items] | |||||||
Derivative, Notional Amount | $ 397,908 | $ 308,071 | |||||
Cross-currency swap contract | Cash Flow Hedge | |||||||
Derivative [Line Items] | |||||||
Derivative, Notional Amount | 352,920 | € 300,000 | 352,920 | € 300,000 | |||
Cross-currency swap contract | Net Investment Hedging | |||||||
Derivative [Line Items] | |||||||
Derivative, Notional Amount | $ 335,940 | € 300,000 | $ 335,940 | € 300,000 | € 300,000 | € 300,000 |
Financial Instruments and Ris_4
Financial Instruments and Risk Management - Fair Values of Derivative Instruments (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Derivatives, Fair Value [Line Items] | ||
Net fair value of derivative assets and liabilities | $ (9,373) | $ (930) |
Assets, Total | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative assets | 24,914 | 11,373 |
Liabilities, Total | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative liabilities | (34,287) | (12,303) |
Forward foreign exchange contract | Other Current Assets | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative assets | 1,892 | 2,898 |
Forward foreign exchange contract | Other Current Assets | Derivatives not designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative assets | 5,402 | 5,439 |
Forward foreign exchange contract | Other noncurrent assets | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative assets | 110 | 83 |
Forward foreign exchange contract | Accrued liabilities | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative liabilities | (1,263) | (349) |
Forward foreign exchange contract | Accrued liabilities | Derivatives not designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative liabilities | (4,841) | (331) |
Forward foreign exchange contract | Other noncurrent liabilities | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative liabilities | (178) | (14) |
Cross-currency swap contract | Other Current Assets | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative assets | 1,033 | 974 |
Cross-currency swap contract | Other noncurrent assets | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative assets | 16,477 | 1,979 |
Cross-currency swap contract | Accrued liabilities | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative liabilities | (252) | (222) |
Cross-currency swap contract | Other noncurrent liabilities | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Total derivative liabilities | $ (27,753) | $ (11,387) |
Financial Instruments and Ris_5
Financial Instruments and Risk Management - Effect of Cash Flow Hedge Derivative Instruments (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Reclassified from AOCI into Income on Cash Flow Hedges | $ (14,927) | $ (34,554) | $ 15,681 | ||
Cost of sales | $ 971,309 | $ 1,084,621 | 4,012,542 | 4,149,541 | 4,524,461 |
Selling, general and administrative expenses | 441,642 | 512,162 | 1,701,563 | 1,853,971 | 1,560,034 |
Interest expense, net | 49,665 | 35,307 | 157,073 | 163,067 | 164,238 |
Income (loss) from discontinued operations, net of tax | $ 0 | $ (7,921) | 3,965 | (443,744) | (43,292) |
Accumulated Other Comprehensive Loss | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Cash Flow Hedges | (11,462) | (2,772) | (15,643) | ||
Forward foreign exchange contract | Accumulated Other Comprehensive Loss | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Cash Flow Hedges | 10,843 | 12,170 | (15,643) | ||
Forward foreign exchange contract | Cost of sales | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Reclassified from AOCI into Income on Cash Flow Hedges | 11,336 | (15,301) | 10,069 | ||
Forward foreign exchange contract | Income (loss) from discontinued operations, net of tax | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Reclassified from AOCI into Income on Cash Flow Hedges | (307) | (3,542) | 5,612 | ||
Cross-currency swap contract | Accumulated Other Comprehensive Loss | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Cash Flow Hedges | (22,305) | (14,942) | 0 | ||
Cross-currency swap contract | Selling, general and administrative expenses | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Reclassified from AOCI into Income on Cash Flow Hedges | (20,016) | (12,155) | 0 | ||
Cross-currency swap contract | Interest expense, net | |||||
Derivatives, Fair Value [Line Items] | |||||
Amount of Gain (Loss) Reclassified from AOCI into Income on Cash Flow Hedges | $ (5,940) | $ (3,556) | $ 0 |
Financial Instruments and Ris_6
Financial Instruments and Risk Management - Effect of Net Investment Hedge Instruments (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Net Investment Hedges | $ (7,485) | $ 7,389 | $ 7,637 | ||
Interest expense, net | $ 49,665 | $ 35,307 | 157,073 | 163,067 | 164,238 |
Income (loss) from discontinued operations, net of tax | $ 0 | $ (7,921) | 3,965 | (443,744) | (43,292) |
Euro-denominated Long-term Debt | Income (loss) from discontinued operations, net of tax | |||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||
Nonderivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net | (13,348) | 0 | 0 | ||
Cross-currency swap contract | |||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||
Amount of Gain (Loss) Recognized in Income on Net Investment Hedges | 8,368 | 7,389 | 7,637 | ||
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net | (2,505) | 0 | 0 | ||
Accumulated Other Comprehensive Loss | |||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Net Investment Hedges | 24,213 | 38,598 | (51,013) | ||
Accumulated Other Comprehensive Loss | Euro-denominated Long-term Debt | |||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Net Investment Hedges | 9,716 | 24,928 | (36,609) | ||
Accumulated Other Comprehensive Loss | Cross-currency swap contract | |||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||
Amount of Gain (Loss) Recognized in AOCI on Net Investment Hedges | $ 14,497 | $ 13,670 | $ (14,404) |
Financial Instruments and Ris_7
Financial Instruments and Risk Management - Effect of Mark to Market Hedge Derivative Instruments (Details) - Forward foreign exchange contract - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Amount of Gain (Loss) Recognized in Income on Mark to Market Hedges | $ (16,847) | $ 31,577 | $ (21,899) |
Cost of sales | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Amount of Gain (Loss) Recognized in Income on Mark to Market Hedges | (16,557) | 24,087 | (16,163) |
Selling, general and administrative expenses | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Amount of Gain (Loss) Recognized in Income on Mark to Market Hedges | (290) | 2,784 | (2,029) |
Income (loss) from discontinued operations, net of tax | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Amount of Gain (Loss) Recognized in Income on Mark to Market Hedges | $ 0 | $ 4,706 | $ (3,707) |
Financial Instruments and Ris_8
Financial Instruments and Risk Management - Additional Information (Details) € in Thousands, $ in Thousands | 12 Months Ended | ||||||||
Apr. 01, 2021 EUR (€) numberOfCrossCurrencySwaps | Jul. 10, 2019 EUR (€) numberOfCrossCurrencySwaps | Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Jan. 01, 2022 EUR (€) | Dec. 31, 2022 EUR (€) | Jan. 01, 2022 USD ($) | Jan. 01, 2022 EUR (€) | Jan. 02, 2021 EUR (€) | |
Derivative [Line Items] | |||||||||
Net gain (loss) expected to be reclassified into earnings during the next twelve months | $ (1,457) | ||||||||
Long-term debt, gross | 3,872,275 | $ 3,368,634 | |||||||
3.5% Senior Notes | |||||||||
Derivative [Line Items] | |||||||||
Long-term debt, gross | $ 535,275 | 568,634 | |||||||
Interest rate on senior notes issued | 3.50% | 3.50% | 3.50% | ||||||
3.5% Senior Notes, Euro Value | |||||||||
Derivative [Line Items] | |||||||||
Long-term debt, gross | € | € 500,000 | € 500,000 | |||||||
4.625% Senior Notes | |||||||||
Derivative [Line Items] | |||||||||
Long-term debt, gross | $ 900,000 | 900,000 | |||||||
Interest rate on senior notes issued | 4.625% | 4.63% | 4.63% | ||||||
Euro-denominated Long-term Debt | Net Investment Hedging | |||||||||
Derivative [Line Items] | |||||||||
Notional amount of nonderivative instruments designated in a net investment hedge | € | € 200,000 | € 500,000 | € 200,000 | € 200,000 | |||||
Euro-denominated long-term debt designated as a partial European net investment hedge | $ 214,110 | 227,454 | |||||||
Forward foreign exchange contract | |||||||||
Derivative [Line Items] | |||||||||
Maximum Length of Time Hedged in Cash Flow Hedge | 14 months | 14 months | |||||||
Cross-currency swap contract | |||||||||
Derivative [Line Items] | |||||||||
Maximum Length of Time Hedged in Cash Flow Hedge | 18 months | 18 months | |||||||
Cross-currency swap contract | Cash Flow Hedge | |||||||||
Derivative [Line Items] | |||||||||
Number of cross currency swaps | numberOfCrossCurrencySwaps | 3 | ||||||||
Notional amount of derivative instruments designated in a net investment hedge | € 300,000 | $ 352,920 | € 300,000 | 352,920 | |||||
Cross-currency swap contract - fixed interest rate | 4.7945% | ||||||||
Cross-currency swap contract | Net Investment Hedging | |||||||||
Derivative [Line Items] | |||||||||
Number of cross currency swaps | numberOfCrossCurrencySwaps | 2 | ||||||||
Notional amount of derivative instruments designated in a net investment hedge | € 300,000 | $ 335,940 | € 300,000 | $ 335,940 | € 300,000 | € 300,000 | |||
Cross-currency swap contract - fixed interest rate | 2.3215% |
Fair Value of Assets and Liab_3
Fair Value of Assets and Liabilities - Fair Value of Financial Assets and Liabilities Measured on Recurring Basis (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | $ 816,244 | $ 973,598 | $ 920,316 |
Net fair value of derivative assets and liabilities | (9,373) | (930) | |
Fair Value, Measurements, Recurring | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 284,875 | 273,932 | |
Deferred compensation plan liability | (16,096) | (20,916) | |
Net effect of financial asset less financial liability | 790,775 | 951,752 | |
Fair Value, Measurements, Recurring | U.S. Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 158,305 | 201,111 | |
Fair Value, Measurements, Recurring | Foreign Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 33,713 | 47,099 | |
Fair Value, Measurements, Recurring | Debt Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 81,812 | 24,125 | |
Fair Value, Measurements, Recurring | Cash and Other | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 11,045 | 1,597 | |
Fair Value, Measurements, Recurring | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Net fair value of derivative assets and liabilities | (9,373) | (930) | |
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1) | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 284,875 | 273,932 | |
Deferred compensation plan liability | 0 | 0 | |
Net effect of financial asset less financial liability | 284,875 | 273,932 | |
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1) | U.S. Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 158,305 | 201,111 | |
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1) | Foreign Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 33,713 | 47,099 | |
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1) | Debt Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 81,812 | 24,125 | |
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1) | Cash and Other | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 11,045 | 1,597 | |
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Net fair value of derivative assets and liabilities | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Deferred compensation plan liability | (16,096) | (20,916) | |
Net effect of financial asset less financial liability | (25,469) | (21,846) | |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | U.S. Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Foreign Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Debt Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Cash and Other | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Net fair value of derivative assets and liabilities | (9,373) | (930) | |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Deferred compensation plan liability | 0 | 0 | |
Net effect of financial asset less financial liability | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | U.S. Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Foreign Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Debt Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Cash and Other | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 0 | 0 | |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Net fair value of derivative assets and liabilities | 0 | 0 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 531,369 | 699,666 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Hedge Fund of Funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 313,521 | 356,289 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Foreign Equity Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 135,076 | 170,741 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Debt Securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 670 | 87,284 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Real Estate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 65,364 | 57,479 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Commodities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Defined benefit pension plan investment assets | 16,738 | 27,873 | |
Fair Value, Measurements, Recurring | Forward foreign exchange contract | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 7,404 | 8,420 | |
Total derivative liabilities | (6,282) | (694) | |
Fair Value, Measurements, Recurring | Forward foreign exchange contract | Quoted Prices In Active Markets for Identical Assets (Level 1) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 0 | 0 | |
Total derivative liabilities | 0 | 0 | |
Fair Value, Measurements, Recurring | Forward foreign exchange contract | Significant Other Observable Inputs (Level 2) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 7,404 | 8,420 | |
Total derivative liabilities | (6,282) | (694) | |
Fair Value, Measurements, Recurring | Forward foreign exchange contract | Significant Unobservable Inputs (Level 3) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 0 | 0 | |
Total derivative liabilities | 0 | 0 | |
Fair Value, Measurements, Recurring | Cross-currency swap contract | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 17,510 | 2,953 | |
Total derivative liabilities | (28,005) | (11,609) | |
Fair Value, Measurements, Recurring | Cross-currency swap contract | Quoted Prices In Active Markets for Identical Assets (Level 1) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 0 | 0 | |
Total derivative liabilities | 0 | 0 | |
Fair Value, Measurements, Recurring | Cross-currency swap contract | Significant Other Observable Inputs (Level 2) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 17,510 | 2,953 | |
Total derivative liabilities | (28,005) | (11,609) | |
Fair Value, Measurements, Recurring | Cross-currency swap contract | Significant Unobservable Inputs (Level 3) | Continuing Operations | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total derivative assets | 0 | 0 | |
Total derivative liabilities | $ 0 | $ 0 |
Fair Value of Assets and Liab_4
Fair Value of Assets and Liabilities (Additional Information) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Carrying value of debt | $ 3,872,275 | $ 3,368,634 |
Fair Value, Inputs, Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of debt | $ 3,697,856 | $ 3,504,412 |
Business Segment Information -
Business Segment Information - Net Sales (Detail) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 USD ($) | Jan. 01, 2022 USD ($) | Dec. 31, 2022 USD ($) numberOfSegments | Jan. 01, 2022 USD ($) | Jan. 02, 2021 USD ($) | |
Schedule Of Sales Revenue By Business Segment [Line Items] | |||||
Number of Operating Segments | numberOfSegments | 3 | ||||
Net sales | $ 1,473,286 | $ 1,752,349 | $ 6,233,650 | $ 6,801,240 | $ 6,127,161 |
Innerwear | |||||
Schedule Of Sales Revenue By Business Segment [Line Items] | |||||
Net sales | 2,429,966 | 2,719,788 | 2,978,009 | ||
Activewear | |||||
Schedule Of Sales Revenue By Business Segment [Line Items] | |||||
Net sales | 1,555,062 | 1,679,639 | 1,184,413 | ||
International | |||||
Schedule Of Sales Revenue By Business Segment [Line Items] | |||||
Net sales | 1,914,268 | 2,066,249 | 1,711,432 | ||
Other | |||||
Schedule Of Sales Revenue By Business Segment [Line Items] | |||||
Net sales | $ 334,354 | $ 335,564 | $ 253,307 |
Business Segment Information _2
Business Segment Information - Segment Operating Profit (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Segment operating profit: | |||||
Total operating profit | $ 60,335 | $ 155,566 | $ 519,545 | $ 797,728 | $ 42,666 |
Operating profit | |||||
General corporate expenses | (232,975) | (219,984) | (218,424) | ||
Amortization of intangibles | (29,973) | (31,069) | (30,858) | ||
Other expenses | (3,646) | (47,359) | (9,734) | (53,586) | (20,655) |
Interest expense, net | (49,665) | (35,307) | (157,073) | (163,067) | (164,238) |
Income (loss) from continuing operations before income tax expense | $ 7,024 | $ 72,900 | 352,738 | 581,075 | (142,227) |
Operating profit | |||||
Operating profit | |||||
Restructuring and other action-related charges | (59,858) | (131,710) | (734,196) | ||
Innerwear | |||||
Segment operating profit: | |||||
Total operating profit | 388,586 | 573,852 | 718,923 | ||
Activewear | |||||
Segment operating profit: | |||||
Total operating profit | 153,710 | 236,400 | 67,643 | ||
International | |||||
Segment operating profit: | |||||
Total operating profit | 283,036 | 339,317 | 249,718 | ||
Other | |||||
Segment operating profit: | |||||
Total operating profit | 17,019 | 30,922 | (10,140) | ||
Total segment operating profit | |||||
Segment operating profit: | |||||
Total operating profit | $ 842,351 | $ 1,180,491 | $ 1,026,144 |
Business Segment Information _3
Business Segment Information - Restructuring and Other Action-Related Charges by Income Statement Line (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Cost of sales | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | $ 17,025 | $ 10,098 | $ 670,618 |
Selling, general and administrative expenses | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | 42,833 | 121,612 | 63,578 |
Total included in operating profit | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | 59,858 | 131,710 | 734,196 |
Other expenses | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | 0 | 45,699 | 0 |
Total included in income (loss) from continuing operations before income tax expense | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | 59,858 | 177,409 | 734,196 |
Total included in income tax expense (benefit) | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | (413,766) | 53,665 | 205,342 |
Total restructuring and other action-related charges | |||
Segment Reporting, Other Significant Reconciling Item [Line Items] | |||
Restructuring and other action-related charges | $ 473,624 | $ 123,744 | $ 528,854 |
Business Segment Information _4
Business Segment Information - Components of Restructuring and Other Action-Related Charges (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Oct. 02, 2021 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
COVID-19 related charges | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | $ 49,460 | |||
Total included in operating profit | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | $ 59,858 | $ 131,710 | 734,196 | |
Total included in operating profit | Supply chain actions | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 19,636 | |
Total included in operating profit | Program exit costs | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 9,854 | |
Total included in operating profit | Other restructuring costs | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 7,763 | |
Total included in operating profit | Write-off of acquisition tax asset | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 16,858 | |
Total included in operating profit | Full Potential plan | Professional services | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 23,994 | 44,617 | 0 | |
Total included in operating profit | Full Potential plan | Loss on classification of assets held for sale | U.S. Sheer Hosiery | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | (3,535) | 38,364 | 0 | |
Total included in operating profit | Full Potential plan | Operating model | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | $ 16,000 | 8,221 | 23,191 | 0 |
Total included in operating profit | Full Potential plan | Impairment of intangible assets | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 7,302 | 0 | |
Total included in operating profit | Full Potential plan | Supply chain segmentation | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 17,982 | 5,419 | 0 | |
Total included in operating profit | Full Potential plan | Technology | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 11,922 | 4,617 | 0 | |
Total included in operating profit | Full Potential plan | Other | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 1,274 | 8,200 | 0 | |
Total included in operating profit | Full Potential plan | Inventory SKU rationalization | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 192,704 | |
Total included in operating profit | Full Potential plan | PPE inventory write-off | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 362,913 | |
Total included in operating profit | Full Potential plan | PPE vendor commitments | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 26,400 | |
Total included in operating profit | COVID-19 related charges | Supply chain re-startup charges | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 48,608 | |
Total included in operating profit | COVID-19 related charges | Bad debt charges | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 9,418 | |
Total included in operating profit | COVID-19 related charges | Inventory | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 14,869 | |
Total included in operating profit | COVID-19 related charges | Goodwill | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 25,173 | |
Early extinguishment and refinancing of debt included in other expenses | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 45,699 | 0 | |
Total included in income (loss) from continuing operations before income tax expense | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 59,858 | 177,409 | 734,196 | |
Total included in income tax expense (benefit) | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | (413,766) | 53,665 | 205,342 | |
Total included in income tax expense (benefit) | Discrete tax benefits | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | (422,918) | 27,147 | 69,628 | |
Total included in income tax expense (benefit) | Tax effect on actions | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 9,152 | 26,518 | 135,714 | |
Total restructuring and other action-related charges | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 473,624 | 123,744 | 528,854 | |
Cost of sales | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 17,025 | 10,098 | 670,618 | |
Selling, general and administrative expenses | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | $ 42,833 | $ 121,612 | $ 63,578 |
Business Segment Information _5
Business Segment Information - Restructuring and Other Action-Related Charges - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Oct. 02, 2021 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Employee termination and other benefits | $ 16,770 | |||
Employee termination and other benefits paid | 16,288 | |||
COVID-19 related charges | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | $ 49,460 | |||
Accrued liabilities and other: Other | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Other employee-related liabilities, current | 16,170 | $ 15,688 | ||
Total included in operating profit | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 59,858 | 131,710 | 734,196 | |
Total included in operating profit | Loss on classification of assets held for sale | Full Potential plan | U.S. Sheer Hosiery | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | (3,535) | 38,364 | 0 | |
Total included in operating profit | Operating model | Full Potential plan | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | $ 16,000 | 8,221 | 23,191 | 0 |
Total included in operating profit | PPE inventory write-off | Full Potential plan | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 362,913 | |
Total included in operating profit | PPE vendor commitments | Full Potential plan | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 26,400 | |
Total included in operating profit | Inventory SKU rationalization | Full Potential plan | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 192,704 | |
Total included in operating profit | Supply chain re-startup charges | COVID-19 related charges | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 0 | 48,608 | |
Selling, general and administrative expenses | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 42,833 | 121,612 | 63,578 | |
Employee termination and other benefits | 9,600 | |||
Impairment of intangible assets, Continuing Operations | 7,302 | |||
Other expenses | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 45,699 | 0 | |
Other expenses | Redemption of 5.375% Senior Notes and Refinancing of Senior Secured Credit Facility | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 0 | 45,699 | 0 | |
Make-whole premium | 34,840 | |||
Write-off of unamortized debt issuance costs | 8,899 | |||
Debt issuance costs expensed | 1,960 | |||
Cost of sales | ||||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||||
Restructuring and other action-related charges | 17,025 | $ 10,098 | $ 670,618 | |
Employee termination and other benefits | $ 7,170 |
Business Segment Information _6
Business Segment Information - Assets (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Jan. 01, 2022 |
Assets: | ||
Inventories | $ 1,979,672 | $ 1,584,015 |
Assets held for sale | 13,327 | 327,157 |
All other assets | 4,510,877 | 5,160,264 |
Total assets | 6,503,876 | 7,071,436 |
Innerwear | ||
Assets: | ||
Inventories | 918,104 | 829,093 |
Activewear | ||
Assets: | ||
Inventories | 665,500 | 447,297 |
International | ||
Assets: | ||
Inventories | 364,231 | 279,379 |
Other | ||
Assets: | ||
Inventories | 31,837 | 28,246 |
Unallocated | ||
Assets: | ||
Inventories | 0 | 0 |
Assets held for sale | 13,327 | 327,157 |
All other assets | $ 4,510,877 | $ 5,160,264 |
Business Segment Information _7
Business Segment Information - Depreciation and Amortization Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Depreciation and amortization expense: | |||
Depreciation and amortization expense | $ 106,267 | $ 110,130 | $ 114,967 |
Innerwear | |||
Depreciation and amortization expense: | |||
Depreciation and amortization expense | 26,518 | 25,816 | 27,407 |
Activewear | |||
Depreciation and amortization expense: | |||
Depreciation and amortization expense | 24,200 | 23,562 | 23,621 |
International | |||
Depreciation and amortization expense: | |||
Depreciation and amortization expense | 19,670 | 22,476 | 24,307 |
Other | |||
Depreciation and amortization expense: | |||
Depreciation and amortization expense | 3,341 | 4,578 | 5,520 |
Operating Segments | |||
Depreciation and amortization expense: | |||
Depreciation and amortization expense | 73,729 | 76,432 | 80,855 |
Corporate | |||
Depreciation and amortization expense: | |||
Depreciation and amortization expense | $ 32,538 | $ 33,698 | $ 34,112 |
Business Segment Information _8
Business Segment Information - Additional Revenue Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Revenue from External Customer [Line Items] | |||||
Worldwide sales by product category | $ 1,473,286 | $ 1,752,349 | $ 6,233,650 | $ 6,801,240 | $ 6,127,161 |
Innerwear Product Category | |||||
Revenue from External Customer [Line Items] | |||||
Worldwide sales by product category | 3,749,168 | 4,077,016 | 4,061,372 | ||
Activewear Product Category | |||||
Revenue from External Customer [Line Items] | |||||
Worldwide sales by product category | $ 2,484,482 | $ 2,724,224 | $ 2,065,789 | ||
Wal-Mart | Revenue Benchmark | Customer Concentration Risk | |||||
Revenue from External Customer [Line Items] | |||||
External customer's percentage of total sales | 16% | 17% | 16% |
Geographic Area Information - S
Geographic Area Information - Sales and Long Lived Assets by Geographical Area (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Net sales | $ 1,473,286 | $ 1,752,349 | $ 6,233,650 | $ 6,801,240 | $ 6,127,161 |
Property, net | 442,404 | 441,401 | 442,404 | 441,401 | 477,821 |
Americas | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Net sales | 4,532,595 | 4,995,230 | 4,544,651 | ||
Property, net | 325,957 | 325,188 | 325,957 | 325,188 | 351,841 |
Asia Pacific | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Net sales | 1,149,954 | 1,257,037 | 1,085,822 | ||
Property, net | 85,966 | 85,538 | 85,966 | 85,538 | 92,582 |
Europe | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Net sales | 534,892 | 530,440 | 482,630 | ||
Property, net | 30,481 | 30,675 | 30,481 | 30,675 | 33,398 |
Other | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Net sales | 16,209 | 18,533 | 14,058 | ||
Property, net | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |
Quarterly Financial Data - Quar
Quarterly Financial Data - Quarterly Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Dec. 31, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | Jan. 02, 2021 | |
Income Statement [Abstract] | |||||
Net sales | $ 1,473,286 | $ 1,752,349 | $ 6,233,650 | $ 6,801,240 | $ 6,127,161 |
Cost of sales | 971,309 | 1,084,621 | 4,012,542 | 4,149,541 | 4,524,461 |
Gross profit | 501,977 | 667,728 | 2,221,108 | 2,651,699 | 1,602,700 |
Selling, general and administrative expenses | 441,642 | 512,162 | 1,701,563 | 1,853,971 | 1,560,034 |
Operating profit | 60,335 | 155,566 | 519,545 | 797,728 | 42,666 |
Other expenses | 3,646 | 47,359 | 9,734 | 53,586 | 20,655 |
Interest expense, net | 49,665 | 35,307 | 157,073 | 163,067 | 164,238 |
Income (loss) from continuing operations before income tax expense | 7,024 | 72,900 | 352,738 | 581,075 | (142,227) |
Income tax expense (benefit) | 425,132 | 4,946 | 483,907 | 60,107 | (109,940) |
Income (loss) from continuing operations | (418,108) | 67,954 | (131,169) | 520,968 | (32,287) |
Income (loss) from discontinued operations, net of tax | 0 | (7,921) | 3,965 | (443,744) | (43,292) |
Net income (loss) | $ (418,108) | $ 60,033 | $ (127,204) | $ 77,224 | $ (75,579) |
Earnings (loss) per share - basic: | |||||
Continuing operations | $ (1.19) | $ 0.19 | $ (0.37) | $ 1.48 | $ (0.09) |
Discontinued operations | 0 | (0.02) | 0.01 | (1.26) | (0.12) |
Net income (loss) | (1.19) | 0.17 | (0.36) | 0.22 | (0.21) |
Earnings (loss) per share - diluted: | |||||
Continuing operations | (1.19) | 0.19 | (0.37) | 1.48 | (0.09) |
Discontinued operations | 0 | (0.02) | 0.01 | (1.26) | (0.12) |
Net income (loss) | $ (1.19) | $ 0.17 | $ (0.36) | $ 0.22 | $ (0.21) |